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Preface
Obesity and diabetes have become “Health Bomb”, which attack every city in the world,
and no country or area are put at exception. Bariatric surgery has been proved to be clinical‐
ly effective and economically viable for obese people when compared to non-surgical inter‐
ventions. Advancement of minimally invasive surgery in the last 20 years has made the
safety and reliability widely accepted by the public and government systems. Bariatric sur‐
gery not only proves its efficacy in marked long-term weight loss, but also aids in achieving
substantial improvement or remission of co-morbidities, attributed to metabolic derange‐
ment, including type 2 diabetes mellitus (T2DM), hypertension, hyperlipidemia, and ob‐
structive sleep apnea. It also has been proved to reduce long-term mortality and cancer
occurrence in morbidly obese patients. Nowadays it is progressing towards the so-called
“metabolic surgery,” which performs similar surgery in lower body weight to benefit pa‐
tients with metabolic derangement, particularly T2DM and also teenagers, although some
controversies still exist. In this book, we review the fundamental knowledge of bariatric sur‐
gery, including preoperative nutrition, selection, and surgical complication. In the second
part, new emerging and novel procedures are thoroughly described and discussed. Unques‐
tionably, this book will offer you essentials as well as the latest concepts of bariatric and
metabolic surgery.
Chih-Kun Huang
Bariatric & Metabolic International (B.M.I) Surgery Center,
E-Da Hospital, Taiwan
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Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/58605
1. Introduction
Bariatric surgery has undergone a revolution since its inception in the 1960’s. Great strides
have been made in technique, safety and outcomes within the past decade and in the face of
the advent of newer procedures. This speaks to a better organization of bariatric surgery as a
specialty, improved training and the unwavering demand and pursuit of excellence. Despite
substantial improvement within the specialty there are a number of comorbid conditions and
preoperative findings revealed that necessitate optimization to obtain the best surgical
outcomes.
The ultimate goal of bariatric surgery should be to achieve, in as safe a manner as possible,
weight loss for the reduction in comorbid conditions and overall long-term effect on mortality
and quality of life. A significant contribution to this task has been a more thorough under‐
standing of obesity-related comorbidities and their effects on patient outcomes with respect
to perioperative morbidity and mortality. The evaluation of different comorbid conditions
through large patient databases has elucidated which comorbid factors contribute towards
perioperative morbidity and mortality.
The goal of this chapter will be to review the preoperative evaluation of patients preparing for
weight loss surgery. An overview of the general concepts will be described, and then a detailed
discussion of the more common comorbid conditions will be presented, along with relevant
points and recent literature to support the recommendations. We will utilize an organ system
approach. The strategy and rationale for the evaluations that are recommended (or not) will
be discussed. Their impact on outcomes will be elucidated for the reader to understand and
use to appropriately assess the patient preparing for surgery. An evidence-based approach
will show us how to maximize our evaluations of these patients. Awareness of these details
© 2014 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Chapter 1
Preoperative Evaluation of Bariatric Surgery Patients
Gurdeep S.  Matharoo, Erika  Renick,
John N.  Afthinos, Tracey  Straker and
Karen E.  Gibbs
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/58605
1. Introduction
Bariatric surgery has undergone a revolution since its inception in the 1960’s. Great strides
have been made in technique, safety and outcomes within the past decade and in the face of
the advent of newer procedures. This speaks to a better organization of bariatric surgery as a
specialty, improved training and the unwavering demand and pursuit of excellence. Despite
substantial improvement within the specialty there are a number of comorbid conditions and
preoperative findings revealed that necessitate optimization to obtain the best surgical
outcomes.
The ultimate goal of bariatric surgery should be to achieve, in as safe a manner as possible,
weight loss for the reduction in comorbid conditions and overall long-term effect on mortality
and quality of life. A significant contribution to this task has been a more thorough under‐
standing of obesity-related comorbidities and their effects on patient outcomes with respect
to perioperative morbidity and mortality. The evaluation of different comorbid conditions
through large patient databases has elucidated which comorbid factors contribute towards
perioperative morbidity and mortality.
The goal of this chapter will be to review the preoperative evaluation of patients preparing for
weight loss surgery. An overview of the general concepts will be described, and then a detailed
discussion of the more common comorbid conditions will be presented, along with relevant
points and recent literature to support the recommendations. We will utilize an organ system
approach. The strategy and rationale for the evaluations that are recommended (or not) will
be discussed. Their impact on outcomes will be elucidated for the reader to understand and
use to appropriately assess the patient preparing for surgery. An evidence-based approach
will show us how to maximize our evaluations of these patients. Awareness of these details
© 2014 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
empowers healthcare providers to choose and counsel patients appropriately in the preoper‐
ative setting.
Weight loss surgery has been shown to have a significant impact on the lives of our patients.
Yet, we still face the issue of effectively evaluating and optimizing these patients in the
preoperative setting to allow them to partake of the benefits that await them on the other side.
The following preoperative evaluations will be addressed in the chapter: indications, cardio‐
vascular, vascular (venous system), pulmonary, endocrine, gastrointestinal, nutritional,
psychological, education, functional status. The significance of the final evaluation by the
anesthesiologist will also be discussed. Irrespective of the procedure chosen (gastric bypass,
gastric bypass, sleeve gastrectomy, duodenal switch), approach used (laparoscopic or open)
the preoperative evaluation is essential to prepare the patient for this major lifestyle change.
2. Indications
In 1991 the National Institutes of Health published a consensus statement regarding weight
loss surgery. Surgery was indicated in patients with a BMI ≥ 40 kg/m2 and in patients with a
BMI between 35 and 40 if they also had comorbidities. Severe sleep apnea, Pickwickian
syndrome, obesity related cardiomyopathy, severe diabetes mellitus and lifestyle limitations
were all considered comorbidities that would allow the patient to pursue surgery [1]. Since
1991 significant strides have been made in the field of weight loss surgery. It has since been
proven to be a method for sustained weight loss and resolution of comorbid conditions. As
the benefits to surgery continually develop, movements to change the indications to allow for
more patients to achieve the benefits of weight loss have been published. In 2009, recommen‐
dations were made to expand the indications to both adolescent (12 – 18 years old) and elderly
(>65 years old) patients [2].
For patients with a BMI ≥ 40 kg/m2, surgery is indicated for ages 19 – 64, even without comorbid
conditions. Adolescents with a BMI ≥ 40 kg/m2 must have prediabetes, diabetes with Hgb
A1c > 9, regardless of therapy or 7-9 on maximal medical therapy, severe hypertension (SBP >
140 and DBP > 90), hyperlipidemia, any degree of sleep apnea or joint pain interfering with
daily life in order to qualify for surgery. Elderly patients with BMI ≥ 40, like adolescents, require
comorbid conditions to qualify for surgery. The presence of diabetes with Hgb A1c > 9,
regardless of therapy or 7-9 on maximal medical therapy, hypertension, hyperlipidemia,
moderate to severe sleep apnea, venous stasis, or severe chronic joint pain would indicate the
need for weight loss surgery.
Patients with a BMI 35 – 39 kg/m2 and aged 19 – 64 should be recommended for surgery as
outlined in the 1991 NIH consensus statement. For adolescents in this BMI range diabetes with
Hgb A1c > 7, refractory severe hypertension or moderate to severe sleep apnea are required to
proceed with surgery. In the elderly population with BMI 35 – 39 kg/m2, diabetes with Hgb
A1c > 9, regardless of therapy or 7-9 on maximal medical therapy, refractory hypertension, and
moderate to severe sleep apnea are all criterion which support proceeding to surgery.
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Around the world, the indications for surgery differ based on the populations and prevalence
of obesity related comorbidities. In Europe, the guidelines allow for surgery in patients with
a BMI ≥40 kg/m2, BMI ≥ 35 kg/m2 with severe comorbidities, BMI 30-35 kg/m2 with diabetes,
in adolescents if BMI ≥ 40 kg/m2 and in the elderly with a favorable risk to benefit profile [3].
In the Asian population, the visceral fat percentage is higher than in Caucasian persons [4].
Asian persons also have a higher risk of developing diabetes mellitus, hypertension and
hyperlipidemia at a lower BMI relative to persons of other ethnicities. These factors support
the guidelines in Asia where surgery is recommended for all patients with a BMI ≥ 35 kg/m2.
Surgery is also considered for patients with a BMI > 30 kg/m2 with diabetes mellitus or
metabolic syndrome and inability to control with lifestyle alterations or medications [5].
3. Cardiovascular
Obesity has a negative effect on cardiovascular health. The presence of obesity increases the
risk for coronary artery disease, heart failure, cardiomyopathy, atrial fibrillation and hyper‐
tension [6]. All of these conditions, if not optimized, can lead to poor surgical outcomes in
bariatric surgery patients.
The approach to perioperative cardiovascular evaluation for non-cardiac surgery has been
extensively studied. The general principle to follow is that intervention is rarely needed in
order to lower risk unless it is indicated irrespective of the perioperative context [7]. There are
clinical predictors which place patients into categories based on risk of perioperative cardiac
events. Major predictors are unstable coronary syndromes, acute or recent myocardial
infarction with ongoing ischemic risk factors, unstable or severe angina, decompensated heart
failure, significant arrhythmias, high-grade atrio-ventricular blocks, certain arrhythmias and
severe valvular disease. Intermediate predictors include mild angina pectoris, previous
myocardial infarctions, compensated or prior heart failure, diabetes mellitus and renal
insufficiency. Minor predictors are advanced age, abnormal ECG, rhythm other than sinus,
low functional capacity, uncontrolled systemic hypertension and previous stroke. The type of
surgery is also associated with cardiac risk. Bariatric surgery is considered an intermediate
risk procedure.
Hypertension is found in 13.8 to 25.7 percent of obese patients [8,9]. In patients with stage
three hypertension, systolic blood pressure ≥180 mm Hg and a diastolic blood pressure ≥
110  mm  Hg,  the  risk  of  proceeding  with  surgery  must  be  evaluated  [7].  Presence  of
hypertension as  a  comorbidity  is  an independent  risk  factor  for  mortality  after  open or
laparoscopic gastric  bypass with an odds ratio of  2.783 [10].  Treatment with beta block‐
ers has been shown to decrease the risk of myocardial infarction and cardiovascular death
in high risk patients [11]. When indicated, beta blockers should be initiated several weeks
prior to surgery and titrated to achieve a resting heart rate of 50 to 60 beats per minute
[12]. As bariatric surgery is an elective procedure, we recommend delaying surgery until
adequate  blood  pressure  control  is  achieved.  Hypertension  should  be  controlled  before
surgery  with  continuation  of  the  preoperative  antihypertensive  treatment  through  the
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perioperative period [7]. Caution is advised when preparing a patient taking clonidine or
beta blockers for surgery, due to known rebound hypertension upon abrupt discontinua‐
tion. These antihypertensive agents may be converted to transdermal or intravenous forms,
respectively, during the time a patient is nil per os (NPO)[11]. Continuation of beta blockers
through the perioperative period is recommended in those patients being treated for angina,
specific  arrhythmias,  hypertension  and  other  American  College  of  Cardiology  (ACC)/
American Heart Association (AHA) Class 1 guideline indications [7].
The myriad of available tests to assess cardiac function can be overwhelming and choosing
which test to order can be confusing. Generally evaluation begins with a 12-lead electrocar‐
diogram (ECG). In bariatric surgery patients ECG abnormalities can uncover predictors of
perioperative and long term cardiovascular risk. ECG is recommended in all patients who
have had a recent episode of chest pain, asymptomatic patients with diabetes mellitus, patients
with prior coronary revascularization, asymptomatic males over 45 years old or females over
55 years old with two or more atherosclerotic risk factors and those patients who have had
prior hospital admissions for cardiac causes [7]. Further evaluation of cardiac function involves
stress testing and coronary angiography. Both methods are geared towards identifying
patients with cardiac ischemia.
Exercise or pharmacological stress testing is recommended in adult patients with intermediate
pretest probability of coronary artery disease based on ECG, those undergoing initial evalua‐
tion for suspected or proven coronary artery disease and patients with a significant change in
clinical status. Exercise testing is also useful to evaluate exercise capacity when subjective
measures are unreliable [7]. Some patients will not tolerate an exercise stress test. In this group
of patients a pharmacological stress test should be considered. Noninvasive cardiac imaging
without the use of pharmacological stressing agents is able to provide visualization of left
ventricular function at rest. Although this test is commonly done during preoperative
evaluations it is not a consistent predictor of perioperative ischemic events. Non-invasive stress
testing, such as a dobutamine stress echocardiogram, is able to predict perioperative cardiac
events by visualizing the amount of myocardium at risk for ischemia [7]. It has been shown,
however, that the accuracy of thallium-201 nuclear cardiac imaging can be diminished in
patients who have a BMI over 30 kg/m2, which is specific to our patient population [13]. There
is mounting evidence that cardiac computed tomography angiogram can be used as a method
to evaluate the coronary vasculature in patients unable to tolerate exercise prior to invasive
imaging procedures [14].
Coronary angiography is the definitive test for intraluminal causes of cardiac ischemia. The
procedure is diagnostic and can also be therapeutic with the usage of balloon angioplasty with
or without stent placement. Coronary angioplasty should be done on patients with suspected
or known coronary artery disease. These patients have a high risk of adverse outcome based
on noninvasive test results, angina unresponsive to adequate medical therapy or unstable
angina [7]. Percutaneous coronary intervention (PCI) does not decrease the risk of periopera‐
tive cardiac events except in those patients in whom PCI is indicated for acute coronary
syndrome. Although the PCI can reduce perioperative cardiac events, one of the major
limitations of treatment is the subsequent delay in surgery due to the direct mechanical effects
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of angioplasty or the required anti platelet therapy. Patients who undergo PCI with balloon
therapy alone should undergo surgery between four and eight weeks after catheterization.
Before four weeks the dilated blood vessels have not fully healed and after eight weeks the
risk of restenosis is high [7].
Cardiac medications after coronary artery stenting present a controversy for the surgeon as
the drugs increase the risk of bleeding during the perioperative period. Stent placement
requires dual anti platelet therapy with clopidogrel and aspirin in the post PCI period to
prevent stent thrombosis. The American College of Cardiology and The American Heart
Association recommend that dual anti platelet treatment is required for at least one month in
patients receiving bare metal stents and for one year with drug eluting stents [7]. In a literature
review currently in press, the authors examined the perioperative management of anti platelet
therapy and they found variability among the recommendations. However, they recommend
delaying surgery for at least four to twelve weeks in patients with bare metal stents. In patients
with drug eluting stents they recommend postponing surgery for at least six to twelve months
[15]. Specific to elective surgery, such as the bariatric population, Katkhouda et al recommends
that patients with bare metal or drug eluting stents should not undergo surgery within the
first year of stent placement. If, as determined by a cardiologist, the patient requires dual
therapy longer than one year after stent placement, clopidogrel and other thienopyridines
should be stopped five to ten days preoperatively and restarted ten days postoperatively [12].
The continuation of aspirin through the perioperative period is recommended [12,15]. In
patients undergoing gastric bypass it is recommended to start proton pump inhibitors one
week preoperatively and subsequently continue them through the perioperative period to
minimize the risk of gastrointestinal bleeding upon restarting clopidogrel therapy [12].
Management of valvular heart disease is dependent on the pathophysiology of the valve.
Patients with symptomatic aortic stenosis should have their surgery delayed and undergo
valve replacement prior to non-cardiac surgery. If the patient has severe stenosis but is
asymptomatic the aortic valve should be evaluated with imaging. Patients unwilling or unable
to undergo cardiac surgery for severe aortic stenosis have a 10% mortality rate from non-
cardiac surgery. With mild or moderate mitral valve stenosis, the heart rate must be controlled
during the perioperative period to minimize pulmonary congestion created by decreased
diastolic filling times. Patients with significant mitral stenosis are at risk for heart failure during
the perioperative period. Operative correction of mitral stenosis is not recommended unless
the valvular condition should be corrected to prolong survival and prevent complications that
are unrelated to the non-cardiac surgery [11].
Congestive heart failure (CHF) has been found to be a significant factor in perioperative cardiac
events. The preoperative evaluation must include screening for CHF which can be done with
history and physical exam alone – look for prior history of heart failure, symptoms of parox‐
ysmal nocturnal dyspnea, presence of an S3 gallop, jugular venous distention, peripheral
edema, bilateral rales on lung auscultation and evidence of pulmonary vascular redistribution
on chest x-ray [11]. The Framingham Heart Study identified obesity as an independent risk
factor for the development of heart failure; with the risk increasing by 5% in men and 7% in
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Exercise or pharmacological stress testing is recommended in adult patients with intermediate
pretest probability of coronary artery disease based on ECG, those undergoing initial evalua‐
tion for suspected or proven coronary artery disease and patients with a significant change in
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of angioplasty or the required anti platelet therapy. Patients who undergo PCI with balloon
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the perioperative period. Operative correction of mitral stenosis is not recommended unless
the valvular condition should be corrected to prolong survival and prevent complications that
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Congestive heart failure (CHF) has been found to be a significant factor in perioperative cardiac
events. The preoperative evaluation must include screening for CHF which can be done with
history and physical exam alone – look for prior history of heart failure, symptoms of parox‐
ysmal nocturnal dyspnea, presence of an S3 gallop, jugular venous distention, peripheral
edema, bilateral rales on lung auscultation and evidence of pulmonary vascular redistribution
on chest x-ray [11]. The Framingham Heart Study identified obesity as an independent risk
factor for the development of heart failure; with the risk increasing by 5% in men and 7% in
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women for every 1 kg/m2 in BMI [16]. The optimal treatment for CHF is determined by
identifying the cause and degree of failure.
Close collaboration with the patient’s cardiologist during the preoperative workup can allow
for a smooth progression through preoperative cardiac testing, while accurately assessing and
optimizing risk factors.
4. Venous
Venous thromboembolic events (VTE) continue to be one of the most significant postoperative
complications after weight loss surgery; the other being staple line leaks and the associated
septic sequelae. Obesity is considered a hypercoagulable state. The odds ratio of VTE is
between 1.97 and 2.39 in those with a BMI greater than 30 kg/m2 [17]. Bariatric surgery has
been also been associated with a hypercoagulable state due to increased levels of clotting
factors during the perioperative period from surgical trauma [18,19]. VTE events are a leading
cause for mortality after bariatric surgery [20]. It is generally recommended that patients
undergoing weight loss surgery receive VTE prophylaxis during the perioperative period.
Postoperative ambulation and lower extremity sequential compression devices are safe and
recommended for all bariatric patients when appropriate. The proper use of chemoprophylaxis
and the preoperative insertion of inferior vena cava (IVC) filters have been controversial.
The identification of deep venous thrombosis is fundamental to preventing further complica‐
tions from clot progression or embolus. The preferred method for evaluation is venous duplex
ultrasound. This study has a sensitivity and specificity of 97% and 94%, respectively, of
diagnosing a proximal lower extremity DVT [21]. Traditionally, many bariatric centers
included this exam as part of the preoperative workup. A five year retrospective review of our
own bariatric patient population revealed that only one of 555 patients (0.2%) was found to
have a DVT on preoperative workup. This patient had a history of a chronic DVT, known prior
to the examination. Our findings coincided with two previous studies which also showed that
no preoperative investigation is needed [22,23]. Based on these finding we do not recommend
routine preoperative venous duplex ultrasound; however, testing may be warranted in
patients with prior history of DVT or significant venous insufficiency.
The preoperative placement of inferior vena cava (IVC) filters has been reported in high risk
bariatric surgery patients. In some institutions, it was routine to have an IVC filter placed in
patients with BMI greater than 55 kg/m2, immobility, venous stasis, pulmonary hypertension,
obesity hypoventilation syndrome, hypercoagulability, and a history of VTE [20]. It was
recommended that patients with BMI greater than 55 kg/m2 undergoing open gastric bypass
undergo placement of IVC filter while those having laparoscopic surgery could forego the filter
placement [24,25]. Recently, however, the routine use of IVC filters has undergone scrutiny.
The Michigan Bariatric Surgery Collaborative (MBSC) published the largest series to date
regarding the efficacy of preoperative IVC filters in gastric bypass patients. They found that
there was no difference in the rates of VTE, serious complications and death or permanent
disability [26]. In the same month, the United States Food and Drug Administration (FDA)
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published an advisory report regarding the use of retrievable IVC filters. They highlighted 921
device related adverse events since 2005. The FDA recommended a judicious approach to
placement and vigilant follow up for prompt removal of IVC filters [27]. This prompted
another study from the MBSC to investigate outcomes in patients treated with IVC filters. They
discovered that patients with IVC filters had worse outcomes than comparable patients
without IVC filters. A significant number of patients with IVC filters were also subjected to
device related complications, such as thrombosis and occlusion, filter migration, contrast
induced nephropathy and incision site infection. They found the rate of DVT and VTE were
significantly higher in patients with IVC filters, odds ratios 2.7 and 3.3, respectively. Further‐
more, there was no difference in the rates of pulmonary embolus between the groups. They
concluded that IVC filters do not reduce the risk of pulmonary embolism in high risk bariatric
surgery patients and that their use should be discouraged in bariatric surgery patients [28].
Chemoprophylaxis is generally achieved with subcutaneous injections of unfractionated
heparin (UFH) or low molecular weight heparin (LMWH). Since patients are most susceptible
to venous stasis during the induction of anesthesia, the first dose of chemoprophylaxis should
be given preoperatively [29]. Our patients receive 5,000 units of unfractionated heparin
administered subcutaneously immediately prior to entering the operating room. All patients
are also treated with bilateral lower extremity sequential compression devices, which are
placed prior to induction of anesthesia. This combination of chemical and mechanical pro‐
phylaxis has been shown to limit the development of deep venous thrombosis and bleeding
complications [22]. Dosages and frequency vary among the different formulations of low
molecular weight heparinoids, as does their method of action. A recent literature review
concluded that there are three “standard regimens” for chemoprophylaxis of VTE – UFH 5000
units 2 – 3 daily, LMWH 30 mg twice daily, 40 mg once daily or weight adjusted LMWH [30].
The authors concluded that there was no difference in the rate of VTE among the different
regimens, but the use of weight adjusted dosing increased the risk of major bleeding.
Patients with a history of heparin induced thrombocytopenia (HIT) type 2 present a unique
challenge in VTE prophylaxis. This population has not been studied in bariatric surgery;
however, VTE prophylaxis in the orthopedic population with HIT type 2 is accomplished by
the use of desirudin administered subcutaneously [31]. More investigation is needed to
recommend this medication usage beyond the specialty of orthopedics.
5. Pulmonary
Obesity related impairment of respiratory function is caused by mechanical restriction of
adequate ventilation. The increased adipose tissue reduces diaphragmatic excursion, chest
wall expansion and oropharyngeal patency. Obesity is also a risk factor for airway disease and
there is a 50% higher incidence of severe asthma in obese patients when compared to normal
controls [32,33].
A  reduction  in  the  expiratory  reserve  volume  (ERV)  is  the  most  commonly  identified
abnormality on spirometry. Both body mass index and body fat distribution contribute to
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own bariatric patient population revealed that only one of 555 patients (0.2%) was found to
have a DVT on preoperative workup. This patient had a history of a chronic DVT, known prior
to the examination. Our findings coincided with two previous studies which also showed that
no preoperative investigation is needed [22,23]. Based on these finding we do not recommend
routine preoperative venous duplex ultrasound; however, testing may be warranted in
patients with prior history of DVT or significant venous insufficiency.
The preoperative placement of inferior vena cava (IVC) filters has been reported in high risk
bariatric surgery patients. In some institutions, it was routine to have an IVC filter placed in
patients with BMI greater than 55 kg/m2, immobility, venous stasis, pulmonary hypertension,
obesity hypoventilation syndrome, hypercoagulability, and a history of VTE [20]. It was
recommended that patients with BMI greater than 55 kg/m2 undergoing open gastric bypass
undergo placement of IVC filter while those having laparoscopic surgery could forego the filter
placement [24,25]. Recently, however, the routine use of IVC filters has undergone scrutiny.
The Michigan Bariatric Surgery Collaborative (MBSC) published the largest series to date
regarding the efficacy of preoperative IVC filters in gastric bypass patients. They found that
there was no difference in the rates of VTE, serious complications and death or permanent
disability [26]. In the same month, the United States Food and Drug Administration (FDA)
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significantly higher in patients with IVC filters, odds ratios 2.7 and 3.3, respectively. Further‐
more, there was no difference in the rates of pulmonary embolus between the groups. They
concluded that IVC filters do not reduce the risk of pulmonary embolism in high risk bariatric
surgery patients and that their use should be discouraged in bariatric surgery patients [28].
Chemoprophylaxis is generally achieved with subcutaneous injections of unfractionated
heparin (UFH) or low molecular weight heparin (LMWH). Since patients are most susceptible
to venous stasis during the induction of anesthesia, the first dose of chemoprophylaxis should
be given preoperatively [29]. Our patients receive 5,000 units of unfractionated heparin
administered subcutaneously immediately prior to entering the operating room. All patients
are also treated with bilateral lower extremity sequential compression devices, which are
placed prior to induction of anesthesia. This combination of chemical and mechanical pro‐
phylaxis has been shown to limit the development of deep venous thrombosis and bleeding
complications [22]. Dosages and frequency vary among the different formulations of low
molecular weight heparinoids, as does their method of action. A recent literature review
concluded that there are three “standard regimens” for chemoprophylaxis of VTE – UFH 5000
units 2 – 3 daily, LMWH 30 mg twice daily, 40 mg once daily or weight adjusted LMWH [30].
The authors concluded that there was no difference in the rate of VTE among the different
regimens, but the use of weight adjusted dosing increased the risk of major bleeding.
Patients with a history of heparin induced thrombocytopenia (HIT) type 2 present a unique
challenge in VTE prophylaxis. This population has not been studied in bariatric surgery;
however, VTE prophylaxis in the orthopedic population with HIT type 2 is accomplished by
the use of desirudin administered subcutaneously [31]. More investigation is needed to
recommend this medication usage beyond the specialty of orthopedics.
5. Pulmonary
Obesity related impairment of respiratory function is caused by mechanical restriction of
adequate ventilation. The increased adipose tissue reduces diaphragmatic excursion, chest
wall expansion and oropharyngeal patency. Obesity is also a risk factor for airway disease and
there is a 50% higher incidence of severe asthma in obese patients when compared to normal
controls [32,33].
A  reduction  in  the  expiratory  reserve  volume  (ERV)  is  the  most  commonly  identified
abnormality on spirometry. Both body mass index and body fat distribution contribute to
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the degree of decrease in ERV. Hamoui et al has shown that in patients undergoing open
duodenal  switch  procedures  there  is  a  relative  risk  of  2.29  to  develop  postoperative
complications for every 10% decrease in percent of predicted value of vital capacity (VC).
They  also  found  that  patients  with  a  VC  of  less  than  80%  of  predicted  have  a  54.5%
prevalence of postoperative complications [34].
The increased rate of complications was also found in laparoscopic bariatric surgery. In 2013,
van Huisstede et al prospectively examined their patients undergoing laparoscopic gastric
bypass and laparoscopic sleeve gastrectomy. Among the 485 patients studied, they found
patients with airflow obstruction (FEV1/FVC < 70%) or airflow reversibility (change in FEV1 >
12%) after administration of a bronchodilator, had an increased risk of postoperative compli‐
cations with an adjusted odds ratio of 2.9 [35]. They recommend spirometry be done routinely
on all patients being evaluated for bariatric surgery. The authors of this chapter follow these
recommendations and routinely evaluate all patients with preoperative pulmonary function
tests.
As pulmonary function tests are often abnormal in obese patients, the causes for abnormality
must be identified and optimized prior to surgery [34]. Smoking is a common entity which
significantly impacts pulmonary function therefore smoking cessation is an essential compo‐
nent of the preoperative assessment. In a study of over 300,000 patients from the Nationwide
Inpatient Sample database smoking was identified as an independent factor associated with
a greater incidence of acute respiratory failure after bariatric surgery [36]. Smoking has also
been shown to be an independent predictor of increased hospital length of stay. Current and
past smokers have been shown to require four and one days longer in the hospital, respectively,
than patients that never smoked [37]. Nicotine, in all forms, is known to have vasoconstrictor
properties. This may add to the microvascular disease caused by smoking which has been
reported to increase the incidence of marginal ulceration and gastrointestinal anastomotic
dehiscence [38,39]. It is our recommendation to not offer surgery to patients who are current
smokers and to those using a nicotine replacement in an attempt to quit smoking. It is our
practice to require smoking cessation to minimize the above mentioned morbidities.
Obstructive sleep apnea (OSA) is a condition in which the upper airway periodically becomes
narrowed or obstructed during sleep and results in reduction or cessation of breathing during
sleep. The reduction in airway caliber is due to the sleep induced loss of muscle tone in the
soft tissues of the oropharyngeal airway. Obstructive sleep apnea is found in 38 – 88% of
morbidly obese patients [40]. There are many screening tools available to the bariatric surgeon
to identify patients at risk for having OSA. The Epworth Sleepiness Score, the Maintenance of
Wakefulness Test, the Berlin Questionnaire and the STOP-BANG Questionnaire are designed
to quickly asses if a patient should be screened further. The definitive diagnosis of OSA is made
with an overnight polysomnography. The test measures the number of hypopnea (30% or
greater decrease in airflow for at least 10 seconds followed by an arousal and/or 3% oxygen
desaturation) and apnea (complete or near complete cessation of airflow for at least 10 seconds
followed by an arousal and/or 3% oxygen desaturation) events and results with an ‘apnea
hypopnea index’, which is classified to the severity of the sleep apnea [41]. Nonoperative
treatment of OSA is achieved with non invasive positive pressure ventilation in the form of
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continuous positive airway pressure (CPAP) or bi-level positive airway pressure (Bi-PAP).
Many patients receive the diagnosis for the first time during the preoperative work up for
bariatric surgery. These patients should be allowed to adapt to the device prior to undergoing
surgery. With regards to anastomotic integrity, the use of CPAP has been proven to be safe
after roux-en-y gastric bypass [42]. In order to maximize compliance, patients should bring
their own machine and mask to the hospital. Although the use of CPAP or BiPAP is recom‐
mended in the postoperative setting, its omission has also been proven safe provided the
patient is an a monitored setting with aggressive pulmonary physiotherapy [40].
In addition to OSA, patients with super morbid obesity can have pulmonary derangements
while awake; this is termed obesity hypoventilation syndrome (OHS). More specifically,
obesity hypoventilation syndrome manifests with daytime hypercapnia with PaCO2 > 44 mm
Hg or 6 kPa, elevated hematocrit, and sleep disordered breathing. These patients are at high
risk for pulmonary complications and VTE [40]. Obesity hypoventilation syndrome occurs in
11% of patients with OSA and in 8% of bariatric surgical patients [43]. Patients with OHS have
severe upper airway obstruction, impaired respiratory mechanics, blunted central respiratory
drive and increased incidence of pulmonary hypertension. The diagnosis of OHS is also made
with polysomnography. The treatment of OHS is similar to OSA in that positive airway
pressure and supplemental oxygen are used to facilitate adequate respiration.
We reviewed our patient database and found that approximately 85% of patients had undiag‐
nosed obstructive sleep apnea with 51% of patients having severe sleep apnea. In the lower
BMI range (35-39.9 kg/m2) our population showed 92% prevalence of OSA. There was a 100%
prevalence of obstructive sleep apnea in those with a BMI greater than or equal to 60 kg/m2.
Based on these results, we can see that BMI does not correlate with the presence of OSA. In a
larger study of 2,458 patients, 509 patients underwent polysomnography within one year prior
to bariatric surgery. In this population 80.7% of patients were found to have obstructive sleep
apnea and 35.5% of these patients had severe sleep apnea [44]. Although some authors advise
that polysomnography should only be used if the patient exhibits symptoms of OSA or OHS,
we recommend that all patients be actively evaluated with polysomnography in the preoper‐
ative period. If found to have sleep apnea, the patients are started on positive pressure
ventilation by mask, at the settings recommended, for several weeks prior to surgery. On the
day of the surgery, the patient is instructed to bring their machine to the hospital and the
machine is routinely used, starting in the recovery room.
6. Anesthesia
The anesthesia preoperative assessment is the culmination of all consults pertinent to the
optimization of the physiological status of the patient. Provided that major cardiopulmonary
issues, cerebral, and metabolic derangements have been addressed, the anesthesiologist
should be able to proceed with the surgery in a controlled and safe manner. As the preoperative
optimization of these organ systems have been addressed previously in this chapter, the focus
of the anesthesiology section will be intravenous access, blood pressure monitoring, aspiration
risk, and airway management on induction of anesthesia.
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narrowed or obstructed during sleep and results in reduction or cessation of breathing during
sleep. The reduction in airway caliber is due to the sleep induced loss of muscle tone in the
soft tissues of the oropharyngeal airway. Obstructive sleep apnea is found in 38 – 88% of
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to identify patients at risk for having OSA. The Epworth Sleepiness Score, the Maintenance of
Wakefulness Test, the Berlin Questionnaire and the STOP-BANG Questionnaire are designed
to quickly asses if a patient should be screened further. The definitive diagnosis of OSA is made
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greater decrease in airflow for at least 10 seconds followed by an arousal and/or 3% oxygen
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mended in the postoperative setting, its omission has also been proven safe provided the
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In addition to OSA, patients with super morbid obesity can have pulmonary derangements
while awake; this is termed obesity hypoventilation syndrome (OHS). More specifically,
obesity hypoventilation syndrome manifests with daytime hypercapnia with PaCO2 > 44 mm
Hg or 6 kPa, elevated hematocrit, and sleep disordered breathing. These patients are at high
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drive and increased incidence of pulmonary hypertension. The diagnosis of OHS is also made
with polysomnography. The treatment of OHS is similar to OSA in that positive airway
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that polysomnography should only be used if the patient exhibits symptoms of OSA or OHS,
we recommend that all patients be actively evaluated with polysomnography in the preoper‐
ative period. If found to have sleep apnea, the patients are started on positive pressure
ventilation by mask, at the settings recommended, for several weeks prior to surgery. On the
day of the surgery, the patient is instructed to bring their machine to the hospital and the
machine is routinely used, starting in the recovery room.
6. Anesthesia
The anesthesia preoperative assessment is the culmination of all consults pertinent to the
optimization of the physiological status of the patient. Provided that major cardiopulmonary
issues, cerebral, and metabolic derangements have been addressed, the anesthesiologist
should be able to proceed with the surgery in a controlled and safe manner. As the preoperative
optimization of these organ systems have been addressed previously in this chapter, the focus
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Peripheral intravenous access in the bariatric patient may be difficult. The anesthesiologist
should be prepared to use ultrasound guided techniques or central venous access placement
in patients where intravenous access is difficult. Arterial line placement may be utilized when
an appropriately sized blood pressure cuff may not reflect accurate readings secondary to the
conical shaped arms in this population [45]. The possibility of central line placement preop‐
eratively should be discussed with the patient prior to going into the operating room.
Airway  management  during  anesthesia  induction  may  be  challenging  in  the  bariatric
population.  BMI ≥ to 40 kg/m2  has been associated with significant airway management
challenges.  Some institutions have mandated having an attending and one other experi‐
enced anesthesia provider (attending, an anesthesia resident with floor intubation creden‐
tialing,  or  CRNA available  for  intubation  in  this  population).  Due  to  excess  soft  tissue
related to the anatomy, face mask ventilation of the morbidly obese patient may be difficult.
Increased BMI and a  history  of  OSA also  increase  the  possibility  of  difficult  face  mask
ventilation  [46].  When  a  Mallampati  3  or  4  score  is  assessed,  there  has  been  increased
difficulty in intubation, see figure 1 [47].
Figure 1. Mallampati Classification and Laryngoscopic View Grades.
Positioning of the bariatric patient in the supine position, as seen in figure 2, such that the
external auditory meatus is in line with the sternal notch, known as ramping, is recommended
[48]. A recent study demonstrated that in the morbidly obese population undergoing bariatric
surgery, when using the “ramping” position, there was no correlation between difficult direct
laryngoscopy and OSA in Mallampati 1 and 2 classifications. Patients with a BMI of 35kg/m2
have been associated with a greater than 6 fold increase in difficult direct laryngoscopy. Neck
circumference over 40 cm has also been implicated in difficult direct laryngoscopy [49].
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In addition to ventilation and intubation concerns, aspiration risk must be considered. It
has been reported that  the gastric  fluid of  morbidly obese patients  is  more voluminous
and of lower pH than that of the leaner patients [50]. These patients can be considered for
rapid  sequence  induction,  a  technique  for  inducing  a  patient  without  ventilation.  This
technique may expose the anesthesiologist to a greater chance of airway failure. Neutrali‐
zation of gastric acid with clear antacid solutions such as sodium citrate can be prophylac‐
tically given preoperatively.
There are many adjunct airway devices available to assist in the intubation of a challenging
airway. The advent of video laryngoscopy, a plethora of supraglottic airways and flexible fiber
optic intubation has provided multiple modalities and techniques for intubation of the
challenging airway.
When assessing the airway of the bariatric patient, a preoperative plan for securing the airway
safely is invaluable. The American Society of Anesthesiology (ASA) Difficult Airway Algo‐
rithm gives several pathways for the management of the difficult airway, whether the patient
is awake or asleep, see figure 3 [51].
If the anesthesiologist’s evaluation raises doubt in the ability to safely manage the airway,
awake intubation should be undertaken [52]. It is also important to remember that BMI alone
does not predict the probability of a difficult intubation. Preparedness, vigilance and commu‐
nication with the surgeon will result in a favorable patient outcome.
Figure 2. Ramping position.
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Figure 3. Difficult Airway Algorithm.
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7. Endocrine
Evidence is accumulating that suggests obesity is closely related to endocrine disorders, some
at a subclinical level. Obesity has been found to be associated with type 2 diabetes mellitus
(T2DM) and hypothyroidism [53,54].
Management of T2DM is important during the perioperative period. Targets have been
established by the American Association of Clinical Endocrinologists, The Obesity Society and
the American Society for Metabolic and Bariatric Surgery for preoperative glycemic control
which may be associated with improved outcomes, see table 1 [53].
• Hemoglobin A1c of 6.5 – 7.0 % or less
• Fasting blood glucose level of less than or equal to 110 mg/dL
•2-hour postprandial blood glucose concentration of less than or equal to 140 ml/dL
Table 1. Recommendations for preoperative glycemic control
Optimal glycemic control should be achieved preoperatively, as patients with an elevated
preoperative hemoglobin A1c are found to have a higher incidence of postoperative compli‐
cations. A hemoglobin A1c level greater than 8% increases the risk of wound infection and acute
renal failure postoperatively. An elevated A1c in the preoperative setting also increases the
likelihood of elevated blood glucose in the postoperative setting and decreases the rate of
resolution of T2DM after bariatric surgery [55]. Preoperative control can be achieved with a
combination of diet modification, weight loss and pharmaceuticals.
Hypothyroidism is a known cause of obesity; however, de novo thyroid dysfunction has been
observed in obese patients. It has been suggested that subclinical hypothyroidism is associated
with obesity [54]. In some patients, the TSH level has been shown to return to normal levels
after significant weight loss, however the outcome is not universal. The ASMBS does not
recommend routine screening for primary hypothyroidism in the obese patients, however
many bariatric programs require such preoperative screening in keeping with the NIH
guidelines to ensure there is no organic cause to the obesity [53,56].
8. Gastrointestinal
Obesity is a risk factor for gastroesophageal reflux disease, erosive esophagitis, and esophageal
adenocarcinoma [57]. The presence of gastrointestinal diseases has an effect on the type of
bariatric procedure, which can be recommended for a patient and may require treatment prior
to weight loss surgery. In addition, after surgery, the restrictions and rearrangement of the
alimentary tract can limit evaluation and surveillance options. There are many modalities for
assessing the gastrointestinal tract in the preoperative setting.
The American Society for Gastrointestinal Endoscopy (ASGE) recommends an upper endos‐
copy be performed in all patients with upper GI tract symptoms and in all patients undergoing
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weight loss surgery [58]. Preoperative esophagogastroduodenoscopy has been found to reveal
abnormalities in 46 to 90% of patients, with 62% having clinically significant findings. In our
practice, all patients being evaluated for bariatric surgery undergo upper endoscopy. How‐
ever, a five year, internal review of 555 patients has shown 98% of our patients had positive
findings on routine upper endoscopy yet the findings did not cause a delay or impact on the
choice of surgical procedure – questioning the clinical significance of the findings.
During endoscopy tissue biopsies should be obtained to evaluate for H. pylori. If the bacterium
is isolated, eradication with one of several standard regimens is recommended. Recently, there
has been growing support for non-invasive testing for H. pylori in an effort to reduce costs
associated with preoperative testing [59]. One potential algorithm for non-invasive testing
involves screening patients with serum H. pylori test and treating the patient if it is positive.
In either case, proof of eradication should be obtained, typically via urea breath test. Recently
published data indicates that preoperative H. pylori status does not increase the risk for
marginal ulcer or stomal stenosis post roux-en-y gastric bypass [60].
The World Health Organization (WHO) reports the incidence of gastric cancer is highest in
the western pacific region, which comprises 27 countries including China, Japan, Republic of
Korea, Malaysia, Singapore and the Philippines. The incidence in this region was 521,000 cases
in 2004, greater than 50% of the worldwide incidence [61]. In countries where gastric and other
upper gastrointestinal cancers are more prevalent, the importance of preoperative upper
endoscopy cannot be underestimated. Ultimately, practice patterns should reflect the preva‐
lence of significant findings specific to the patient population being prepared for weight loss
surgery.
As an adjunct to endoscopic examination of the gastrointestinal tract several radiographic
investigations are also considered during the preoperative evaluation for bariatric surgery.
Gastroesophageal reflux disease associated with hiatal hernias is commonly found in obese
patients. Completing a bariatric procedure without recognizing and repairing a hiatal hernia
can potentially lead to worsening of reflux and poor surgical outcomes [62]. In order to identify
a hiatal hernia some surgeons obtain contrast enhanced upper GI series. We do not employ
upper GI series routinely in our preoperative evaluations. Hiatal hernias that are identified on
preoperative upper endoscopy are discussed with the patient for informed consent and
subsequently investigated during the operation. In our experience, clinically significant hiatal
hernias are readily identifiable upon laparoscopic inspection and repaired as indicated.
In our practice we routinely assess the size of the liver prior to surgery by abdominal ultra‐
sound. Greater than 30% of morbidly obese patient show fatty infiltration of the liver [63]. As
an enlarged liver is one of the most common reasons for conversion to an open procedure, it
is our practice to place the patient on a liquid diet for two weeks prior to surgery if hepatic
steatosis is identified [64]. Two weeks of a low energy diet has been shown to decrease liver
size and body fat by greater than 5% [63]. In addition to liver size, the gallbladder is also
evaluated for the presence of stones and wall thickening to suggest chronic gallstone disease.
The management of concurrent gallstones in the morbidly obese patient undergoing bariatric
surgery has been a controversial topic. During the era of open weight loss surgery concomitant
cholecystectomy was recommended for all patients undergoing open gastric bypass [65,66].
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The view on cholecystectomy has changed since the widespread adoption of laparoscopic
bariatric surgery. Addition of cholecystectomy to laparoscopic roux-en-y gastric bypass was
found to add approximately 50 minutes to the operative time and significantly increased
hospital length of stay, 2.69 days versus 4.35 days [67]. A study of 625 patients by D’Hount et
al showed that only 6.9% of patients developed symptomatic gallstone disease post gastric
bypass. The mean time between gastric bypass and cholecystectomy was 17.4 ± 13.1 months
[68]. We do not advocate performing cholecystectomy at the same time as primary bariatric
procedures unless absolutely necessary due to the increased operative time and length of stay.
We do employ the use of ursodeoxycholic acid in the postoperative period to reduce the rate
of gallstone formation in our gastric bypass patients due to the challenge of addressing
choledocholithiasis in this patient population [53].
9. Nutritional
A preoperative nutritional assessment with a registered dietitian is essential when preparing
for surgery. The preoperative nutritional assessment is designed to help the patient recognize
the need for positive lifestyle changes and develop a plan to implement them. This will likely
result in improvement of nutritional status, better management of nutrition-related comor‐
bidities and development of habits that will positively influence weight loss outcomes and
maintenance [69]. It is also a time to thoroughly review the postoperative diet with the patient,
which includes gradually advancing the diet in terms of texture and variety, including exercise
on a regular basis, staying hydrated with appropriate fluids, and adhering to the recommended
vitamin and mineral regimen. In this section, we will discuss preoperative behavior changes
that could potentially affect long-term outcomes.
A thorough preoperative nutritional assessment should include review of anthropometrical
data, weight history, past diet history, medical history, available laboratory values, psycho‐
logical history (including history of eating disorders), social history, substance abuse history,
nutrition-focused physical findings (such as poor dentition), dietary intake, physical activity,
and psychosocial factors that affect weight loss [70]. When discussing dietary intake with a
patient, it is important to determine how many meals the patient includes on a daily basis,
whether or not the patient snacks all day (i.e. grazing, picking, nibbling), if the patient has a
past or current history of eating disorders, macronutrient and micronutrient composition of
frequently chosen foods and beverages, and alcohol intake [69]. Preoperative nutrition
counseling should be adapted to each individual patient.
Patients' eating habits and exercise patterns are determined by a variety of environmental,
psychological, biological, and social factors. Environmental factors include work schedule,
occupation, socioeconomic status, and family traditions. Psychological factors include low self-
esteem, feeling a lack of control in life, feeling inadequate, depression, anxiety, stress, and
loneliness. Social factors include cultural glorification of the "perfect body", society placing
more value on physical appearance and not on inner qualities, and stress related to size/body
shape due to past discrimination [71]. Biological and biochemical factors are still being
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explored, but recent research has shown that gastrointestinal hormone imbalance can affect
hunger and appetite [72]. It is important for patients to understand that, regardless of the
reasons behind them, current eating patterns will likely result in poor weight loss, weight
regain, and malnutrition after surgery. Preoperative nutritional counseling should focus on
addressing these behaviors, working with the patient to avoid or manage them, and having
the patient demonstrate compliance with the recommended changes.
Two environmental factors that are of particular concern are socioeconomic status and shift
work. In low-income areas, access to nutrient-rich foods is oftentimes limited [73]. Planning
grocery lists and affordable recipes with a low-income patient would be an appropriate
intervention. Having the patient complete food logs that show more meals are prepared in the
home with the ingredients purchased from the grocery list will demonstrate that he/she is able
to incorporate this healthy behavior on a routine basis, thus lowering the risk of postoperative
malnutrition. Obesity is frequently seen in people who work overnight shifts or who have
alternating shifts and late shift workers have higher rates of weight gain after starting their
jobs [74,75]. In our practice, patients report that they feel it is inappropriate to eat in the middle
of the night. This often results in eating large portions before work and after work, as well as
grazing on empty-calorie foods during the night. Working with the patient to break the idea
that it is "bad" to be eating in the night is key when it comes to changing behaviors to positively
affect weight loss and nutrition status postoperatively. Including regularly-timed meals and
snacks that include an appropriate balance of protein, carbohydrates, and fat will set the patient
up for long-term success.
Sometimes, patients have a past or present history of eating disorders that likely require
additional psychological counseling in addition to nutritional counseling. Hence, coordination
between the dietitian and the mental health care provider is critical. There is a fair amount of
literature regarding Binge Eating Disorder (BED), subdiagnostic BED, and night eating
syndrome in the preoperative setting, most of which states that psychological counseling is
encouraged for patients that have either been diagnosed with an eating disorder or show
tendencies towards one [76-78]. Some studies have suggested that patients with preoperative
BED might be more inclined to graze after surgery, thus sabotaging weight loss, while other
research suggests that prior history of eating disorders is not a predictor of poor outcomes
following bariatric surgery [78,79]. Emotional eating is technically not considered an eating
disorder, but its presence oftentimes has psychological roots. Some case studies have shown
that cognitive behavioral therapy can help manage emotional eating both pre and postopera‐
tively [80]. The only eating disorder that is a contraindication to bariatric surgery is active
bulimia nervosa, but ultimately it is up to the multidisciplinary bariatric surgery team to decide
if they feel a patient's past history of eating disorders could potentially jeopardize the patient's
health [78]. Bariatric surgical teams should keep in mind that the psychological evaluation is
not the only setting in which a patient might disclose episodes of disordered eating. Questions
inquiring about eating disorders should be included in the nutrition evaluation, and if during
subsequent visits the patient suggests that he or she has tendencies towards these behaviors,
the patient should undergo psychological treatment before proceeding with surgery.
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Most commonly, the areas dietitians will find they need to counsel patients on before surgery
include portion control, macronutrient and micronutrient composition of frequently chosen
foods, skipping meals, and physical activity. Dietitians use various tools to help assess a
patient's food and beverage intake, including the 24-hour recall and food frequency question‐
naires. When counseling patients preoperatively, it is important to put the emphasis on how
dietary and lifestyle changes positively affect long-term weight maintenance. Adhering to
portion control before surgery will likely lead to preoperative weight loss, resulting in a lower
weight 24 months after surgery. It will also help patients maintain their weight loss over the
long term. Patients often state they are limited in food choices postoperatively. Developing a
menu before surgery that includes a variety of soft proteins (e.g. low-fat dairy, beans, nut
butters, fish), whole grains, fruits, vegetables, and healthy fats will empower patients to try
new foods and recipes after surgery that are appropriate for the texture that they are able to
tolerate. This will help stave off taste fatigue and provide a more nutritious diet as they are
able to include more solid, textured foods [81]. Patients should also be working towards
eliminating intake of sugar-sweetened beverages in the preoperative period and including
mostly water and sugar-free beverages. While skipping any meal is discouraged, observational
studies highlight that eating breakfast regularly can be an effective tool for weight manage‐
ment [82]. Regularly eating breakfast is associated with lower BMI in adults, and inclusion of
whole grains, fruit, and low-fat dairy may be related to appetite control and blood glucose
regulation, both contributing factors to obesity [83]. Patients often have the misconception that
skipping breakfast will lead to eating fewer calories in the day, when in fact, skipping breakfast
can lead to cravings of high-calorie foods later in the day [84]. Therefore, patients should be
encouraged to include breakfast daily in order to better maintain weight loss after surgery.
Lastly, physical activity is consistently cited as a predictor of weight loss maintenance [85].
Despite being aware that physical activity has health benefits, barriers to exercise still remain.
They include inability to self-motivate, lack of encouragement from family and friends, time
constraints, low self-efficacy, fear of being injured, recent injury, and lack of resources (i.e. no
sidewalks or parks in neighborhood) [86]. Overcoming barriers to exercise will likely take a
team approach, including the dietitian, psychologist, and possibly a physical therapist. The
patient should be encouraged to begin a rather simple exercise program that takes into account
reservations about exercise and physical limitations. We often see that as patients begin
exercise programs, they are hesitant and resistant; however, as their self-esteem improves and
physical activity becomes less taxing on the body, they build upon the program and welcome
the exercise. They report having more energy, looking forward to the time by themselves, and
overall mood improvement. Walking for as little as 5 minutes per day can often lead to walking
for 30 minutes 3-4 times per week over a 3-month span.
With regard to micronutrients, it is estimated that 2 billion people worldwide suffer from
vitamin and mineral malnutrition despite adequate calorie intake. In the United States greater
than 75% of people are taking in below the daily recommended value of vitamins A, D and E.
Additionally, 50 to 75% of Americans are also not taking enough vitamin C [87]. These
deficiencies are also seen in patients presenting for weight loss surgery. Obese patients are at
increased risk for nutritional abnormalities in the preoperative setting; they have been found
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Most commonly, the areas dietitians will find they need to counsel patients on before surgery
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reservations about exercise and physical limitations. We often see that as patients begin
exercise programs, they are hesitant and resistant; however, as their self-esteem improves and
physical activity becomes less taxing on the body, they build upon the program and welcome
the exercise. They report having more energy, looking forward to the time by themselves, and
overall mood improvement. Walking for as little as 5 minutes per day can often lead to walking
for 30 minutes 3-4 times per week over a 3-month span.
With regard to micronutrients, it is estimated that 2 billion people worldwide suffer from
vitamin and mineral malnutrition despite adequate calorie intake. In the United States greater
than 75% of people are taking in below the daily recommended value of vitamins A, D and E.
Additionally, 50 to 75% of Americans are also not taking enough vitamin C [87]. These
deficiencies are also seen in patients presenting for weight loss surgery. Obese patients are at
increased risk for nutritional abnormalities in the preoperative setting; they have been found
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to be deficient in thiamine, folate, zinc, iron, ferritin, selenium, beta-carotene, magnesium, and
vitamins A, B-12, C and D [88-92]. Vitamin D levels are also affected by latitude and this should
also be taken into consideration when screening and supplementing these deficiencies. It is
imperative to evaluate and supplement all nutritional deficits prior to surgery to prevent
deficiencies which can be significantly more difficult to correct in the postoperative period.
These micronutrients should be supplemented in the preoperative setting and monitored to
ensure normal values before surgery. All patients undergo postoperative monitoring to guide
supplementation after bariatric surgery with frequent regularly scheduled blood tests.
As bariatric surgery becomes a safer, more popular, and more accepted form of weight loss
amongst health professionals, it is clear that a thorough preoperative nutritional assessment
and consistent preoperative follow-up with the dietitian is essential for the patient to lose an
appropriate amount of weight, avoid malnutrition, and to maintain the weight loss hopefully
for life [93-95]. Whether the dietitian has 6 weeks or 6 months to work with the patient
preoperatively, the main focus should be to build the foundation for a healthier lifestyle and
better eating habits.
10. Psychological
The fight against obesity has many fronts. Simply reducing the capacity or absorption of the
gastrointestinal tract will not have long lasting effects on weight if the psychosocial aspects of
the disease are not addressed. An essential part of the preoperative evaluation is a psycho‐
logical clearance [96]. The psychosocial and behavioral evaluation is geared to confirm the
patient’s ability to incorporate nutritional and behavioral changes before and after bariatric
surgery. The psychological investigation is also used to identify cognitive, environmental, or
psychiatric contraindications prior to surgery and to offer treatment for any disorders
identified [97]. The obese adult population in the United States has been found to have higher
incidence of major depression, bipolar disorder, generalized anxiety and panic disorder [98].
Intervening in these disease processes can enhance postoperative weight reduction; however,
no definitive significant improvement in weight loss has been shown [53].
The interview consists of a standard psychological evaluation, evaluation of the patient’s
appropriateness  for  surgery,  an  assessment  of  eating  behavior,  stress,  coping  mecha‐
nisms,  and social  support.  It  is  also  used to  confirm that  the  patient  has  the  ability  to
consent  and  evaluate  all  the  potential  risks  and  possible  benefits  to  surgery  [96].  The
psychosocial evaluation should be performed by a credentialed expert in psychology and
behavior  modification  for  all  patients.  Screening  for  eating  disorders  can  involve  using
standardized assessments, see table 2 [96].
Mental illnesses and eating disorders identified during the screening process are not necessa‐
rily contraindications to surgery [99]. Their optimization is key for a durable and satisfying
outcome. The bariatric surgeon should be aware that the patient may exhibit impression
management during the preoperative psychological evaluation. This is done by purposefully
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minimizing psychological symptoms to receive a recommendation to proceed with surgery
from the mental health professional. It is recommended that mental health professionals use
measures to assess for impression management, as this will allow for proper preoperative
treatment and minimize postoperative surprises [97].
11. Education
The process towards obtaining successful results after bariatric surgery begins during the
preoperative period. The algorithm of care is a multi step process and requires full participa‐
tion of both the practitioners and the patient. The ability to follow the plan of care and manage
lifestyle changes required for successful weight loss depends on how well the patients are
prepared prior to surgery. High patient satisfaction rating has been demonstrated after
instituting a preoperative class for their bariatric patients [100]. Their class covered the
following content: presurgery appointments, preparing for surgery, postoperative procedures,
pain management, activity levels, wound care, nutrition, lifestyle changes and discharge
instructions.
The ASMBS recommends having educational objectives and assessments throughout the
preoperative period. It is suggested that the materials provided to the patients be at a sixth to
eighth grade reading level to maximize comprehension [53]. Multimedia tools are also useful,
however patients should be cautioned against using the internet as an information source as
there is a high degree of bias, conflicting statements and out of date information [100]. The
main goal of preoperative education is to provide information needed for informed consent,
prepare the patient for the required lifestyle change and to establish realistic expectations
regarding potential weight loss and quality of life improvements.
12. Functional status
A crucial component of the preoperative evaluation includes assessing the patient’s ability to
complete the activities of daily living. Bariatric patients have a high rate of comorbid condi‐
• Eating Disorder Examination Questionnaire
• Cleveland Clinic Behavioral Rating System
• Millon Behavioral Medicine Diagnostic (MBMD) (Pearson, San Antonio, Texas, USA)
• Alcohol Use Disorder Identification Test – Consumption (AUDIT-C)
• Beck Depression Inventory – II (BDI-II)
• Beck Anxiety Inventory (BAI)
• Multidimensional Health Locus of Control Scale
• Overeater’s questionnaire
Table 2. Mental health assessment tools prior to weight loss surgery
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tions, some of which can cause physical limitation. Morbidly obese patients are also limited
by their body habitus and weight related pain; this is especially true in the super morbidly
obese patients. The limitations in mobility can impede on preoperative weight loss, cause
psychological stress and limit access to care [101]. Preoperative functional status should be
evaluated as it has been shown to be the strongest predictor for postoperative in hospital
morbidity and mortality [102]. Our previously published data revealed that a completely
dependent patient was 27 times more likely to experience mortality after bariatric surgery. The
information gained from investigations into the patient’s functional status is shared with the
patient and risks, benefits and alternatives are discussed with the ability to offer a reasonable
prognosis of the postoperative period.
Preoperative exercise has been found to reduce surgical  complications,  facilitate healing,
achieve  the  mindset  needed  for  positive  behavior  changes,  and  augment  the  rate  of
increased  postoperative  physical  activity  [103].  The  ASMBS  suggests  exercise  for  20
minutes, three to four days a week is sufficient to achieve these results [104]. Most bariatric
surgery patients have sedentary lifestyles and low physical activity level. King and Bond
describe a five step process to providing physical activity counseling to patients undergo‐
ing weight loss surgery [103].
The first step is to assess the patient’s knowledge, beliefs and values regarding exercise along
with prior and current levels of physical activity. The potential barriers successful implemen‐
tation of a physical activity program should also be investigated at this point. Prior to begin‐
ning a physical activity program, the patients with current or a history of exercise intolerance
should be referred to a cardiologist for proper exercise testing. Aside from cardiopulmonary
restrictions to exercise, patients should be assessed for physical limitations such as sensory,
balance and gait abnormalities – all of which can increase the risk of injury.
The second step is to advise the patient on the benefits of physical activity and develop realistic
expectations. Strategies to increase safety and decrease barriers should be established. The
patients should be taught how to gauge the level of intensity using the talk test or by measuring
their own heart rate.
The thirds step is to come to a mutual agreement with the patient regarding their short,
intermediate and long term physical activity goals. The goals should not be end results such
as weight loss or maximal activity, but rather, specific goals regarding the frequency, duration
and type of physical activity performed. It is recommended that the clinician set one goal that
the patient has a high likelihood of achieving to boost confidence and encourage the patient
to continue increasing their level of physical activity.
The fourth step is to assist the patient in achieving the goals by providing the patient printed
materials and other resources that support self monitored physical activity. Such items include
diaries, pedometers and a list of safe walking paths or fitness facilities. Patients who need a
high level of encouragement or guidance, and those with significant barriers should be referred
to professional personal trainers or other exercise professionals to achieve the best results.
The final step is to arrange for follow up and monitoring to answer questions and provide
reinforcement. The patient and clinician should not be discouraged if the level of physical
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activity is not immediately increased after one meeting. It may take many visits for the patients
to overcome their barriers and begin a physical activity plan. The healthcare provider should
remain vigilant and provide continual counseling to the patient.
13. Conclusions
The preoperative evaluation of the bariatric surgery patient requires a multidisciplinary
approach, ultimately coordinated by the surgeon. There are many details to which attention
must be paid including medical, nutritional and psychological aspects in an effort to fully
evaluate the patient as a whole. This multi faceted approach is one of the factors which have
allowed bariatric surgery to become a safe and effective method for weight loss and comor‐
bidity amelioration. These evaluations may reveal problems which should be addressed before
surgery to ensure safety and success in the postoperative period. These assessments offer the
best way to prepare and counsel a patient for these life altering operations and provide a
reasonable basis of expectation on the part of the surgeon and the patient. Many of the learning
points incorporated into the preoperative evaluation of bariatric patients can potentially be
applied to other disciplines.
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1. Introduction
Obesity ultimately results from an unbalance between the intake and oxidation of the energy
obtained from foods, and its treatments are based on correcting this unbalance by basically
restricting energy intake. Consequently, food intake is the center of attention when the subject
is obesity, either as an etiological, protection, or even therapeutic factor.
The inability of severely obese individuals to reduce or maintain their body weight using
traditional methods makes them candidates to bariatric surgery, which is admittedly an
effective method to reduce body weight significantly and obesity-associated morbidities.
Bariatric surgery involves anatomic and physiological changes in the gastrointestinal tract that
promote energy restriction, essential for weight loss, but also the restriction of many essential
dietary nutrients. In addition to the anatomic aspects, bariatric surgery decreases appetite and
increases postprandial satiety, possibly because of its effect on the secretion of hormones that
regulate these systems (Kohli, Stefater e Inge, 2011).
In addition to reducing body weight significantly, bariatric surgery also decreases some
systemic inflammation markers (Chen et al., 2009; Miller et al., 2011), improves insulin
sensitivity, promoting remission of type 2 diabetes (T2D), and lowers high blood pressure,
among others.
Although bariatric surgery is associated with better quality of life, nutritional deficiencies may
occur after surgery because of the dramatically reduced food intake and/or micronutrient
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restricting energy intake. Consequently, food intake is the center of attention when the subject
is obesity, either as an etiological, protection, or even therapeutic factor.
The inability of severely obese individuals to reduce or maintain their body weight using
traditional methods makes them candidates to bariatric surgery, which is admittedly an
effective method to reduce body weight significantly and obesity-associated morbidities.
Bariatric surgery involves anatomic and physiological changes in the gastrointestinal tract that
promote energy restriction, essential for weight loss, but also the restriction of many essential
dietary nutrients. In addition to the anatomic aspects, bariatric surgery decreases appetite and
increases postprandial satiety, possibly because of its effect on the secretion of hormones that
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absorption. Unmonitored postoperative patients may develop severe malnutrition (Dodell et
al., 2012). The literature has often reported deficiencies of vitamin B complex, iron, folic acid,
vitamin D, and calcium (Saltzman e Karl, 2013). These deficiencies may cause neurological
symptoms, osteopenia, and anemia.
Hence, the nutritional approach of the bariatric patient, which began when the patient was in
line for surgery and continued after surgery, is one of the most important themes of the
interdisciplinary care of obese patients. The objective of this chapter is to review the theoretical
bases for the nutritional approach of bariatric patients, the instruments for assessing food
intake, and the nutritional recommendations, both preoperatively, when the patient is
preparing for surgery, and postoperatively, during follow-up. The chapter also includes
practical examples.
2. The nutrition process after bariatric surgery
The surgeries used for treating severe obesity include restrictive surgeries that limit food
intake, such as vertical banded gastroplasty (VBG), adjustable gastric band (AGB), and sleeve
gastrectomy (SG); and mixed surgeries that combine food intake restriction with nutrient
malabsorption, such as Roux-en-Y gastric bypass (RYGB) and biliopancreatic diversion (BPD)
with duodenal switch (BPD-DS) (Pories, 2008).
The implications of surgery on nutritional status stem specifically from the types of anatomic
and physiological changes the surgery makes. The main macro-and micronutrient absorption
sites reflect the dimension of the nutritional impairment, especially in the long run, and the
possible nutritional complications promoted by bariatric surgery, a situation that should be
prevented with appropriate monitoring and supplementation.
In restrictive surgeries, nutritional deficiencies are associated with inadequate food intake,
while in malabsorptive interventions, deficiencies are more associated with the hindrance of
nutrient digestion and absorption. In summary, the energy deficit caused by low macronu‐
trient intake and/or absorption is accompanied by inadequate intake of essential nutrients.
The small intestine, target of the bypasses associated with malabsorptive techniques, is where
most of food digestion and absorption occurs. The absorption of iron (Fe), calcium (Ca), zinc
(Zn), selenium (Se), copper (Cu), and some water-soluble vitamins, such as vitamin C, thiamin
(B1), and riboflavin (B2) occurs in the duodenum; the absorption of Fe, Zn, chromium, amino
acids, peptides, carbohydrates, lipids, the fat-soluble vitamins A, D, E, and K, and most of the
water-soluble vitamins occurs in the jejunum; and the absorption of amino acids, peptides,
lipids, fat-soluble vitamins, magnesium, vitamin B12, and folic acid occurs in the ileum.
Generally, the most common micronutrient deficiencies after bariatric surgery are Fe, Ca,
vitamin D, vitamin B12, folic acid, and Zn (Bloomberg et al., 2005).
In BPD associated with gastrectomy, mostly a malabsorptive mixed surgery, nutrient malab‐
sorption is even greater, causing massive nutrient loss. Nutrient malabsorption is one of the
factors that explain weight loss promoted by malabsorptive techniques, but techniques that
Essentials and Controversies in Bariatric Surgery34
are mostly malabsorptive reduce the intestinal absorption capacity significantly. BPD, for
instance, decreases protein absorption by 25% and fat absorption by 72%, impairing the
absorption of fat-soluble vitamins (Aills et al., 2008). BPD-DS lowers the serum concentration
of thiamin in the first few months after surgery and of vitamins A and D one year after surgery
more than RYGB does (Aasheim et al., 2009).
Today the main type of bariatric surgery done globally is RYGB, which reduces gastric capacity
and causes a small degree of malabsorption as it bypasses the duodenum and a small part of
the jejunum, namely, 30 centimeters of the proximal jejunum. Nevertheless, the bypassed
segments can influence the absorption of proteins and some water-soluble vitamins, namely
vitamins C, B1, B2, B6, and folic acid, absorbed in the proximal jejunum. Fat-soluble vitamins
that require lipids to be absorbed may also be affected. Hence, mineral deficiencies in RYGB,
such as Fe, Ca, and Zn stem from proximal small intestine bypass, specifically from duodenum
bypass.
Vitamin and mineral deficiencies at first are asymptomatic or present unspecific symptoms.
Laboratory tests are necessary to monitor and avoid the development of postoperative
nutritional and clinical complications. Nutritional deficiencies found one year after surgery
included Fe (51%), Ca and vitamin D (47%), folic acid (39%), and Zn (12%) (Gasteyger et al.,
2008).
• Calcium and vitamin D
Calcium and vitamin D deficiencies in obese patients in line for bariatric surgery are common,
as well as high parathyroid hormone (PTH). Assessment of calcium metabolism should include
measuring serum PTH, total calcium, phosphorus, 25-hydroxycholecalciferol, and the calcium
present in 24 hours of urine. The normal levels of vitamin D, 25-hydroxycholecalciferol, or
25(OH)D range from 30 to 80 ng/mL. Vitamin D insufficiency occurs when these levels are
below 30 but above 20ng/mL and deficiency when below 20ng/mL. The prevalences of vitamin
D deficiency before and one year after RYGB were 86% and 70%, respectively (Signori et al.,
2010). This deficiency may stem from inadequate intake and higher calcium and vitamin D
requirements after surgery since the main calcium absorption sites are located in the bypassed
intestinal section. Calcium, PTH, and vitamin D levels should be normalized before and after
surgery to avoid bone loss.
In a sample of 30 female RYGB patients assessed eight years ago, Duran de Campos et al.
(2008) found osteopenia (67%), osteoporosis (13%), low urine calcium (70%), vitamin D
deficiency (90%), and high markers of bone metabolism, namely high PTH (54%) and high
alkaline phosphatase (57%). Their mean calcium intake was roughly 50% of their daily
requirement (1000mg), suggesting that bariatric patients should be encouraged to consume an
adequate amount of calcium.
• Iron
Iron deficiency is the main cause of anemia in bariatric patients. However, other nutrients
associated with anemia are also malabsorbed, such as proteins and micronutrients required
for iron metabolism and erythropoiesis, such as zinc, copper, folic acid, vitamin B12, and
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absorption. Unmonitored postoperative patients may develop severe malnutrition (Dodell et
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interdisciplinary care of obese patients. The objective of this chapter is to review the theoretical
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intake, and the nutritional recommendations, both preoperatively, when the patient is
preparing for surgery, and postoperatively, during follow-up. The chapter also includes
practical examples.
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sites reflect the dimension of the nutritional impairment, especially in the long run, and the
possible nutritional complications promoted by bariatric surgery, a situation that should be
prevented with appropriate monitoring and supplementation.
In restrictive surgeries, nutritional deficiencies are associated with inadequate food intake,
while in malabsorptive interventions, deficiencies are more associated with the hindrance of
nutrient digestion and absorption. In summary, the energy deficit caused by low macronu‐
trient intake and/or absorption is accompanied by inadequate intake of essential nutrients.
The small intestine, target of the bypasses associated with malabsorptive techniques, is where
most of food digestion and absorption occurs. The absorption of iron (Fe), calcium (Ca), zinc
(Zn), selenium (Se), copper (Cu), and some water-soluble vitamins, such as vitamin C, thiamin
(B1), and riboflavin (B2) occurs in the duodenum; the absorption of Fe, Zn, chromium, amino
acids, peptides, carbohydrates, lipids, the fat-soluble vitamins A, D, E, and K, and most of the
water-soluble vitamins occurs in the jejunum; and the absorption of amino acids, peptides,
lipids, fat-soluble vitamins, magnesium, vitamin B12, and folic acid occurs in the ileum.
Generally, the most common micronutrient deficiencies after bariatric surgery are Fe, Ca,
vitamin D, vitamin B12, folic acid, and Zn (Bloomberg et al., 2005).
In BPD associated with gastrectomy, mostly a malabsorptive mixed surgery, nutrient malab‐
sorption is even greater, causing massive nutrient loss. Nutrient malabsorption is one of the
factors that explain weight loss promoted by malabsorptive techniques, but techniques that
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more than RYGB does (Aasheim et al., 2009).
Today the main type of bariatric surgery done globally is RYGB, which reduces gastric capacity
and causes a small degree of malabsorption as it bypasses the duodenum and a small part of
the jejunum, namely, 30 centimeters of the proximal jejunum. Nevertheless, the bypassed
segments can influence the absorption of proteins and some water-soluble vitamins, namely
vitamins C, B1, B2, B6, and folic acid, absorbed in the proximal jejunum. Fat-soluble vitamins
that require lipids to be absorbed may also be affected. Hence, mineral deficiencies in RYGB,
such as Fe, Ca, and Zn stem from proximal small intestine bypass, specifically from duodenum
bypass.
Vitamin and mineral deficiencies at first are asymptomatic or present unspecific symptoms.
Laboratory tests are necessary to monitor and avoid the development of postoperative
nutritional and clinical complications. Nutritional deficiencies found one year after surgery
included Fe (51%), Ca and vitamin D (47%), folic acid (39%), and Zn (12%) (Gasteyger et al.,
2008).
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Calcium and vitamin D deficiencies in obese patients in line for bariatric surgery are common,
as well as high parathyroid hormone (PTH). Assessment of calcium metabolism should include
measuring serum PTH, total calcium, phosphorus, 25-hydroxycholecalciferol, and the calcium
present in 24 hours of urine. The normal levels of vitamin D, 25-hydroxycholecalciferol, or
25(OH)D range from 30 to 80 ng/mL. Vitamin D insufficiency occurs when these levels are
below 30 but above 20ng/mL and deficiency when below 20ng/mL. The prevalences of vitamin
D deficiency before and one year after RYGB were 86% and 70%, respectively (Signori et al.,
2010). This deficiency may stem from inadequate intake and higher calcium and vitamin D
requirements after surgery since the main calcium absorption sites are located in the bypassed
intestinal section. Calcium, PTH, and vitamin D levels should be normalized before and after
surgery to avoid bone loss.
In a sample of 30 female RYGB patients assessed eight years ago, Duran de Campos et al.
(2008) found osteopenia (67%), osteoporosis (13%), low urine calcium (70%), vitamin D
deficiency (90%), and high markers of bone metabolism, namely high PTH (54%) and high
alkaline phosphatase (57%). Their mean calcium intake was roughly 50% of their daily
requirement (1000mg), suggesting that bariatric patients should be encouraged to consume an
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Iron deficiency is the main cause of anemia in bariatric patients. However, other nutrients
associated with anemia are also malabsorbed, such as proteins and micronutrients required
for iron metabolism and erythropoiesis, such as zinc, copper, folic acid, vitamin B12, and
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vitamin A. Specifically, iron deficiency may stem from three events: 1) less dietary iron,
especially heme iron present in meats; 2) less hydrochloric acid because of the stomach bypass,
which reduces the dissolution of iron salts; and 3) duodenum bypass, given that the duodenum
is the main site of iron absorption (Ruz et al. 2009).
The prevalence of anemia in bariatric patients varies according to time elapsed since surgery,
type of surgery, and sex, with women of childbearing age being more vulnerable. In a
prospective study of 1125 RYGB patients of which 999 were females, Drygalski et al. (2011)
found a prevalence of anemia of 12% six months after surgery, which increased to 21% eighteen
months after surgery and 23% one to two years after surgery. Six months after surgery, the
prevalence of anemia in menopausal women was 6% against 16% in premenopausal women.
• Vitamin B12
The absorption of vitamin B12 is also impaired by gastric restriction, a procedure performed
in restrictive, mixed, and mostly malabsorptive surgeries. Although the absorption of vitamin
B12 occurs in the terminal ileum, B12 can only be absorbed when bound to an intrinsic factor,
a glycoprotein produced by parietal cells, in the presence of hydrochloric acid and pepsin.
These molecular interactions usually occur in the distal stomach and duodenum, and RYGB
bypasses both (Flancbaum et al., 2006).
Vitamin B12 deficiency is common: 33-40% of the patients develop it one year after RYGB
(Brolin et al., 2002). A study found that RYGB patients taking conventional nutrient supple‐
mentation still developed B12 deficiency and required further supplementation. The most
common deficiency was of vitamin B12: 62% and 80% of the patients had it one and two years
after surgery, respectively. A combined deficiency of vitamin B12 and folic acid may cause
megaloblastic anemia (Heber et al., 2010). Other studies have reported that conventional
supplementation is enough to prevent folic acid deficiency. In addition to the dosages present
in multivitamins, our patients take a quarterly injection of Citoneurin 5000UI, rich in B
complex.
• Generality
Deficiencies present preoperatively, such as iron (44%), vitamin D (68%), and thiamin (29%)
deficiencies (Flancbaum et al., 2006), may worsen after surgery, but few studies have investi‐
gated how preoperative deficiencies relate to postoperative nutritional complications, another
theme requiring further investigation. Another particularity that deserves attention regards
iron, since preoperative deficiency may not be exclusively nutritional: the inflammation
associated with obesity hinders the regulation of iron metabolism, promoting the development
of functional iron deficiency. Iron homeostasis is regulated by hepcidin, a circulating peptide
hormone produced mainly by hepatocytes but also by adipocytes, which acts as a negative
regulator of iron metabolism (Bekri et al., 2006). Studies grouping these two situations,
preoperative functional deficiency and postoperative iron levels, may clarify current perspec‐
tives and establish new ones on iron supplementation.
The significant changes made by bariatric surgery reduce energy intake and intestinal
absorptive capacity, factors that contribute to weight loss. In addition to the anatomic and
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physiological changes, bariatric surgery promotes hormonal changes, such as reducing ghrelin
production in the fundus of the stomach (an important endogenous orexigenic) and increasing
intestinal hormones, namely peptide YY, glucagon-like peptide-1 (GLP-1), and gastric
inhibitory polypeptide (GIP). The presence of poorly digested food in the distal small intestine
after RYGB and BPD seem to stimulate the production of gut hormones, increasing incretins,
GLP-1, and GIP, which help to control postoperative weight and glycemia (Rodieux et al.,
2008). GLP-1 has a significant postprandial incretin effect, affecting insulin secretion, modu‐
lating appetite and gastric emptying, and eventually impacting the capture of glucose by
tissues. Although some studies emphasize the role of lower serum ghrelin and higher incretin
on satiety and weight control, other studies have not ultimately confirmed that hunger, satiety,
and weight loss are related to these hormonal changes, so more studies are needed (Heber et
al., 2010).
3. The nutritional needs of obese and ex-obese individuals
Although obesity is caused by an intake of macronutrients in excess of the body’s requirement,
certain nutrient deficiencies are often present in obese individuals. High intake of processed,
energy-dense foods of usually poor nutritional value contributes significantly to micronutrient
deficiencies. Additionally, an increase in adiposity and consequent oxidative stress may reduce
the levels of some fat-soluble vitamins and nonenzymatic antioxidants. As a matter of fact,
population data have shown that micronutrient inadequacy is greater among overweight and
obese adults (Kimmons et al., 2006).
Patients in the waiting line for bariatric surgery have a high to moderate prevalence of the
following deficiencies: calcium (Jastrzębska-Mierzyńska et al., 2012), folic acid (Schweiger et
al., 2010; Jastrzębska-Mierzyńska et al., 2012; de Luis et al., 2013), iron (Flancbaum et al.,
2006; Schweiger et al., 2010; Jastrzębska-Mierzyńska et al., 2012), vitamin A (Nicoletti et al.,
2013), vitamin C (Aasheim et al., 2008; Nicoletti et al., 2013), vitamin E (Aasheim et al., 2008),
vitamin B1 (Flancbaum et al., 2006), vitamin B6 (Aasheim et al., 2008; Moizé et al., 2011;), vitamin
B12 (Ernst et al., 2009; Nicoletti et al., 2013), magnesium (Moizé et al., 2011; Nicoletti et al.,
2013), copper (de Luis et al., 2013), and zinc (Ernst et al., 2009; de Luis et al., 2013). The
prevalence of anemia is also moderate to high (Flancbaum et al., 2006; Schweiger et al., 2010;
Moizé et al., 2011). Finally, vitamin D deficiency has been the most often reported deficiency
(Flancbaum et al., 2006; Carlin et al., 2006; Aasheim et al., 2008; Toh, Zarshenas, Jorgensen,
2009; Gammel et al., 2009; Fish et al., 2010; Casagrande et al., 2010; Ducloux et al., 2011; Moizé
et al., 2011; Jastrzębska-Mierzyńska et al., 2012; de Luis et al., 2013; Censani et al., 2013).
Vitamin D is a fat-soluble vitamin with hormonal functions. It acts on many tissues especially
through nuclear and membrane receptors. Evidence shows that vitamin D is essential for bone
mineralization and acts on the pancreas, immune system, and nervous system, among others.
Low vitamin D in obese individuals may be related to low dietary bioavailability, inadequate
sunlight exposure, and even sequestration by adipose tissue (Brouwer et al., 1998). Some
studies report a low to moderate inverse correlation between serum vitamin D and body mass
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hormone produced mainly by hepatocytes but also by adipocytes, which acts as a negative
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preoperative functional deficiency and postoperative iron levels, may clarify current perspec‐
tives and establish new ones on iron supplementation.
The significant changes made by bariatric surgery reduce energy intake and intestinal
absorptive capacity, factors that contribute to weight loss. In addition to the anatomic and
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physiological changes, bariatric surgery promotes hormonal changes, such as reducing ghrelin
production in the fundus of the stomach (an important endogenous orexigenic) and increasing
intestinal hormones, namely peptide YY, glucagon-like peptide-1 (GLP-1), and gastric
inhibitory polypeptide (GIP). The presence of poorly digested food in the distal small intestine
after RYGB and BPD seem to stimulate the production of gut hormones, increasing incretins,
GLP-1, and GIP, which help to control postoperative weight and glycemia (Rodieux et al.,
2008). GLP-1 has a significant postprandial incretin effect, affecting insulin secretion, modu‐
lating appetite and gastric emptying, and eventually impacting the capture of glucose by
tissues. Although some studies emphasize the role of lower serum ghrelin and higher incretin
on satiety and weight control, other studies have not ultimately confirmed that hunger, satiety,
and weight loss are related to these hormonal changes, so more studies are needed (Heber et
al., 2010).
3. The nutritional needs of obese and ex-obese individuals
Although obesity is caused by an intake of macronutrients in excess of the body’s requirement,
certain nutrient deficiencies are often present in obese individuals. High intake of processed,
energy-dense foods of usually poor nutritional value contributes significantly to micronutrient
deficiencies. Additionally, an increase in adiposity and consequent oxidative stress may reduce
the levels of some fat-soluble vitamins and nonenzymatic antioxidants. As a matter of fact,
population data have shown that micronutrient inadequacy is greater among overweight and
obese adults (Kimmons et al., 2006).
Patients in the waiting line for bariatric surgery have a high to moderate prevalence of the
following deficiencies: calcium (Jastrzębska-Mierzyńska et al., 2012), folic acid (Schweiger et
al., 2010; Jastrzębska-Mierzyńska et al., 2012; de Luis et al., 2013), iron (Flancbaum et al.,
2006; Schweiger et al., 2010; Jastrzębska-Mierzyńska et al., 2012), vitamin A (Nicoletti et al.,
2013), vitamin C (Aasheim et al., 2008; Nicoletti et al., 2013), vitamin E (Aasheim et al., 2008),
vitamin B1 (Flancbaum et al., 2006), vitamin B6 (Aasheim et al., 2008; Moizé et al., 2011;), vitamin
B12 (Ernst et al., 2009; Nicoletti et al., 2013), magnesium (Moizé et al., 2011; Nicoletti et al.,
2013), copper (de Luis et al., 2013), and zinc (Ernst et al., 2009; de Luis et al., 2013). The
prevalence of anemia is also moderate to high (Flancbaum et al., 2006; Schweiger et al., 2010;
Moizé et al., 2011). Finally, vitamin D deficiency has been the most often reported deficiency
(Flancbaum et al., 2006; Carlin et al., 2006; Aasheim et al., 2008; Toh, Zarshenas, Jorgensen,
2009; Gammel et al., 2009; Fish et al., 2010; Casagrande et al., 2010; Ducloux et al., 2011; Moizé
et al., 2011; Jastrzębska-Mierzyńska et al., 2012; de Luis et al., 2013; Censani et al., 2013).
Vitamin D is a fat-soluble vitamin with hormonal functions. It acts on many tissues especially
through nuclear and membrane receptors. Evidence shows that vitamin D is essential for bone
mineralization and acts on the pancreas, immune system, and nervous system, among others.
Low vitamin D in obese individuals may be related to low dietary bioavailability, inadequate
sunlight exposure, and even sequestration by adipose tissue (Brouwer et al., 1998). Some
studies report a low to moderate inverse correlation between serum vitamin D and body mass
Theoretical Bases and Dietary Approach of Bariatric Patients
http://dx.doi.org/10.5772/58636
37
index (Parikn et al., 2004; Carlin et al., 2005; McGil et al., 2008; Cimbek et al., 2012; Taheri et
al., 2012).
The prevalences of micronutrient deficiencies vary between studies (Flancbaum et al., 2006;
Carlin et al., 2006; Aasheim et al., 2008; Toh, Zarshenas, Jorgensen, 2009; Gammel et al., 2009;
Fish et al., 2010; Casagrande et al., 2010; Ducloux et al., 2011; Moizé et al., 2011; Jastrzębska-
Mierzyńska et al., 2012; de Luis et al., 2013; Censani et al., 2013). These differences may stem
from different food habits, which vary between cities, states, and countries. Therefore,
nutritional assessment by laboratory tests and food surveys is strongly recommended to detect
nutritional insufficiencies early and make the necessary nutritional interventions. Symptoms
caused by undetected preexisting deficiencies may become worse during the postoperative
period. Since biochemical tests are expensive, Mechanick et al., (2013) suggest starting
micronutrient supplementation in the preoperative period.
Gastric surgery is essential for promoting energy intake restriction and consequently, energy
deficit and weight loss. Nonetheless, this procedure may induce strong aversion to certain
foods, malnutrition, and specific micronutrient deficiencies. Recently, the American Associa‐
tion of Clinical Endocrinologists, The Obesity Society and the American Society for Metabolic
& Bariatric Surgery (Mechanick et al., 2013) published the nutritional requirements of ex-obese
bariatric patients. In summary, these individuals should take multivitamin and multimineral
supplements that help them to meet their daily requirements of the main micronutrients
(elemental calcium: 1200-1500 mg; vitamin D: 3000 IU; vitamin B12: 1000 mcg; folic acid: 400
μg; iron: 45-60 mg) and protein (1.5 grams (60g/d) per kilogram of body weight).
4. Food intake assessment
Determining food intake is a constant challenge for the science and practice of nutrition and
dietetics. Food surveys indirectly assess nutritional status. They are always under scrutiny
because of their limited ability to measure energy and nutrient intakes. Quantitative and
qualitative food intake can be determined by different methods, such as recalls, in which
individuals remember the foods they ate. The most important of these retrospective methods
are the food frequency questionnaire (FFQ) and the 24-hour recall (24HR). Food intake may
also be investigated prospectively by asking individuals to write down the foods they eat in a
food diary or record (FD) the moment they eat them (Gibson, 2005; Anjos et al., 2009).
The food intake survey of choice depends on the study objectives and population, but
administering a single 24HR or FD to assess habitual food intake is not recommended, not
even for obese individuals. Intraindividual variations, that is, daily variations in food intake,
occur, so at least two surveys should be administered on alternate days. Some studies
recommend three 24HR or FD administered on alternate days, including a weekend day
(Johnson, 2002), which allows statistical adjustment of the variances of the study days‘ mean.
Some factors may distort food intake data, such as the interviewer’s skill, interviewee’s
memory, and interview’s environment. Moreover, the assessment itself may affect an indi‐
vidual’s intake pattern and consequently, information quality. Nutrient intake estimates may
Essentials and Controversies in Bariatric Surgery38
also err because of the use of standard recipes and data variation in food composition tables
(Dodd et al., 2006).
The food intake assessment of obese patients consists of many challenges, such as obtaining
reliable information, identifying underreporting, correctly estimating energy and nutrient
requirements, and establishing the appropriate interventions (Anjos et al., 2009).
A common finding in studies that assess the food intake of obese individuals is low energy
intake, which may stem from food intake underreporting and/or physical activity overreport‐
ing (Macdiarmid; Blundell, 1998; Lichtman et al., 1992). Individual characteristics associated
with underreporting include being older, female, and physically inactive; having low social
and educational levels; restricting foods; experiencing emotional changes (Abbot et al., 2008;
Macdiarmid; Blundell, 1998); and especially, having a high body mass index, that is, being
overweight or obese (Rennie, Coward, Jebb, 2007; Scagliusi et al, 2009).
The classification of individuals as underreporters is based on the premise that individuals in
energy balance, that is, whose weights are constant, have equivalent energy intake and
expenditure (Goldberg et al., 1991; Trabulsi; Schoeller, 2001). Energy intake determined by
quantitative survey can be confirmed by doubly labeled water (DLW), which accurately
measures total energy expenditure (TEE) (Schoeller, 1999). The energy intake reported in food
intake assessments is usually much lower than the actual energy intake (Black, Cole, 2001).
A review of DLW and calorimetry studies treated the intra-and interindividual energy intake
variations statistically to establish the cutoff points that identify the lowest, plausible energy
intake levels and expressed them as multiples of the resting energy expenditure (REE)
(Goldberg et al., 1991). The TEE:REE ratio is known as the physical activity level (PAL). In
energy balance, reported energy intake (EIrep) divided by REE should be equal to the TEE
divided by REE, that is, EIrep:REE=TEE:REE or EIrep:REE=PAL. Many adjustments have been
proposed to maximize the sensitivity and specificity of the cutoff point. Different studies have
replaced variables of the Goldberg’s equation, one at a time, by constants (Black, 2000),
especially PAL, sample size, and number of food intake assessments (Black et al., 1991; Black,
2000; Goldberg et al., 1991; Abbot et al., 2008). Our research group Quesada (2011) used the
Goldberg’s equation in six different ways to classify the underreporting of 100 morbidly obese
women. The prevalence of underreporting varied significantly, from 43% to 92%. This
difference stemmed mainly from the intraindividual variations of the study sample, namely
PAL and sample size, which minimized the underreporting interpretation error when used in
the equation.
Nowadays studies tend to investigate food pattern, as opposed to individual nutrients, to
establish relationships between diet and the health statuses of intragroup individuals (Hu,
2002). Dietary pattern analysis characterizes the eating behavior of population groups,
elucidating the association between diet and health and/or other factors (Moeller et al., 2007).
Dietary patterns characterized by the intake of fruits, vegetables, whole grains, fish, and
poultry have been associated with a high intake of micronutrients and with selected biomark‐
ers of dietary exposure and disease risk in the expected direction (Kant, 2004).
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index (Parikn et al., 2004; Carlin et al., 2005; McGil et al., 2008; Cimbek et al., 2012; Taheri et
al., 2012).
The prevalences of micronutrient deficiencies vary between studies (Flancbaum et al., 2006;
Carlin et al., 2006; Aasheim et al., 2008; Toh, Zarshenas, Jorgensen, 2009; Gammel et al., 2009;
Fish et al., 2010; Casagrande et al., 2010; Ducloux et al., 2011; Moizé et al., 2011; Jastrzębska-
Mierzyńska et al., 2012; de Luis et al., 2013; Censani et al., 2013). These differences may stem
from different food habits, which vary between cities, states, and countries. Therefore,
nutritional assessment by laboratory tests and food surveys is strongly recommended to detect
nutritional insufficiencies early and make the necessary nutritional interventions. Symptoms
caused by undetected preexisting deficiencies may become worse during the postoperative
period. Since biochemical tests are expensive, Mechanick et al., (2013) suggest starting
micronutrient supplementation in the preoperative period.
Gastric surgery is essential for promoting energy intake restriction and consequently, energy
deficit and weight loss. Nonetheless, this procedure may induce strong aversion to certain
foods, malnutrition, and specific micronutrient deficiencies. Recently, the American Associa‐
tion of Clinical Endocrinologists, The Obesity Society and the American Society for Metabolic
& Bariatric Surgery (Mechanick et al., 2013) published the nutritional requirements of ex-obese
bariatric patients. In summary, these individuals should take multivitamin and multimineral
supplements that help them to meet their daily requirements of the main micronutrients
(elemental calcium: 1200-1500 mg; vitamin D: 3000 IU; vitamin B12: 1000 mcg; folic acid: 400
μg; iron: 45-60 mg) and protein (1.5 grams (60g/d) per kilogram of body weight).
4. Food intake assessment
Determining food intake is a constant challenge for the science and practice of nutrition and
dietetics. Food surveys indirectly assess nutritional status. They are always under scrutiny
because of their limited ability to measure energy and nutrient intakes. Quantitative and
qualitative food intake can be determined by different methods, such as recalls, in which
individuals remember the foods they ate. The most important of these retrospective methods
are the food frequency questionnaire (FFQ) and the 24-hour recall (24HR). Food intake may
also be investigated prospectively by asking individuals to write down the foods they eat in a
food diary or record (FD) the moment they eat them (Gibson, 2005; Anjos et al., 2009).
The food intake survey of choice depends on the study objectives and population, but
administering a single 24HR or FD to assess habitual food intake is not recommended, not
even for obese individuals. Intraindividual variations, that is, daily variations in food intake,
occur, so at least two surveys should be administered on alternate days. Some studies
recommend three 24HR or FD administered on alternate days, including a weekend day
(Johnson, 2002), which allows statistical adjustment of the variances of the study days‘ mean.
Some factors may distort food intake data, such as the interviewer’s skill, interviewee’s
memory, and interview’s environment. Moreover, the assessment itself may affect an indi‐
vidual’s intake pattern and consequently, information quality. Nutrient intake estimates may
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also err because of the use of standard recipes and data variation in food composition tables
(Dodd et al., 2006).
The food intake assessment of obese patients consists of many challenges, such as obtaining
reliable information, identifying underreporting, correctly estimating energy and nutrient
requirements, and establishing the appropriate interventions (Anjos et al., 2009).
A common finding in studies that assess the food intake of obese individuals is low energy
intake, which may stem from food intake underreporting and/or physical activity overreport‐
ing (Macdiarmid; Blundell, 1998; Lichtman et al., 1992). Individual characteristics associated
with underreporting include being older, female, and physically inactive; having low social
and educational levels; restricting foods; experiencing emotional changes (Abbot et al., 2008;
Macdiarmid; Blundell, 1998); and especially, having a high body mass index, that is, being
overweight or obese (Rennie, Coward, Jebb, 2007; Scagliusi et al, 2009).
The classification of individuals as underreporters is based on the premise that individuals in
energy balance, that is, whose weights are constant, have equivalent energy intake and
expenditure (Goldberg et al., 1991; Trabulsi; Schoeller, 2001). Energy intake determined by
quantitative survey can be confirmed by doubly labeled water (DLW), which accurately
measures total energy expenditure (TEE) (Schoeller, 1999). The energy intake reported in food
intake assessments is usually much lower than the actual energy intake (Black, Cole, 2001).
A review of DLW and calorimetry studies treated the intra-and interindividual energy intake
variations statistically to establish the cutoff points that identify the lowest, plausible energy
intake levels and expressed them as multiples of the resting energy expenditure (REE)
(Goldberg et al., 1991). The TEE:REE ratio is known as the physical activity level (PAL). In
energy balance, reported energy intake (EIrep) divided by REE should be equal to the TEE
divided by REE, that is, EIrep:REE=TEE:REE or EIrep:REE=PAL. Many adjustments have been
proposed to maximize the sensitivity and specificity of the cutoff point. Different studies have
replaced variables of the Goldberg’s equation, one at a time, by constants (Black, 2000),
especially PAL, sample size, and number of food intake assessments (Black et al., 1991; Black,
2000; Goldberg et al., 1991; Abbot et al., 2008). Our research group Quesada (2011) used the
Goldberg’s equation in six different ways to classify the underreporting of 100 morbidly obese
women. The prevalence of underreporting varied significantly, from 43% to 92%. This
difference stemmed mainly from the intraindividual variations of the study sample, namely
PAL and sample size, which minimized the underreporting interpretation error when used in
the equation.
Nowadays studies tend to investigate food pattern, as opposed to individual nutrients, to
establish relationships between diet and the health statuses of intragroup individuals (Hu,
2002). Dietary pattern analysis characterizes the eating behavior of population groups,
elucidating the association between diet and health and/or other factors (Moeller et al., 2007).
Dietary patterns characterized by the intake of fruits, vegetables, whole grains, fish, and
poultry have been associated with a high intake of micronutrients and with selected biomark‐
ers of dietary exposure and disease risk in the expected direction (Kant, 2004).
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The association of one or a few nutrients with a given disease has conceptual and methodo‐
logical limitations (Hu, 2002). These limitations are evidenced by the fact that they do not take
into account the complex synergy between dietary nutrients, the cumulative effects and
multiple nutrients that compose dietary patterns, the statistical significance that a wide range
of chemical elements or foods can produce, and the relationship of association between the
intake of certain nutrients and dietary patterns (Moeller et al., 2007). Hence, dietary pattern
analysis has emerged as an alternative and complementary approach in nutritional epidemio‐
logical studies that evidence the relationship between the overall diet and the risk of chronic
diseases (Hu, 2002).
Multivariate statistical analyses have been used for defining dietary patterns. Factor analysis,
which includes both principal component analysis (PCA) and factorial analysis, is a multi‐
variate statistical technique that uses food intake data to identify common subjacent dietary
factors or patterns (Hu, 2002; Moeller et al., 2007). Cluster analysis, another multivariate
method, aggregates individuals into relatively homogeneous subgroups with similar dietary
characteristics. These techniques allow the classification of individuals into distinct groups or
in groups according to food intake frequency; classification of foods or food groups according
to their percentage energy contribution or mean amount consumed in grams; establishment
of nutrient intake patterns; and combination of dietary and biochemical measurements (Hu,
2002; Moeller et al., 2007).
The association between dietary pattern and the prevalence of obesity and/or cardiovascular
diseases has indicated a positive correlation between certain dietary patterns and indicators
of these diseases (Berg et al., 2009; Howarth et al., 2007; Ma et al., 2003; Meyer et al., 2011;
Newby et al., 2003; Neumann et al., 2007; Sherafat-kazemzadeh et al., 2010; Sichieri, 2002).
Nevertheless, reviews on dietary patterns and their relationship with certain diseases have
found data inconsistencies, signaling the need of more thorough studies on this theme
(Bhupathiraju; Tucker, 2011; Kant, 2004; Togo et al., 2001).
Based on the high frequency of food intake underreporting among the obese, some food groups
and/or nutrients in the dietary patterns of obese women classified as energy intake underre‐
porters may vary, so more studies are needed to identify the intake particularities of this
population. In our group, Ravelli (2013) found that women often underreported their energy
intake and that underreporting was associated with a healthier dietary pattern than the pattern
of women who reported their intake correctly. This suggests that underreporting involves
foods that obese individuals should restrict.
5. Dietary approach of preoperative patients
The objective of bariatric surgery is to reduce energy intake and consequently promote weight
loss, better quality of life, and the improvement of associated comorbidities. Long-term weight
loss maintenance depends on the development of a multidisciplinary education program
focusing on the surgery, making patients and family members aware of its risks and benefits,
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the importance of adhering to the dietary recommendations because of the anatomical and
hormonal changes, and the resultant biopsychosocial and physical activity changes.
Once the type of surgery is selected, patients should undergo a nutritional assessment as soon
as possible to identify possible nutritional deficiencies, establish a plan to promote dietary
adequacy, and make sure they understand the dietary changes they will experience to prevent
postoperative complications. Factors such as the patient‘s readiness for change, realistic
expectations, general food and nutrition knowledge, and financial aspects must be investigat‐
ed and clarified during the preoperative nutritional treatment.
5.1. Initial interventions and strategies for preoperative weight loss
Planning the nutritional intervention requires defining treatment objectives. Goals are
individual and based on associated diseases, personal preferences, and habits mentioned in
the nutritional anamnesis. Weight loss maintenance demands the adoption of proper food
choice-related habits and practices, eating behaviors, and energy expenditure.
The preoperative nutritional approach may be collective or individual. We conduct a complete
nutritional anamnesis in our first meeting with the patients and seize the opportunity to help
them to improve their dietary habits, bond with them, destroy misconceptions and myths, and
inform them about the surgery and the necessary postoperative dietary changes required by
the surgery of choice.
5.1.1. Nutritional anamnesis
Nutritional anamnesis has a critical role in nutrition and health research. Its objective is to
characterize the general nutritional status of an individual to determine the appropriate
intervention.
Anamnesis consists of:
• Anthropometric assessment: preoperative weight, height, body mass index (BMI=kg/m2),
percentage of excess weight (%), and body composition determined by bioelectrical
impedance analysis;
• History of weight and previous treatments: patients are asked about the details of their
obesity history, unsuccessful weight loss treatments, life events that may have promoted
weight changes, weight loss expectations, and previous clinical treatments;
• Biochemical parameters: includes the tests routinely requested by the surgeon and endo‐
crinologist during the preoperative period as recommended by the Brazilian Society of
Bariatric and Metabolic Surgery and American Society for Metabolic & Bariatric Surgery;
• Clinical history: assesses the patients’ comorbidities and the drugs and supplements they
are taking and verifies the presence of orthodontic and sight problems and of food allergies.
Bowel movements, voiding habits, and menstrual frequency are also investigated;
• Smoking: the patients are asked about their smoking habits, including the number of
cigarettes consumed per day;
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The association of one or a few nutrients with a given disease has conceptual and methodo‐
logical limitations (Hu, 2002). These limitations are evidenced by the fact that they do not take
into account the complex synergy between dietary nutrients, the cumulative effects and
multiple nutrients that compose dietary patterns, the statistical significance that a wide range
of chemical elements or foods can produce, and the relationship of association between the
intake of certain nutrients and dietary patterns (Moeller et al., 2007). Hence, dietary pattern
analysis has emerged as an alternative and complementary approach in nutritional epidemio‐
logical studies that evidence the relationship between the overall diet and the risk of chronic
diseases (Hu, 2002).
Multivariate statistical analyses have been used for defining dietary patterns. Factor analysis,
which includes both principal component analysis (PCA) and factorial analysis, is a multi‐
variate statistical technique that uses food intake data to identify common subjacent dietary
factors or patterns (Hu, 2002; Moeller et al., 2007). Cluster analysis, another multivariate
method, aggregates individuals into relatively homogeneous subgroups with similar dietary
characteristics. These techniques allow the classification of individuals into distinct groups or
in groups according to food intake frequency; classification of foods or food groups according
to their percentage energy contribution or mean amount consumed in grams; establishment
of nutrient intake patterns; and combination of dietary and biochemical measurements (Hu,
2002; Moeller et al., 2007).
The association between dietary pattern and the prevalence of obesity and/or cardiovascular
diseases has indicated a positive correlation between certain dietary patterns and indicators
of these diseases (Berg et al., 2009; Howarth et al., 2007; Ma et al., 2003; Meyer et al., 2011;
Newby et al., 2003; Neumann et al., 2007; Sherafat-kazemzadeh et al., 2010; Sichieri, 2002).
Nevertheless, reviews on dietary patterns and their relationship with certain diseases have
found data inconsistencies, signaling the need of more thorough studies on this theme
(Bhupathiraju; Tucker, 2011; Kant, 2004; Togo et al., 2001).
Based on the high frequency of food intake underreporting among the obese, some food groups
and/or nutrients in the dietary patterns of obese women classified as energy intake underre‐
porters may vary, so more studies are needed to identify the intake particularities of this
population. In our group, Ravelli (2013) found that women often underreported their energy
intake and that underreporting was associated with a healthier dietary pattern than the pattern
of women who reported their intake correctly. This suggests that underreporting involves
foods that obese individuals should restrict.
5. Dietary approach of preoperative patients
The objective of bariatric surgery is to reduce energy intake and consequently promote weight
loss, better quality of life, and the improvement of associated comorbidities. Long-term weight
loss maintenance depends on the development of a multidisciplinary education program
focusing on the surgery, making patients and family members aware of its risks and benefits,
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the importance of adhering to the dietary recommendations because of the anatomical and
hormonal changes, and the resultant biopsychosocial and physical activity changes.
Once the type of surgery is selected, patients should undergo a nutritional assessment as soon
as possible to identify possible nutritional deficiencies, establish a plan to promote dietary
adequacy, and make sure they understand the dietary changes they will experience to prevent
postoperative complications. Factors such as the patient‘s readiness for change, realistic
expectations, general food and nutrition knowledge, and financial aspects must be investigat‐
ed and clarified during the preoperative nutritional treatment.
5.1. Initial interventions and strategies for preoperative weight loss
Planning the nutritional intervention requires defining treatment objectives. Goals are
individual and based on associated diseases, personal preferences, and habits mentioned in
the nutritional anamnesis. Weight loss maintenance demands the adoption of proper food
choice-related habits and practices, eating behaviors, and energy expenditure.
The preoperative nutritional approach may be collective or individual. We conduct a complete
nutritional anamnesis in our first meeting with the patients and seize the opportunity to help
them to improve their dietary habits, bond with them, destroy misconceptions and myths, and
inform them about the surgery and the necessary postoperative dietary changes required by
the surgery of choice.
5.1.1. Nutritional anamnesis
Nutritional anamnesis has a critical role in nutrition and health research. Its objective is to
characterize the general nutritional status of an individual to determine the appropriate
intervention.
Anamnesis consists of:
• Anthropometric assessment: preoperative weight, height, body mass index (BMI=kg/m2),
percentage of excess weight (%), and body composition determined by bioelectrical
impedance analysis;
• History of weight and previous treatments: patients are asked about the details of their
obesity history, unsuccessful weight loss treatments, life events that may have promoted
weight changes, weight loss expectations, and previous clinical treatments;
• Biochemical parameters: includes the tests routinely requested by the surgeon and endo‐
crinologist during the preoperative period as recommended by the Brazilian Society of
Bariatric and Metabolic Surgery and American Society for Metabolic & Bariatric Surgery;
• Clinical history: assesses the patients’ comorbidities and the drugs and supplements they
are taking and verifies the presence of orthodontic and sight problems and of food allergies.
Bowel movements, voiding habits, and menstrual frequency are also investigated;
• Smoking: the patients are asked about their smoking habits, including the number of
cigarettes consumed per day;
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• Alcohol intake: the patients are asked about their drinking habits, including amount and
frequency;
• Food-related emotional aspect: the patients are asked about how their emotions affect their
eating habits;
• Physical activity: the patients are asked about their physical endurance, the types of activity
they performed in the past, and what they expect to achieve physically after surgery. At this
time the patients are informed about the importance of starting a physical activity program
supervised by a certified professional as soon as the surgeon releases them;
• Dietary history: collects information on snacking habits, mastication, fluid intake during
meals, and daily water intake;
• Food preferences: investigates patients’ food and preparation preferences, aversions, and
intolerances;
• Food intake: the patients are asked about their habitual food intake during weekdays and
weekend days; intake frequency of the main foods of each food group; meal number and
location; food preferences and aversions; possible religious and/or cultural food restrictions;
and food preparation techniques and purchasing habits to identify preparation problems
or facilities. We also routinely ask the patients to make a food diary on three nonconsecutive
days, including a weekend day, to better determine their food intake profiles.
We also take into account the reality of the patients, their jobs, routines, schedules, financial
resources, literacy levels, and regional habits to personalize the intervention, otherwise it
would be difficult to obtain good adherence to treatment.
The patients receive nutrition education based on the information collected by the nutritional
anamneses, with emphasis on healthy food choices, the importance of consuming foods from
all food groups, and the relationship between hunger and satiety. A personalized eating plan
with lower energy content is created for the patients for them to start losing weight before
surgery, reducing surgery risks and allowing us to assess their discipline.
The number and frequency of visits may vary according to the particularities of the patient
and determination of the bariatric surgery team. The objective of the follow-ups is to assess
adherence to the recommendations, weight loss, and changes in dietary habits, and to clarify
surgery-related doubts. In the last visit prior to surgery, the patient and his/her companion
receive verbal and written advice about the pre-and postoperative fluid diet.
Many issues are discussed with the patients in more detail during the visits, such as their need
to lose 5% to 10% of their body weight before surgery, the preoperative eating plan, mastica‐
tion, surgical techniques and resulting nutritional changes, healthy food choices, and specifics
about the fluid diet that should be followed before and after surgery, always emphasizing
healthy food choices and habits. The nutritional intervention also has the following cognitive
objectives:
• The surgery helps the patient to limit food intake by reducing gastric volume and absorption
area, depending on surgical technique, thereby promoting weight loss;
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• The importance of the patient assuming a compromise with his/her health, since postoper‐
ative eating discipline is critical to avoid nutritional inadequacies and/or weight regain;
• The intake of energy-dense fluids and alcoholic beverages and early or excessive inclusion
of simple sugars and fats may cause treatment failure or dumping syndrome;
• Dumping syndrome – definition, symptoms, how to avoid;
• Mastication – the patient must eat slowly to avoid the sensation of having food stuck on the
way down, malaise, or even vomiting. This is valid for fluid and solid preparations;
• Advice and required dietary changes for the preoperative (fluid) and postoperative (fluid,
soft, and general) periods, and foods that should be avoided after the surgery.
The advice regarding patients‘ new eating behavior should be provided by a dietician together
with a psychologist to encourage patients to identify inappropriate eating behaviors and teach
them new eating habits even before surgery. These recommendations increase postoperative
adherence to the nutritional therapy and reduce the incidence of postoperative complications.
6. Dietary approach of postoperative patients
Nutritional counseling after surgery is essential because of all the changes patients must make
to their eating habits. Follow-ups must be periodical to assess weight loss, encourage the
adoption of healthy eating habits, clarify doubts, and identify possible nutritional inadequa‐
cies. Counseling is critical to ensure surgery success and avoid future complications.
Nutritional recommendations may vary by type of surgery, but all of them have similar diet
therapy objectives: to reduce the work of the stomach and intestinal overload in the immediate
postoperative period and to promote healthy food choices and habits using a diet plan
associated with specific, personalized nutritional supplementation to meet the nutritional
requirements of the patient.
Patient noncompliance with postoperative control programs is usually high, especially one
year after surgery, which means lower adherence to the recommended healthy behaviors, and
consequently, risk of bariatric surgery failure. Therefore, it is essential for the patient to learn
and recognize the importance of adherence to treatment before the surgery.
6.1. Dietary changes
Ingestion is forbidden in the 24 hours that follow surgery, regardless of type. After this period
the patient may start ingesting fluids. The objective of the fluid diet is to allow gastric rest and
adaptation to small volumes, promote systemic hydration, ease the digestive process and
gastric emptying, and prevent the ingestion of residues (Aills et al., 2008).
Our patients are placed on a fluid diet three days before surgery and recommended to stay on
the diet until the twentieth day after surgery. This diet must consist exclusively of fluids.
Patients receive verbal advice and a written document containing instructions regarding
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• Alcohol intake: the patients are asked about their drinking habits, including amount and
frequency;
• Food-related emotional aspect: the patients are asked about how their emotions affect their
eating habits;
• Physical activity: the patients are asked about their physical endurance, the types of activity
they performed in the past, and what they expect to achieve physically after surgery. At this
time the patients are informed about the importance of starting a physical activity program
supervised by a certified professional as soon as the surgeon releases them;
• Dietary history: collects information on snacking habits, mastication, fluid intake during
meals, and daily water intake;
• Food preferences: investigates patients’ food and preparation preferences, aversions, and
intolerances;
• Food intake: the patients are asked about their habitual food intake during weekdays and
weekend days; intake frequency of the main foods of each food group; meal number and
location; food preferences and aversions; possible religious and/or cultural food restrictions;
and food preparation techniques and purchasing habits to identify preparation problems
or facilities. We also routinely ask the patients to make a food diary on three nonconsecutive
days, including a weekend day, to better determine their food intake profiles.
We also take into account the reality of the patients, their jobs, routines, schedules, financial
resources, literacy levels, and regional habits to personalize the intervention, otherwise it
would be difficult to obtain good adherence to treatment.
The patients receive nutrition education based on the information collected by the nutritional
anamneses, with emphasis on healthy food choices, the importance of consuming foods from
all food groups, and the relationship between hunger and satiety. A personalized eating plan
with lower energy content is created for the patients for them to start losing weight before
surgery, reducing surgery risks and allowing us to assess their discipline.
The number and frequency of visits may vary according to the particularities of the patient
and determination of the bariatric surgery team. The objective of the follow-ups is to assess
adherence to the recommendations, weight loss, and changes in dietary habits, and to clarify
surgery-related doubts. In the last visit prior to surgery, the patient and his/her companion
receive verbal and written advice about the pre-and postoperative fluid diet.
Many issues are discussed with the patients in more detail during the visits, such as their need
to lose 5% to 10% of their body weight before surgery, the preoperative eating plan, mastica‐
tion, surgical techniques and resulting nutritional changes, healthy food choices, and specifics
about the fluid diet that should be followed before and after surgery, always emphasizing
healthy food choices and habits. The nutritional intervention also has the following cognitive
objectives:
• The surgery helps the patient to limit food intake by reducing gastric volume and absorption
area, depending on surgical technique, thereby promoting weight loss;
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• The importance of the patient assuming a compromise with his/her health, since postoper‐
ative eating discipline is critical to avoid nutritional inadequacies and/or weight regain;
• The intake of energy-dense fluids and alcoholic beverages and early or excessive inclusion
of simple sugars and fats may cause treatment failure or dumping syndrome;
• Dumping syndrome – definition, symptoms, how to avoid;
• Mastication – the patient must eat slowly to avoid the sensation of having food stuck on the
way down, malaise, or even vomiting. This is valid for fluid and solid preparations;
• Advice and required dietary changes for the preoperative (fluid) and postoperative (fluid,
soft, and general) periods, and foods that should be avoided after the surgery.
The advice regarding patients‘ new eating behavior should be provided by a dietician together
with a psychologist to encourage patients to identify inappropriate eating behaviors and teach
them new eating habits even before surgery. These recommendations increase postoperative
adherence to the nutritional therapy and reduce the incidence of postoperative complications.
6. Dietary approach of postoperative patients
Nutritional counseling after surgery is essential because of all the changes patients must make
to their eating habits. Follow-ups must be periodical to assess weight loss, encourage the
adoption of healthy eating habits, clarify doubts, and identify possible nutritional inadequa‐
cies. Counseling is critical to ensure surgery success and avoid future complications.
Nutritional recommendations may vary by type of surgery, but all of them have similar diet
therapy objectives: to reduce the work of the stomach and intestinal overload in the immediate
postoperative period and to promote healthy food choices and habits using a diet plan
associated with specific, personalized nutritional supplementation to meet the nutritional
requirements of the patient.
Patient noncompliance with postoperative control programs is usually high, especially one
year after surgery, which means lower adherence to the recommended healthy behaviors, and
consequently, risk of bariatric surgery failure. Therefore, it is essential for the patient to learn
and recognize the importance of adherence to treatment before the surgery.
6.1. Dietary changes
Ingestion is forbidden in the 24 hours that follow surgery, regardless of type. After this period
the patient may start ingesting fluids. The objective of the fluid diet is to allow gastric rest and
adaptation to small volumes, promote systemic hydration, ease the digestive process and
gastric emptying, and prevent the ingestion of residues (Aills et al., 2008).
Our patients are placed on a fluid diet three days before surgery and recommended to stay on
the diet until the twentieth day after surgery. This diet must consist exclusively of fluids.
Patients receive verbal advice and a written document containing instructions regarding
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volume, fractioning, the foods they may and may not consume, a menu example, recipes, and
supplementation. The preoperative fluid diet differs from the postoperative fluid diet only in
volume. During the hospitalization period, which varies from two to four days, the patients
are given a residue-free fluid diet consisting only of water, light-colored tea, sugar-free gelatin
dessert, isotonic drinks, coconut water, and stock.
All diets are adapted to the type of surgery and the particularities of each patient. When our
patients return for a follow-up visit fifteen days after the surgery, we verify the volume they
are ingesting, meal fractioning, the use of protein and micronutrient supplements, daily water
intake, voiding habits, bowel movements, possible eating difficulties, and physical signs of
nutritional deficiencies. Our patients also receive verbal and written advice about the soft diet
that should be started twenty days after the surgery.
The second follow-up visit occurs 25 to 35 days after surgery. During this visit, we advise
patients about the general diet, examine them for physical signs of nutritional deficiencies, and
collect information about food intake during the soft-diet period, such as amounts consumed,
number of meals consumed per day, ingestion of the recommended nutrient supplements,
water intake, voiding habits, bowel movements, and eating difficulties. We also advise the
patients to start the general diet slowly, according to their recovery and food acceptance. The
general diet (solid) should begin 35 days after surgery.
Bariatric surgery patients should be nutritionally monitored. Visiting the dietician regularly
is extremely important because the small volume of the stomach greatly restricts nutrient
intake. In the first months after surgery, nausea and vomiting are common; nevertheless, they
must be investigated and the patients, counseled (Mechanick et al. 2009). The follow-up
schedule may vary according to individual needs and possible surgery complications. Some
patients even require special follow-up (Mechanick et al., 2009). We ask our patients to visit
us once a month for five months after they start the general diet, then quarterly for six months,
then semiannually or as needed.
Nutritional care after bariatric surgery has two objectives: the first is to adjust the energy and
nutrient intakes necessary for tissue repair after surgery and for preserving lean body mass
during extreme weight loss, and the second is to minimize the symptoms caused by surgery-
induced changes, such as reflux, early satiety, and dumping syndrome (Aills et al., 2008).
The manner in which postoperative weight loss factors interact determines how surgery affects
body weight in the short and long terms, hence the importance of knowing the weight loss
pattern and related factors. Long-term follow-up is also advised to monitor the outcome and
make sure that the surgery-related benefits are long-lived.
7. Dietary approaches to prevent and treat postoperative complications
The main comorbidities associated with obesity, such as diabetes and high blood pressure,
improve significantly shortly after bariatric surgery, but other complications may arise given
the surgery-induced anatomic and physiological changes. The most common postoperative
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complications include nutritional deficiencies, anemia, dumping syndrome, vomiting, and
alopecia.
Nutritional deficiencies (iron and anemia, calcium, vitamins D, B12, B6, and B1, zinc, and protein-
energy malnutrition) and their consequences may occur after surgery, especially in the long-
term. The severity of these complications depends on the extension of the anatomic and
physiological changes made to the gastrointestinal tract, as mentioned earlier. Nutritional
deficiencies may cause severe morbidity and irreversible damage, and conventional supple‐
mentation is often not enough. Specific inadequacies must be corrected to restore normal
serum levels and avoid greater consequences. It is essential to perform periodical tests as
recommended by the guidelines to measure the serum levels of certain nutrients (Heber et al.,
2010).
Patients who undergo mixed surgeries (RYGB) and mostly malabsorptive mixed surgeries
(BPD) require specific monitoring and supplementation, especially in the first year after
surgery. Additional supplements of iron and calcium, water-soluble vitamins, and vitamins
A and D are prescribed more often to BPD-DS (55%) patients than to RYGB (26%) patients
(Aasheim et al., 2009).
Bariatric patients require a minimum daily mineral and vitamin supplementation of one (AGB)
to two (RYGB, BPD, and SG) multivitamin and multimineral tablets, 1200-1500 mg of elemental
calcium in the form of citrate divided throughout the day, 3000 IU of vitamin D (to keep serum
25(OH)D above 30ng/mL), and enough vitamin B12 to maintain normal serum values. Vitamin
B12 can be taken orally, sublingually, intranasally, or intramuscularly as follows: 350 mcg orally
per day; or 500 mcg intranasally per week; or 1000 mcg intramuscularly per month; or 3000
mcg intramuscularly semiannually. Finally, the amount of folic acid present in multivitamins
is adequate (400 mcg) (Mechanick et al., 2009; Mechanick, et al., 2013).
The vitamin B12 status of all patients undergoing bariatric surgery, regardless of type, should
be assessed before surgery, and of patients who lost the lower part of their stomach (SG, RYGB
and BPD), should also be assessed annually after surgery. Supplementation with 1000 ug or
more of crystalline vitamin B12 daily may be necessary to maintain adequate serum levels of
this vitamin (Kehagias et al., 2011).
Conventional or additional supplementation should provide 45 to 60 mg of iron per day. Iron
serum levels should be monitored in all bariatric surgery patients and individuals with iron-
deficiency anemia. Anemia treatment includes the prescription of 150 to 200 mg of elemental
iron orally per day in the form of iron sulfate, fumarate, or gluconate. Vitamin C may be taken
simultaneously to increase iron absorption. Intravenous iron infusion is indicated for patients
with severe deficiency, oral intolerance, or refractory anemia due to severe iron malabsorption.
Nutritional anemia stemming from malabsorptive bariatric surgeries also include deficiency
of vitamin B12, folic acid, protein-energy, copper, selenium, and zinc, so these deficiencies must
be assessed and corrected in patients with persistent anemia (Aills et al., 2008).
Protein-energy malnutrition is usually accompanied by hypoalbuminemia, alopecia, asthenia,
and anemia. Some studies have found that two years after surgery, 5% to 13% of RYGB patients
and 3% to 18% of BPD patients have hypoalbuminemia. Bariatric patients should ingest at least
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volume, fractioning, the foods they may and may not consume, a menu example, recipes, and
supplementation. The preoperative fluid diet differs from the postoperative fluid diet only in
volume. During the hospitalization period, which varies from two to four days, the patients
are given a residue-free fluid diet consisting only of water, light-colored tea, sugar-free gelatin
dessert, isotonic drinks, coconut water, and stock.
All diets are adapted to the type of surgery and the particularities of each patient. When our
patients return for a follow-up visit fifteen days after the surgery, we verify the volume they
are ingesting, meal fractioning, the use of protein and micronutrient supplements, daily water
intake, voiding habits, bowel movements, possible eating difficulties, and physical signs of
nutritional deficiencies. Our patients also receive verbal and written advice about the soft diet
that should be started twenty days after the surgery.
The second follow-up visit occurs 25 to 35 days after surgery. During this visit, we advise
patients about the general diet, examine them for physical signs of nutritional deficiencies, and
collect information about food intake during the soft-diet period, such as amounts consumed,
number of meals consumed per day, ingestion of the recommended nutrient supplements,
water intake, voiding habits, bowel movements, and eating difficulties. We also advise the
patients to start the general diet slowly, according to their recovery and food acceptance. The
general diet (solid) should begin 35 days after surgery.
Bariatric surgery patients should be nutritionally monitored. Visiting the dietician regularly
is extremely important because the small volume of the stomach greatly restricts nutrient
intake. In the first months after surgery, nausea and vomiting are common; nevertheless, they
must be investigated and the patients, counseled (Mechanick et al. 2009). The follow-up
schedule may vary according to individual needs and possible surgery complications. Some
patients even require special follow-up (Mechanick et al., 2009). We ask our patients to visit
us once a month for five months after they start the general diet, then quarterly for six months,
then semiannually or as needed.
Nutritional care after bariatric surgery has two objectives: the first is to adjust the energy and
nutrient intakes necessary for tissue repair after surgery and for preserving lean body mass
during extreme weight loss, and the second is to minimize the symptoms caused by surgery-
induced changes, such as reflux, early satiety, and dumping syndrome (Aills et al., 2008).
The manner in which postoperative weight loss factors interact determines how surgery affects
body weight in the short and long terms, hence the importance of knowing the weight loss
pattern and related factors. Long-term follow-up is also advised to monitor the outcome and
make sure that the surgery-related benefits are long-lived.
7. Dietary approaches to prevent and treat postoperative complications
The main comorbidities associated with obesity, such as diabetes and high blood pressure,
improve significantly shortly after bariatric surgery, but other complications may arise given
the surgery-induced anatomic and physiological changes. The most common postoperative
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complications include nutritional deficiencies, anemia, dumping syndrome, vomiting, and
alopecia.
Nutritional deficiencies (iron and anemia, calcium, vitamins D, B12, B6, and B1, zinc, and protein-
energy malnutrition) and their consequences may occur after surgery, especially in the long-
term. The severity of these complications depends on the extension of the anatomic and
physiological changes made to the gastrointestinal tract, as mentioned earlier. Nutritional
deficiencies may cause severe morbidity and irreversible damage, and conventional supple‐
mentation is often not enough. Specific inadequacies must be corrected to restore normal
serum levels and avoid greater consequences. It is essential to perform periodical tests as
recommended by the guidelines to measure the serum levels of certain nutrients (Heber et al.,
2010).
Patients who undergo mixed surgeries (RYGB) and mostly malabsorptive mixed surgeries
(BPD) require specific monitoring and supplementation, especially in the first year after
surgery. Additional supplements of iron and calcium, water-soluble vitamins, and vitamins
A and D are prescribed more often to BPD-DS (55%) patients than to RYGB (26%) patients
(Aasheim et al., 2009).
Bariatric patients require a minimum daily mineral and vitamin supplementation of one (AGB)
to two (RYGB, BPD, and SG) multivitamin and multimineral tablets, 1200-1500 mg of elemental
calcium in the form of citrate divided throughout the day, 3000 IU of vitamin D (to keep serum
25(OH)D above 30ng/mL), and enough vitamin B12 to maintain normal serum values. Vitamin
B12 can be taken orally, sublingually, intranasally, or intramuscularly as follows: 350 mcg orally
per day; or 500 mcg intranasally per week; or 1000 mcg intramuscularly per month; or 3000
mcg intramuscularly semiannually. Finally, the amount of folic acid present in multivitamins
is adequate (400 mcg) (Mechanick et al., 2009; Mechanick, et al., 2013).
The vitamin B12 status of all patients undergoing bariatric surgery, regardless of type, should
be assessed before surgery, and of patients who lost the lower part of their stomach (SG, RYGB
and BPD), should also be assessed annually after surgery. Supplementation with 1000 ug or
more of crystalline vitamin B12 daily may be necessary to maintain adequate serum levels of
this vitamin (Kehagias et al., 2011).
Conventional or additional supplementation should provide 45 to 60 mg of iron per day. Iron
serum levels should be monitored in all bariatric surgery patients and individuals with iron-
deficiency anemia. Anemia treatment includes the prescription of 150 to 200 mg of elemental
iron orally per day in the form of iron sulfate, fumarate, or gluconate. Vitamin C may be taken
simultaneously to increase iron absorption. Intravenous iron infusion is indicated for patients
with severe deficiency, oral intolerance, or refractory anemia due to severe iron malabsorption.
Nutritional anemia stemming from malabsorptive bariatric surgeries also include deficiency
of vitamin B12, folic acid, protein-energy, copper, selenium, and zinc, so these deficiencies must
be assessed and corrected in patients with persistent anemia (Aills et al., 2008).
Protein-energy malnutrition is usually accompanied by hypoalbuminemia, alopecia, asthenia,
and anemia. Some studies have found that two years after surgery, 5% to 13% of RYGB patients
and 3% to 18% of BPD patients have hypoalbuminemia. Bariatric patients should ingest at least
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60 grams of protein a day, or 1.5g/kg of the ideal body weight a day, or if necessary 2.1g/kg of
the ideal body weight a day (Mechanick, et al., 2013).
Bone loss may occur in the long run, especially in women, so complete assessment of calcium
metabolism is essential to make sure that the ingested and absorbed amounts are enough to
prevent metabolic bone disease. RYGB, BPD, or BPD-DS patients must take calcium citrate and
vitamin D [ergocalciferol (D2) or cholecalciferol (D3)] orally to prevent or minimize secondary
hyperparathyroidism without inducing hypercalciuria. In severe cases of vitamin D malab‐
sorption, oral doses may be increased to 50,000 IU one to three times a week or even daily.
Hypophosphatemia is usually due to vitamin D deficiency. An oral phosphate supplement
should be taken when the serum level is in the 1.5 to 2.5 mg/dL bracket (Mechanick, et al., 2013).
Vitamin A deficiency may cause vision problems. Supplementation, isolated or combined with
other fat-soluble vitamins, is recommended for patients who undergo purely malabsorptive
procedures, such as BPD or BPD-DS. There is no evidence to suggest that bariatric surgery
patients should be routinely screened for low levels of essential fatty acids, vitamin E, or
vitamin K. However, health care providers should consider vitamin K assessment when they
find an established deficiency of fat-soluble vitamins (hepatopathy, coagulopathy, or osteo‐
porosis) (Aasheim et al., 2009).
There is also no evidence to suggest that routine selenium screening or supplementation is
necessary after bariatric surgery. Nevertheless, health care providers should measure the
serum selenium levels of patients who undergo malabsorptive surgeries or of patients with
anemia, fatigue, persistent diarrhea, cardiomyopathy, or metabolic bone disease. Zinc
deficiency should be assessed routinely in BPD or BPD-DS patients or patients with alopecia,
ageusia, and dysgeusia (Aills et al., 2008).
Copper supplementation (2 mg/day) should be included as part of the supplementation
routine. Consider measuring the serum copper level of patients with persistent anemia,
neutropenia, myeloneuropathy, and poor wound healing. Patients being treated for zinc
deficiency and alopecia should take 1 mg of copper for each 8 to 15 mg of zinc since zinc
supplementation may cause copper deficiency (Mechanick, et al., 2013).
Vomiting may occur in the postoperative period, especially in the first months after surgery,
and is generally precipitated by eating more than the stomach can hold or not chewing well.
It may also indicate other problems, such as stenosis or intolerance to solid foods (Fujioka,
2005).
Intolerance to solid foods is the main characteristic of patients who are not chewing foods well
enough, especially foods that are harder to chew, such as meats, non-starchy vegetables, and
all foods with a more fibrous consistency. These patients prefer softer foods, such as soups
(with a high proportion of carbohydrates), pasta, puree, soufflé, ice cream, cookies, certain
savory snacks and pastries, and other foods that do not require much effort to chew and
swallow.
After surgery bariatric patients may also experience trauma or fear for not knowing how much
food to put in their mouths at a time or how much to chew before swallowing, and end up
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feeling nauseated, vomiting, or feeling that the bolus got stuck somewhere between the throat
and the stomach.
Patients with persistent vomiting who chew well but are intolerant to solids should be
specifically examined for stenosis by the surgeon to rule out functional disorders, even if the
intolerance developed postoperatively (Fujioka, 2005).
Frequent vomiting may cause thiamine deficiency. Thiamine should be part of the conven‐
tional supplementation, as the other water-soluble vitamins. Susceptible patients include those
with rapid weight loss, prolonged vomiting, excessive alcohol intake, neuropathy, encephal‐
opathy, and heart failure. Patients with suspected or established severe thiamine deficiency
should receive 500mg of intravenous thiamine daily for three to five days, followed by 250 mg
daily for three to five days until the symptoms subside. Health care providers should consider
further supplementation with 100mg orally per day for an indeterminate period or until the
risk factors are eliminated (Mechanick, et al., 2009).
Dumping syndrome is a common bariatric surgery complication experienced by roughly 70%
of RYGB patients. Foods with high osmolarity, such as those with high sugar content, cause
osmotic overload in the small intestine (Fujioka, 2005; Mechanick et al., 2009). The symptoms
include hypoglycemia, abdominal pain, nausea, diarrhea, rubor, and tachycardia (Elliot,
2003; Merchanick et al., 2009). Late dumping syndrome symptoms may be caused by reactive
hypoglycemia, normally controlled through diet or treated prophylactically with half a cup of
orange juice roughly one hour after a meal (Mechanick et al., 2009).
Bariatric patients must learn about dumping syndrome, its symptoms, and which foods to
avoid before surgery. During the nutrition education process, we strongly encourage our
patients to restrict the intake of simple sugars and reduce the intake of high-fat foods before
and after surgery. Patients are also encouraged to eat small amounts at a time, avoid ingesting
fluids thirty minutes before and after a solid meal, prefer complex carbohydrates to simple
ones, and increase protein intake.
Alopecia, classified as a nutritional complication of bariatric surgery, occurs mainly in the first
year after surgery, a time of intense weight loss and patients‘ adaptation to diet and their new
gastrointestinal system. Nutritional deficiency-related alopecia is mainly associated with the
deficiency of zinc, iron, proteins, and essential fatty acids, so requires proper supplementation.
Most bariatric patients may experience one or more nutritional deficiencies, justifying the need
of lifelong vitamin and mineral supplementation after surgery, and macronutrient supple‐
mentation when necessary. Thus, the dietician assumes the critical role of preventing and
correcting nutritional changes after bariatric surgery.
8. Dietary approach for preventing weight regain
Bariatric surgery promotes the control of obesity, not the cure, and complications may occur
at any time (Novais et al., 2010). Weight loss after bariatric surgery is clearly visible, with
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60 grams of protein a day, or 1.5g/kg of the ideal body weight a day, or if necessary 2.1g/kg of
the ideal body weight a day (Mechanick, et al., 2013).
Bone loss may occur in the long run, especially in women, so complete assessment of calcium
metabolism is essential to make sure that the ingested and absorbed amounts are enough to
prevent metabolic bone disease. RYGB, BPD, or BPD-DS patients must take calcium citrate and
vitamin D [ergocalciferol (D2) or cholecalciferol (D3)] orally to prevent or minimize secondary
hyperparathyroidism without inducing hypercalciuria. In severe cases of vitamin D malab‐
sorption, oral doses may be increased to 50,000 IU one to three times a week or even daily.
Hypophosphatemia is usually due to vitamin D deficiency. An oral phosphate supplement
should be taken when the serum level is in the 1.5 to 2.5 mg/dL bracket (Mechanick, et al., 2013).
Vitamin A deficiency may cause vision problems. Supplementation, isolated or combined with
other fat-soluble vitamins, is recommended for patients who undergo purely malabsorptive
procedures, such as BPD or BPD-DS. There is no evidence to suggest that bariatric surgery
patients should be routinely screened for low levels of essential fatty acids, vitamin E, or
vitamin K. However, health care providers should consider vitamin K assessment when they
find an established deficiency of fat-soluble vitamins (hepatopathy, coagulopathy, or osteo‐
porosis) (Aasheim et al., 2009).
There is also no evidence to suggest that routine selenium screening or supplementation is
necessary after bariatric surgery. Nevertheless, health care providers should measure the
serum selenium levels of patients who undergo malabsorptive surgeries or of patients with
anemia, fatigue, persistent diarrhea, cardiomyopathy, or metabolic bone disease. Zinc
deficiency should be assessed routinely in BPD or BPD-DS patients or patients with alopecia,
ageusia, and dysgeusia (Aills et al., 2008).
Copper supplementation (2 mg/day) should be included as part of the supplementation
routine. Consider measuring the serum copper level of patients with persistent anemia,
neutropenia, myeloneuropathy, and poor wound healing. Patients being treated for zinc
deficiency and alopecia should take 1 mg of copper for each 8 to 15 mg of zinc since zinc
supplementation may cause copper deficiency (Mechanick, et al., 2013).
Vomiting may occur in the postoperative period, especially in the first months after surgery,
and is generally precipitated by eating more than the stomach can hold or not chewing well.
It may also indicate other problems, such as stenosis or intolerance to solid foods (Fujioka,
2005).
Intolerance to solid foods is the main characteristic of patients who are not chewing foods well
enough, especially foods that are harder to chew, such as meats, non-starchy vegetables, and
all foods with a more fibrous consistency. These patients prefer softer foods, such as soups
(with a high proportion of carbohydrates), pasta, puree, soufflé, ice cream, cookies, certain
savory snacks and pastries, and other foods that do not require much effort to chew and
swallow.
After surgery bariatric patients may also experience trauma or fear for not knowing how much
food to put in their mouths at a time or how much to chew before swallowing, and end up
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feeling nauseated, vomiting, or feeling that the bolus got stuck somewhere between the throat
and the stomach.
Patients with persistent vomiting who chew well but are intolerant to solids should be
specifically examined for stenosis by the surgeon to rule out functional disorders, even if the
intolerance developed postoperatively (Fujioka, 2005).
Frequent vomiting may cause thiamine deficiency. Thiamine should be part of the conven‐
tional supplementation, as the other water-soluble vitamins. Susceptible patients include those
with rapid weight loss, prolonged vomiting, excessive alcohol intake, neuropathy, encephal‐
opathy, and heart failure. Patients with suspected or established severe thiamine deficiency
should receive 500mg of intravenous thiamine daily for three to five days, followed by 250 mg
daily for three to five days until the symptoms subside. Health care providers should consider
further supplementation with 100mg orally per day for an indeterminate period or until the
risk factors are eliminated (Mechanick, et al., 2009).
Dumping syndrome is a common bariatric surgery complication experienced by roughly 70%
of RYGB patients. Foods with high osmolarity, such as those with high sugar content, cause
osmotic overload in the small intestine (Fujioka, 2005; Mechanick et al., 2009). The symptoms
include hypoglycemia, abdominal pain, nausea, diarrhea, rubor, and tachycardia (Elliot,
2003; Merchanick et al., 2009). Late dumping syndrome symptoms may be caused by reactive
hypoglycemia, normally controlled through diet or treated prophylactically with half a cup of
orange juice roughly one hour after a meal (Mechanick et al., 2009).
Bariatric patients must learn about dumping syndrome, its symptoms, and which foods to
avoid before surgery. During the nutrition education process, we strongly encourage our
patients to restrict the intake of simple sugars and reduce the intake of high-fat foods before
and after surgery. Patients are also encouraged to eat small amounts at a time, avoid ingesting
fluids thirty minutes before and after a solid meal, prefer complex carbohydrates to simple
ones, and increase protein intake.
Alopecia, classified as a nutritional complication of bariatric surgery, occurs mainly in the first
year after surgery, a time of intense weight loss and patients‘ adaptation to diet and their new
gastrointestinal system. Nutritional deficiency-related alopecia is mainly associated with the
deficiency of zinc, iron, proteins, and essential fatty acids, so requires proper supplementation.
Most bariatric patients may experience one or more nutritional deficiencies, justifying the need
of lifelong vitamin and mineral supplementation after surgery, and macronutrient supple‐
mentation when necessary. Thus, the dietician assumes the critical role of preventing and
correcting nutritional changes after bariatric surgery.
8. Dietary approach for preventing weight regain
Bariatric surgery promotes the control of obesity, not the cure, and complications may occur
at any time (Novais et al., 2010). Weight loss after bariatric surgery is clearly visible, with
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consequent improvement of the comorbidities and quality of life. Therefore, weight loss is
considered one of the main parameters for defining bariatric surgery success (Brolin, 2002;
Brolin, 2007; Silver et al., 2006; Novais et al., 2010). Researchers unanimously agree that a
successful outcome requires an excess weight loss (%EWL) of at least 50% and the long-term
maintenance of the weight loss (Capella, Capella, 1996; Brolin et al., 1994; Brolin, 2002; Fobi,
2004; Brolin 2007; Silver et al., 2006; Novais, 2010).
Weight regain after surgery may be promoted by physiological adaptations of the gastroin‐
testinal tract. Adoption of a healthy lifestyle protects bariatric patients from old habits directly
related to obesity. This new behavior is important to maintain the new body weight in the long
run, so the support of a certified multidisciplinary team is critical (Bond et al., 2004; Novais et
al., 2010).
Weight loss and control after surgery are checked routinely. Many indicators are used for this
purpose, such as BMI, percentage of the initial weight loss, and percentage of excess weight
loss. We use the latter in our practice.
Most of the weight loss occurs in the six months after surgery, when food intake restriction is
greater (Novais et al., 2010). Patients submitted to malabsorptive procedures may lose 0.2 –
0.5 kg per day, achieving a loss of 18 – 40.5 kg in the first three months after surgery. The weight
lost peaks between 12 and 18 months after surgery (Mechanick et al., 2009, Novais et al., 2010).
Small weight loss after surgery should be investigated by the multidisciplinary team. The
dietician must check the patient’s food habits, especially the intake of energy-dense foods.
Some studies found that even bariatric patients may regain weight (Kaplan, 2005; Livingston,
2005), especially three to five years after surgery (Brolin et al., 1994; Buchwald et al., 2004;
Mechanick et al., 2009). Obesity may recur because it is a chronic disease. Patients must
understand that weight fluctuations are normal and perfectly acceptable. Weight-loss plateau
or even a small weight regain are part of the normal weight loss process. Professionals must
emphasize on the better quality of life, healthy behaviors, and better health status instead of
percentage of excess weight loss as a measure of success.
Our group (Novais, 2009) investigated the food intake, weight history, and quality of life of
141 females two years after bariatric surgery and found that 84.4% lost more than 50% of their
excess perioperative weight. Significant weight loss occurred in the first six months after
surgery and stabilized two years after surgery. About 15% of the patients regained part of their
excess weight. In another study our group (Fogaça, 2009) assessed the factors associated with
weight regain in women two years after bariatric surgery and found that the resting energy
expenditure adjusted for total and lean body mass, and the serum lipids, glucose, insulin, and
leptin of women who regained more than 10% of their weight did not differ significantly from
those of the controls-women who did not regain weight.
Food habits impact weight loss speed and long-term maintenance. Hence, dieticians and
psychologists work side by side with bariatric patients with eating disorders that may promote
weight regain. Psychologists help patients to find skills that satisfy their emotional needs and
dieticians help them to effectively learn to nourish their minds and bodies, enabling them to
deal with their emotions, desires, and biological needs.
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The relationship between psychologist and dietician is essential to treat each patient individ‐
ually. Many patients do not assimilate so many changes, justifying their weight regain or
replacement of a symptom by another eating disorder or compulsive behavior. Others manage
to carry out the necessary changes, improving their emotional status and reducing their levels
of anxiety and depression. The importance of psychological and sometimes psychiatric follow-
up is clear as it helps to improve patients’ quality of life and interpersonal relationships.
Weight regain after bariatric surgery is a reality, hence the need of prospective studies with
patients in line for bariatric surgery and the critical work of a multidisciplinary team to provide
the best treatment possible and ensure a successful outcome, not only in terms of weight loss
but also in terms of body nourishment and quality of life.
9. Final considerations
As a result of the knowledge we have accumulated in our clinical and research practice and
consonant with the literature, we can state that bariatric surgery changes the nourishment
process substantially, implying the need of permanently monitoring the patients’ nutritional
status. This practice should begin already in the waiting line for bariatric surgery because
nutritional deficiencies may occur in obese individuals despite their excessive food intake; they
may either have a poor diet.
In addition to anthropometric assessment, patients should undergo a thorough assessment of
the signs and symptoms associated with nutritional deficiencies, measurement of serum
nutrient levels, and food intake assessment. Food intake assessment has technical and
operational limitations, but it is an essential tool for dietary diagnosis and prescription, and
for food and nutrition education. Food and nutrition education must be based on science and
supported by the other professionals in the team. In addition to a dietician, a psychologist is
needed to help patients to develop the skills they need to practice self-care. Furthermore,
although surgery improves the metabolic disorders associated with adipose tissue, nutritional
deficiencies should always be a target of concern, prophylactic intervention, and monitoring.
Therefore, a multidisciplinary health care team is critically needed for providing the lifelong
care required by bariatric patients.
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1. Introduction
The widespread adoption of bariatric surgery as a major therapeutic option for patients with
severe obesity, especially when associated with serious metabolic comorbidities, is a relatively
recent phenomenon and has inevitably resulted in large numbers of patients who may present
to physicians who have not had specific training in this field of medicine. Bariatric surgery has
also become one of the targets of the medical tourist industry, where patients can choose to go
abroad to get surgery which may cost only a fraction of what it would cost in the USA. In the
event of a problem occurring after the patients return home, they will most likely present to
an adjacent Emergency Room, often with little knowledge or documentation of what they had
and why. The purpose of this chapter is to highlight the major things that can go wrong after
bariatric surgery. The term complications is generally restricted to situations where surgery has
caused an identifiable disease process, for example abdominal sepsis, bowel obstruction, or
hemorrhage or malnutrition. In addition there are other adverse effects of surgery which are
not true complications but which nevertheless result in a dissatisfied patient, for example,
weight regain after initial success, the presence of large floppy folds of skin, or persistent GI
symptoms of nausea and vomiting. Although major complications after contemporary surgery
are relatively rare, they do consume a great deal of healthcare resources to investigate and
treat. They not only cause symptoms and anxiety for the patient and family, but also may be
a major source of stress for the bariatric team especially if hostility in the doctor-patient
relationship leads to a lawsuit. It is therefore especially important that all physicians are
familiar with the major forms of bariatric surgery and the spectrum of complications to which
the surgery may give rise.
Early recognition of complications and prompt treatment or referral to a specialist center is the
most important way to minimize their ill effects. This chapter will focus on the definition,
recognition and range of treatment options for the major complications of the principal
bariatric procedures in contemporary practice, based on our own experience in a tertiary
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referral center as well as major reports in the recent literature. The details of individual
operations are covered in other chapters in this book and will not be recapitulated here.
The simplest way to classify complications is to stratify them according to the time since
surgery, generally into three major time periods
• Perioperative (the first month)
• Intermediate (the first 12 months)
• Late (one or more years after the surgery)
Although there is some overlap, the spectrum of complications in each time period is suffi‐
ciently distinct to consider them separately. Perioperative complications are always managed
primarily by the surgeon but later events may be managed by the primary care physician or
other specialists.
2. Perioperative complications
Responsibility for recognition of perioperative complications always rests with the operating
surgeon. There is evidence to suggest that complications are more frequent after open bariatric
surgery than laparoscopic procedures, but some of these differences are undoubtedly related
to the fact that until recently, open procedures were used for the most high risk patients who
were felt unsuitable for laparoscopy [1].
Perioperative complications can be classified simply into Cardiorespiratory problems which
include myocardial infarction (MI), pulmonary embolism (PE) and/or Deep Venous Throm‐
bosis (DVT), Surgical problems (leak or stenosis of the anastomosis, bleeding, and incisional
problems) and issues related to the underlying comorbidities, such as the management of
CPAP machines or diabetic, transplant or antipsychotic medications.
2.1. The moribund patient
The most alarming situation confronting the surgeon in the early postoperative phase is the
patient who deteriorates within a very short time, usually with tachycardia and hypotension
and hypoxia, prompting the need for intubation and administration of pressors. Although rare,
it is important to reach a diagnosis quickly or the patient will rapidly go into an irreversible
decline. Most such cases are accounted for by a quartet of conditions – pulmonary embolism,
myocardial infarction, bleeding and sepsis (usually from a leak) – which must be immediately
considered before thinking of more esoteric conditions. When this state occurs years after
surgery, it is generally thought to be due to sepsis, but micronutrient deficiencies, particularly
of Thiamine (Vitamin B1) have occasionally been incriminated in the pathogenesis of this
critical state. This is discussed in the section of late complications.
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2.2. Cardiorespiratory complications
All of these typically present with chest pain or discomfort, shortage of breath, anxiety and
tachycardia. Perioperative myocardial infarction is high on the list in a patient with a known
history of coronary artery disease especially if it has required stenting or coronary artery
bypass grafting in the past [2]. Typically such a patient is on antiplatelet medication such as
aspirin and clopidrogel (Plavix) which has been discontinued a week before surgery and not
restarted because of the risk of creating bleeding. A patient with chest pain after surgery should
have immediate 12-lead EKG and measurement of troponin levels. Elevated troponin levels
or the presence of ST elevation should prompt immediate cardiology consultation as early clot
dissolution or re-stenting can limit the myocardial damage. Surgeons are naturally worried
about resumption of antiplatelet agents soon after surgery, but a reasonable compromise for
patients who have stopped antiplatelet therapy is to resume aspirin in the recovery ward,
usually by suppository, and restart other agents such as Clopidrogel a week later when the
risk of bleeding should have receded.
2.2.1. Venous thromboembolism (VTE)
Many factors commonly found in the bariatric population predispose to VTE, including the
mechanical effects of superobesity, prior VTE history, obesity hypoventilation syndrome, use
of hormonal therapy, immobility and venous stasis disease. Most surgeons advocate both
mechanical and chemical modes of prophylaxis in the perioperative period, and many also
recommend continuation of heparin therapy for several weeks after discharge [3].
Pulmonary embolism (PE) is very rare after laparoscopic bariatric surgery, but is a significant
risk in patients undergoing open surgery or who have surgery for complications especially in
the context of a prolonged hospital stay. The overall incidence has been estimated at 0.9% but
fatalities are estimated at 0.03% [4, 5].
Patients with a past history of Venous Thromboembolism are at greatest risk, especially if
anticoagulation was stopped in preparation for the surgery. The key features are hypoxia and
hypotension and tachypnea, and the patients are often anxious, sometimes causing the
symptoms to be dismissed as “hyperventilation syndrome.” The patient may be cyanosed with
cool sweating extremities. An EKG and chest x ray will be done immediately, chiefly to exclude
other serious pathology such as MI or tension pneumothorax. Massive pulmonary embolism
may be so rapidly fatal that no confirmation of diagnosis is possible, and the majority of deaths
that occur in contemporary practice from pulmonary embolism happen within an hour of the
onset of the symptoms.
A patient with these features suspected of pulmonary embolism needs a rapid diagnosis.
To begin anticoagulation or more invasive treatment such as fibrinolytic therapy shortly
after  major  surgery requires  more  than strong clinical  suspicion.  A bedside  echocardio‐
gram may show right ventricular dilation, and commonly a chest CT angiogram will show
significant filling defects. CT scanning is immediately available in most facilities and gives
information about massive embolism comparable to pulmonary angiography. CT confirma‐
tion is sufficient to justify invasive therapy such as anticoagulation or thrombolysis. There
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is  no time to wait for biomarkers such as BNP and D-Dimer or the results of a nuclear
medicine (V/Q) scan. The therapeutic options depend on the severity of the situation and
include anticoagulation, fibrinolytic agents,  catheter directed thrombolysis and pulmona‐
ry embolectomy. Insertion of a caval filter pending the introduction of anticoagulation is
often  recommended  in  patients  with  new-onset  deep  venous  thrombosis.  However,
prophylactic  insertion  of  caval  filters  in  patients  with  significant  risk  factors  is  more
controversial and is generally not recommended [6].
Deep venous thrombosis may occur in up to 1.3% of patients after open or laparoscopic
bariatric surgery. Despite the enhanced mobility after laparoscopic surgery, the incidence of
DVT may not be reduced as much as expected because the benefit of early motility may be
offset by the tendency of pneumoperitoneum to promote DVT. All major bariatric surgeons
are agreed that a combination of mechanical (sequential calf compression devices or anti-
embolism compressive stockings) and chemical (either unfractionated or low-molecular-
weight heparin) should be employed prophylactically. Some surgeons advocate continuation
of heparin after discharge for up to 30 days [7]. Detection on purely clinical grounds is often
difficult because of the physical dimensions of the patient’s legs, but asymmetrical edema or
leg pain should encourage the surgeon to search for DVT, usually by duplex scanning.
2.3. Bleeding
Postoperative bleeding rarely presents with such a catastrophic deterioration, but is associated
with tachycardia, oliguria and falling hemoglobin (Hb) level. Obvious risk factors include the
need for preoperative anticoagulation, or surgery rendered difficult by adhesions or limited
visibility [8].
In a patient who is hemodynamically stable there is time for confirmatory checks to ensure
a downward trend in Hb, because sometimes a patient with tachycardia or hypotension for
other  reasons  will  be  administered  large  volumes  of  IV  fluid  causing  the  Hb  to  drop
transiently by hemodilution. Postoperative bleeding may occur into the peritoneal cavity
or into the GI tract [9-11].
In the former, the only evidence of bleeding is indirect, and is inferred when the patient shows
general signs of hemorrhage including tachycardia, oliguria, hypotension and falling Hb
levels. If the recent surgery was known to be difficult the source may be easy to suspect: typical
sites are the dissection round the cardia, the omentum, or inadvertent injury to the liver or
spleen. Unless the patient is becoming hemodynamically unstable, most surgeons would
recommend transfusion of up to two units of packed red cells, since most of these bleeding
sites are self limiting. A patient who continues to bleed as evidenced by persistent tachycardia
and failure of the Hb to come up and stay up appropriately after transfusion is most safely
managed by return to the operating room. Repeat laparoscopy generally shows a substantial
amount of clot in the peritoneal cavity, but in the majority of cases the bleeding has stopped.
GI Bleeding is associated with the general signs of hemorrhage but there is also vomiting of
blood or passage of blood per rectum. The source of GI bleeding is almost always from the
staple or suture lines. Other sources of GI bleeding seen in non-bariatric practice such as
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esophageal varices or peptic ulceration are largely irrelevant to the bariatric surgery patient.
The three potential sources are from the Gastrojejunal (GJ) anastomosis, from the Jejuno-
jejunostomy (JJ), or from the long staple line in the bypassed stomach (Figure 1). GI bleeding
is more serious than intraperitoneal bleeding because the low pH of the stomach inhibits the
coagulation process and the bleed is less likely to be self limiting. Therefore, a hemodynami‐
cally unstable patient with a GI bleed should be rapidly resuscitated and returned to the
operating room immediately. It is important to have an experienced upper GI endoscopist
available. If, on putting in the laparoscope, the remnant stomach is seen to be very distended,
the source is likely in the suture line of the bypassed stomach. The stomach should be opened
and the clot evacuated. A continuous running suture to under-run the staple line is all that is
required to stop the hemorrhage and it is not necessary to open the staple line itself.
Figure 1. Diagram illustrating the potential sites of GI bleeding after gastric bypass.
Bleeding from the GJ or JJ anastomosis is more problematic and may require intraoperative
upper GI endoscopy to identify the site. The bariatric surgeon who is also a skilled endoscopist
has the advantage of knowing the anatomy of the reconstruction, but in typical practice, a
gastroenterologist or other GI surgical colleague will be helpful during return to the operating
room. Extreme gentleness of manipulation and limitation of air insufflation is essential. If the
operating surgeon sees that the remnant stomach is not distended, the Roux limb should be
clamped with long grasping forceps while the endoscopist inspects the gastric pouch and GJ
anastomosis. This limits the diffuse dilation of the entire GI tract by the endoscopist. If bleeding
is identified, it may be clipped if it is from a single site and accessible to the endoscopist, or
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the surgeon can reinforce it with a full thickness layer of running monofilament absorbable
suture. If there is no blood in the gastric pouch and the anastomosis is not bleeding, the bowel
should be clamped just distal to the JJ anastomosis and the scope advanced distally. Bleeding
of sufficient magnitude to justify return to the OR often causes large amounts of clot into the
jejunum which can then become obstructed [12].
In this case, the surgeon can make a small enterotomy and evacuate the clot because manip‐
ulating the anastomosis in this situation may cause the whole reconstruction to fall apart. If
there are no big clots visible, the operating surgeon can assist the passage of the scope by
pushing the jejunum up over the scope rather like putting the foot into a long sock. In this way
the JJ anastomosis may be reached with a conventional endoscope.
In addition to physical control of bleeding, either endoscopically or surgically, an intravenous
infusion of pantoprazole (4-8mg /hour) is recommended to produce sustained reduction of
gastric acidity and facilitate the clotting process within the upper GI tract.
2.4. Leakage and sepsis
This is the commonest and most feared early complication, and the one most directly related
to surgical technique. Leakage can occur from any suture or staple line after gastric bypass or
sleeve gastrectomy or even from unrecognized perforation at the time of adjustable band
insertion. In practice the two most common sites to leak are the staple line after sleeve
gastrectomy (where the incidence is 1-3%) and the GJ anastomosis after gastric bypass where
the incidence is in the 1% range. In revisional bariatric surgery, the risks are much higher and
the incidence may be ten times higher than in first time cases.
There are two major forms of presentation: early and delayed. Very early leaks (while the
patient is still in hospital) present with severe abdominal pain and signs of peritonitis because
there has been no time for localization. They are generally anxious or agitated. Early leaks are
presumed to be due to a technical problem in anastomotic construction such as misfiring of a
stapler or inadequate suture technique. In contrast, leaks presenting in the second week, after
the patient has left hospital and is taking a liquid diet, present more like intra-abdominal
abscess with fever and often shoulder tip pain. These later leaks may be due to ischemia of the
suture line. The development of the perforation is sufficiently gradual for some localization
by omentum and adjacent structures to have occurred.
Sometimes the symptoms of chest and shoulder discomfort and shortage of breath predomi‐
nate, leading to a workup to rule out pulmonary embolism. The surgeon should be aware that
statistically such a patient is much more likely to have a leak than a PE and should be inves‐
tigated accordingly. We often quote an old aphorism which states “the lung is the mirror of the
abdomen” meaning that pulmonary symptoms are merely reflecting some pathologic process
in the upper abdomen. There is a strong temptation for the surgeon to be in denial when faced
with a patient with pain and tachycardia after surgery. Psychologically it easier to attribute
the clinical picture to some less critical factor such as bowel distention, pneumonia, or narcotic
dependency, but the surgeon should make strenuous efforts to detect a leak before considering
these other putative causes.
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Large leaks may be detected by a contrast swallow but the sensitivity is low and the study may
not be available out of hours. It is easier to obtain an abdominal CT scan with oral and IV
contrast, which will most likely show signs of bubbles of free air and extravasated contrast
(Figure 2).
Figure 2. (a) CT Scan showing early leakage after gastric bypass. Note the small pocket of air and the small amount of
fluid over the liver, (b) A more extreme example with a greater degree of free air and fluid after a gastric bypass revi‐
sion. Note that the patient has residual barium many years after a prior leakage after a laparoscopic adjustable gastric
band
Not every leak requires an automatic return to the operating room [13]. The range of thera‐
peutic options for leaks includes simple drainage under CT guidance, stenting, clipping or
return to the OR for resuture or revision of the anastomosis, and placement of accurate drains.
It may be very difficult to identify the precise site of the leak at surgery because of the
surrounding tissue distortion and adhesions. When the leak is located, resuture alone is rarely
successful. Placement of accurate drainage is helpful, because if subsequently it is possible to
seal the leak endoscopically by clipping or deployment of a stent, there will not be a contained
pocket of contaminated contents. One promising approach is actually to insert a drain into the
leak endoscopically and provide internal drainage. Typically a biliary stent is employed for
this purpose. As the leak heals and the extraluminal cavity shrinks, the stent gets pushed more
and more into the lumen.
Leaks from sleeve gastrectomy, regardless of whether or not it was combined with a duodenal
switch, are harder to manage. Their characteristics are becoming well recognized as sleeve
gastrectomy increases in popularity almost exponentially. These leaks almost always occur at
the most proximal portion of the staple line. This is partly because it is a watershed area with
relatively poor blood supply, and also because there is frequently a relative obstruction in the
mid body portion of the stomach as the narrow gastric sleeve traverses the incisura angularis.
High pressure in the proximal portion of the gastric body promotes leakage of the staple line
and retards healing because the leak offers the path of least resistance for ingested liquids.
Gastric juice and bile as well as swallowed saliva are present, thus patients leaking from SG
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the surgeon can reinforce it with a full thickness layer of running monofilament absorbable
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the incidence is in the 1% range. In revisional bariatric surgery, the risks are much higher and
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stapler or inadequate suture technique. In contrast, leaks presenting in the second week, after
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abscess with fever and often shoulder tip pain. These later leaks may be due to ischemia of the
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by omentum and adjacent structures to have occurred.
Sometimes the symptoms of chest and shoulder discomfort and shortage of breath predomi‐
nate, leading to a workup to rule out pulmonary embolism. The surgeon should be aware that
statistically such a patient is much more likely to have a leak than a PE and should be inves‐
tigated accordingly. We often quote an old aphorism which states “the lung is the mirror of the
abdomen” meaning that pulmonary symptoms are merely reflecting some pathologic process
in the upper abdomen. There is a strong temptation for the surgeon to be in denial when faced
with a patient with pain and tachycardia after surgery. Psychologically it easier to attribute
the clinical picture to some less critical factor such as bowel distention, pneumonia, or narcotic
dependency, but the surgeon should make strenuous efforts to detect a leak before considering
these other putative causes.
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Large leaks may be detected by a contrast swallow but the sensitivity is low and the study may
not be available out of hours. It is easier to obtain an abdominal CT scan with oral and IV
contrast, which will most likely show signs of bubbles of free air and extravasated contrast
(Figure 2).
Figure 2. (a) CT Scan showing early leakage after gastric bypass. Note the small pocket of air and the small amount of
fluid over the liver, (b) A more extreme example with a greater degree of free air and fluid after a gastric bypass revi‐
sion. Note that the patient has residual barium many years after a prior leakage after a laparoscopic adjustable gastric
band
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tend to be sicker than patients leaking from gastric bypass. The same principles of treatment
are necessary, but in addition the surgeon must ensure that there is no distal resistance in the
narrow stomach. Insertion of a stent may straighten out this tight angulation, and it may in
fact be the way in which stents promote healing, since they do not produce a water tight seal.
When conservative treatments fail, operative approaches include either transecting the
stomach above the leak, which usually entails an esophago-jejunostomy, or bringing up a Roux
limb to cover the leak as described by Baltasar et al [14].
In large series reported from specialist centers, leaks after laparoscopic gastric bypass have an
incidence of 1% or less, and after sleeve gastrectomy the reported risks are in the range of 1-3%.
It is likely that in routine clinical practice these rates are higher than what is reported because
of publication bias, since units with higher complication rates are less likely to publish the
results.
In future, advances in endoscopic technology may permit better endoscopic clipping and
suturing, but these methods at present are rarely successful, mostly because the underlying
conditions-tissue ischemia and high intraluminal pressure – have not been dealt with.
2.4.1. Newer operations
Gastric plication has gained some popularity in a few centers because it is potentially reversible
and avoids the need for actual resection. Patients presenting with problems after these kinds
of procedures are usually well informed and it is generally easy to find literature reports to
elucidate confusing clinical pictures [15-17].
2.5. Wound complications
Wound problems after laparoscopic surgery are very rare, unless a circular stapler was used
to create the GJ anastomosis, in which case it is difficult to protect the wound edge from the
contaminated stapler as it is extracted from the body. After open surgery, in contrast, wound
infections are quite common, because the great depth of subcutaneous fat permits the exuda‐
tion of serum or blood which leads to infection when the surgical wound is categorized as
contaminated. Quite often it only appears after the patient is discharged and it is important to
be vigilant in the early postoperative course for signs of wound infection, which include
erythema, induration, “peau d’orange” changes in the skin, and actual fluctuation. Although
wound infection is traditionally treated by simple incision and drainage, and subsequently by
frequent packing or continuous low pressure suction, it is a very long drawn out process that
may require weeks or months to heal by secondary intention and increases the chance of
subsequent incisional herniation.
2.6. Other rare complications
2.6.1. Mesenteric venous thrombosis
This serious complication has been described after both gastric bypass and sleeve gastrectomy,
and it presents with non-specific findings of abdominal pain, nausea, vomiting and low grade
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fever and are initially suspected to have a leak. The finding of thrombosis of the mesenteric
and portal veins is readily apparent on CT scanning. Milder cases respond to systemic
anticoagulation, but some require intraportal administration of thrombolytics, and occasion‐
ally bowel resection or splenectomy is required. It is thought to represent a manifestation of
the hypercoagulable state, and a significant percentage have a history of venous thromboemb‐
olism in the past or current oral contraceptive use [18].
2.6.2. Rhabdomyolysis
One rare but immediately recognizable early complication is rhabdomyolysis of the gluteal
muscles, which presents with severe pain in the buttocks or legs. It appears to be the result of
pressure necrosis of the muscles, initially by unrelieved pressure on the operating table, and
amplified by edema and swelling within the gluteal muscle compartment [19]. If unrecognized,
extensive skin necrosis overlying the gluteal muscles may develop (Figure 3).
Figure 3. Extensive skin necrosis of the buttocks as a consequence of gluteal muscle rhabdomyolysis
It is most often noted in superobese males with diabetes and central obesity who have a
prolonged operative procedure. The swollen muscle can compress the sciatic nerve or its roots
and can release myoglobin and cause renal failure. The diagnosis is clinched by very elevated
creatine kinase (CK) levels. After uncomplicated surgery, CK levels may be up to 1200
units/l in the first 48 hours, but rhabdomyolysis causes values of 30, 000 units/l or even more.
It is important not to dismiss the symptoms as due to “arthritis” or its cutaneous manifestation
as a decubitus ulcer, because immediate decompression may limit the loss of muscle and the
extent of nerve injury. Since it was first described, widespread attention to careful padding on
the operating table and limiting the duration of surgery in high risk patients have helped
prevent the condition.
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In a similar way, compression of peripheral nerves such as the ulnar or common peroneal
nerve may occur because of positioning on the operating table during a lengthy operation.
Traction injury to the brachial plexus may occur if the angle of the outstretched arms on the
operating table is greater than 90°. When the table is put into reverse Trendelenburg position,
the body tends to slide down the table and increase this angle, leading to a traction injury
causing dysesthesia and motor weakness in the arms and hands. When a patient reports such
findings after surgery, it is important to document the time of onset and to obtain neurological
consultation, because persistence of the symptoms may prompt the patient to file a lawsuit,
especially if there was a perception that the complaint was not taken seriously [20-22].
3. Intermediate term complications: the first year
After recovery from surgery, the initial rapid rate of weight loss (often 0.5kg per day at first)
levels off so that the body weight has reached a plateau by the end of the first year. Several
issues may arise during this time, some of them surgical problems and others related to
comorbidities of difficulties in adjusting to the new state of the GI tract.
3.1. Small Bowel Obstruction
Small bowel obstruction can follow any abdominal operation. In practice, it is extremely rare
after a purely gastric operation such as SG or LAGB. The potential causes are more numerous
after operations involving intestinal rearrangement. In the first few weeks, trapping of a loop
of bowel may occur in a laparoscopic port site, or an umbilical or incisional hernia that was
not repaired at the time of the bypass. This is why it is recommended not to dissect omentum
out of abdominal wall hernias at the time of bariatric surgery unless the hernia is to be formally
repaired as part of the case. Internal hernias may occur in three situations after bypass (Figure
4). The commonest is underneath the free edge of the mesentery of the biliopancreatic limb.
There is a free cut edge of mesentery in the Roux limb in addition, but herniation under this
limb is rare if it is antecolic. If it is retrocolic, the opening in the transverse mesocolon or the
space between the mesentery and the mesocolon (Petersen’s space) are also potential sites for
herniation. Most surgeons close these defects at the time of surgery but as weight is lost and
the mesentery becomes thinner, it is possible for the defect to open months or years later. They
are commoner after laparoscopic gastric bypass than in open operations, presumably because
there are fewer adhesions after laparoscopic surgery [23].
The investigation of choice is the CT scan, because it will make the diagnosis, identify any
abdominal wall defects trapping the bowel, and has the highest specificity and sensitivity for
detecting an internal hernia, the so-called “mesenteric swirl” sign [24].
It is often possible to correct these situations laparoscopically because the adhesions are much
less numerous that after open surgery. In addition to hernia as a cause of small bowel ob‐
struction, adhesions especially to the J-J anastomosis may cause mechanical obstruction.
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A unique form of small bowel obstruction may affect patients with the DS, when the bilio‐
pancreatic limb becomes obstructed (Figure 5). This presents with very severe central abdomi‐
nal pain though normal bowel movements may be preserved: it may progress rapidly to
intestinal ischemia and gangrene if not decompressed because it is a closed-loop obstruction.
Since it is not accessible to nasogastric suction or endoscopic decompression, it requires urgent
surgery. Consequently a patient presenting with severe abdominal pain after DS should have
an immediate CT scan of the abdomen to check for dilated loops of the biliopancreatic limb.
Figure 5. CT scan showing obstruction to the biliopancreatic limb after duodenal switch. Note the dilated non-opaci‐
fied loops of bowel in the left upper quadrant.
In the retrocolic approach, a loop of bowel can get trapped between the Roux limb mesentery and the transverse
mesocolon (1, sometimes called Peterson’s space), in the opening of the transverse mesocolon (2) or in the mesenteric
opening of the biliopancreatic limb (3). In the more common antecolic approach, there is no opening in the transverse
mesocolon and hernia behind the Roux limb is less common.
Figure 4. Three potential sites for internal herniation after Roux Y gastric bypass.
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3.1.1.1. Stricture and ulcer
The narrow gastric pouch after GBP or SG is very restrictive at the beginning, and patients can
usually tolerate only clear liquids in small quantities at first. Patients are usually given written
instructions to guide the gradual increase in the quantity and range of foods they can tolerate.
Patients who do not receive or who do not understand such instruction have a high incidence
of vomiting postoperatively. Many patients will experience a few episodes of vomiting if they
relax the vigilance with which they increase their dietary intake, and some vomiting is
probably inevitable as they learn how to cope with a sensation of fullness, which is a novel
experience for most bariatric patients. However, in well instructed and supported patients, it
should be rare. Rather than berate the patient for failure of compliance, or attribute vomiting
to persistence of a psychological compulsion to eat large quantities quickly, the physician
should consider organic causes, namely a stricture [25].
Some degree of stricturing of the GJ anastomosis is common, and usually resolves with time
(less than 3 months) and can be managed by going back to softer or liquid foods. A more severe
stricture may be due to an ulcer at the anastomosis, and the physician should inquire about
consumption of NSAID or large pills, or resumption of smoking. Endoscopy typically reveals
an ulcer with visible suture material or staples (Figure 6). A fibrous stricture may develop later
Such strictures generally respond to one or two dilations (Figure 7). Patients are often put on
proton pump inhibitors (PPI) empirically to help reduce recurrence.
Figure 6. Ulcer at the G-J anastomosis visible on endoscopy
Severe or refractory strictures usually are caused by ulcers which do not heal, and are more
frequent in smokers. Other contributing factors are consumption of over the counter medica‐
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tions for headaches or other painful conditions. This persistent ulceration may also have an
ischemic component, in which case it appears to respond well to reoperation when the gastric
pouch is shortened and the weight loss permits the Roux limb to be easily brought up to the
stomach without tension.
3.1.1.2. Gastroesophageal reflux disease (GERD)
In general, patients with pre-existing GERD experience a profound improvement in reflux
symptoms after GBP. This is largely because only a tiny fraction of the acid secreting mucosa
has any access to the esophagus. Persistence or recurrence of reflux symptoms suggests that
the pouch is too large, or that a hiatal hernia was undetected or uncorrected. If reflux symptoms
occur for the first time after an interval of months or years postoperatively, it suggests the
presence of a gastro-gastric fistula (see below).
The situation is quite different after operations such as the Sleeve Gastrectomy and duodenal
switch. In both operations there is a notable incidence of persistent or new-onset GERD [26,
27]. It may be caused by overzealous resection of the proximal fundus including the gastric
sling fibers, thus weakening the lower esophageal sphincter. Failure to identify and repair a
hiatal hernia has also been incriminated. Finally, the configuration of the sleeve tends to
produce a sharp angle at the incisura angularis which acts as a relative obstruction, thus
promoting reflux. GERD after DS or SG is problematic because sometimes PPI medications are
of limited efficacy or limited by side effects such as diarrhea. The most efficacious way of
controlling this is to convert the situation to a Roux Y gastric bypass by transecting the stomach
high up, leaving a pouch the size of a typical GBP. This effectively abolishes GERD and
disconnects the esophagus from all but the smallest quantities of acid.
3.1.1.3. Constipation and diarrhea
Operations confined to the stomach, namely SG and LAGB, rarely affect bowel function.
Gastric bypass typically causes constipation, which can be managed by regular stool softeners
and over the counter remedies. Severe constipation is common in patients who take continuous
Figure 7. Stricture at the G-J anastomosis (a) obscured by food particles, (b) after removal of food material and (c)
during dilation
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narcotic pain medications, but otherwise it may be a manifestation of Small Bowel Bacterial
Overgrowth (SIBO). This is diagnosed by a breath test in response to ingested glucose and
often responds to a course of Rifaximin, a non-absorbable antibiotic. Diarrhea after gastric
bypass is rare and the stool should be checked for Clostridium Difficile before resorting to
symptomatic treatment. Most such cases are managed by dietary adjustments such as avoid‐
ance of lactose containing products. Anecdotal evidence supports the use of probiotics in this
situation. Intractable diarrhea is a terribly crippling social problem and patients will usually
be referred to a gastroenterologist. In a person with no prior history of diarrhea and no
evidence of infective colitis, the cause is rarely clear, and has been attributed to such entities
as vagal nerve damage or bacterial overgrowth. Colonoscopy is useful to look for other forms
of colitis, and long term somatostatin analogues may be helpful. We have had several patients
with refractory and crippling diarrhea in which the only measure that proved of value was
reversal of the gastric bypass.
The bowel habit after DS and other malabsorptive operations is typically characterized by 2-3
soft and malodorous stools daily, depending on the intake of fat or refined carbohydrates.
More than this suggests either lack of dietary compliance, or bacterial overgrowth, or both.
When these symptoms occur in an otherwise asymptomatic patient, we have found empirically
that low-dose Metronidazole (250mg bid) produces significantly improvement. The physician
should be alert to the possibility that it may be a manifestation of serious malnutrition, as
discussed below.
3.1.1.4. Hyperinsulinemic hypoglycemia
Hypoglycemia associated with excessive insulin secretion, has been reported after GBP, and
has been attributed to nesidiobastosis [28, 29], possibly mediated by the effect of GLP-1 on the
pancreas.
It presents with episodes of altered mental status associated with profound hypoglycemia, and
seems to occur in those who were non-diabetic at the time of surgery. T here is recent evidence
that the phenomenon is much more prevalent than suggested by the literature, consisting as
it does of small case series. A recent presentation to the American Diabetic Association
described prospective continuous blood sugar monitoring after both GBP and DS and found
hypoglycemic episodes, most of them asymptomatic, averaging 42 minutes per day after GBP
and 85 minutes per day after DS, whereas none of the controls experienced hypoglycemia.
Any patient reporting symptoms suggestive of episodic hypoglycemia should be provided
with a home glucose monitor and instructed in it use over a period of several days, to document
if hypoglycemia is actually occurring. This simple step often eliminates it as a diagnosis.
Typically, fasting blood glucose is normal, but drops occur after food. It thus resembles an
extreme form of reactive hypoglycemia. The workup for hypoglycemia is complex, and since
the episodes can cause serious mental status changes, they may have very serious consequen‐
ces, for example if the patient is driving a vehicle or operating machinery. Hence prompt
referral to an endocrinologist is recommended. Dietary adjustment to increase protein and
reduce carbohydrate consumption may help, as may administration of diazoxide or even
streptozotocin.
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Some of these patients have been found to respond to distal pancreatectomy, but we have had
several patients who were much improved by the much simpler technique of shortening of
the Roux limb by anastomosing it to the biliopancreatic limb more proximally.
3.2. Surgical complications specific to individual bariatric operations
3.2.1. Laparoscopic adjustable gastric banding – slippage and erosion
The band in this procedure typically sits immediately below the gastroesophageal junction. It
can gradually slip downwards and allow a large portion of fundus or the body of the stomach
to prolapse through it, which can result in compartmentalization of the stomach with outlet
obstruction [30]. Such patients have severe vomiting, dysphagia and gastroesophageal reflux.
This is a serious situation where there is a risk of gastric necrosis or perforation. The band is
immediately deflated in the emergency room and the patient should be taken to the operating
room without delay. Most surgeons would simply remove the band and allow the stomach to
recover. In delayed cases there may be necrosis of a large portion of the stomach, in which case
it is safest to excise the ischemic portion, insert a feeding tube in the distal remnant stomach,
and a drainage tube the remaining viable fundus and then do a planned reconstruction a few
months later when the patient is in stable condition and there are no nutritional or infective
problems. The reconstructive options are to do a simple gastro-gastrostomy or to convert to a
Roux-Y gastric bypass.
Band erosion typically presents more slowly. Here the band erodes gradually into the lumen
of the stomach. This presents with loss of any sense of restriction, weight gain, and tracking
of infection from the stomach presenting as infection of the site of the subcutaneous port
[31].  It  is  readily diagnosed on endoscopy, when the stained plastic of the band will  be
readily seen near the cardia. It is less common in recent years with the adoption of the pars
flaccida technique rather than the perigastric technique. Bands which are almost complete‐
ly eroded into the stomach may be removed endoscopically by cutting the band, pulling it
into  the  lumen of  the  stomach,  transecting the  tubing,  and withdrawing it  through the
mouth. This avoids the need to dissect the dense adhesions and scar that have sealed off
the band from the peritoneal cavity [32].
3.2.2. Malabsorptive operations (Biliopancreatic Diversion and Duodenal Switch)
The principal surgical complications especially found after malabsorptive operations include
1. Biliopancreatic limb obstruction, discussed above
2. Protein-energy and other forms of malnutrition, discussed in the following section.
3. Severe and refractory gastroesophageal reflux. This has emerged as a leading cause of
morbidity after any kind of sleeve gastrectomy, whether as a stand-alone operation or as
part of a duodenal switch.
Complications of Bariatric Surgery
http://dx.doi.org/10.5772/58920
73
narcotic pain medications, but otherwise it may be a manifestation of Small Bowel Bacterial
Overgrowth (SIBO). This is diagnosed by a breath test in response to ingested glucose and
often responds to a course of Rifaximin, a non-absorbable antibiotic. Diarrhea after gastric
bypass is rare and the stool should be checked for Clostridium Difficile before resorting to
symptomatic treatment. Most such cases are managed by dietary adjustments such as avoid‐
ance of lactose containing products. Anecdotal evidence supports the use of probiotics in this
situation. Intractable diarrhea is a terribly crippling social problem and patients will usually
be referred to a gastroenterologist. In a person with no prior history of diarrhea and no
evidence of infective colitis, the cause is rarely clear, and has been attributed to such entities
as vagal nerve damage or bacterial overgrowth. Colonoscopy is useful to look for other forms
of colitis, and long term somatostatin analogues may be helpful. We have had several patients
with refractory and crippling diarrhea in which the only measure that proved of value was
reversal of the gastric bypass.
The bowel habit after DS and other malabsorptive operations is typically characterized by 2-3
soft and malodorous stools daily, depending on the intake of fat or refined carbohydrates.
More than this suggests either lack of dietary compliance, or bacterial overgrowth, or both.
When these symptoms occur in an otherwise asymptomatic patient, we have found empirically
that low-dose Metronidazole (250mg bid) produces significantly improvement. The physician
should be alert to the possibility that it may be a manifestation of serious malnutrition, as
discussed below.
3.1.1.4. Hyperinsulinemic hypoglycemia
Hypoglycemia associated with excessive insulin secretion, has been reported after GBP, and
has been attributed to nesidiobastosis [28, 29], possibly mediated by the effect of GLP-1 on the
pancreas.
It presents with episodes of altered mental status associated with profound hypoglycemia, and
seems to occur in those who were non-diabetic at the time of surgery. T here is recent evidence
that the phenomenon is much more prevalent than suggested by the literature, consisting as
it does of small case series. A recent presentation to the American Diabetic Association
described prospective continuous blood sugar monitoring after both GBP and DS and found
hypoglycemic episodes, most of them asymptomatic, averaging 42 minutes per day after GBP
and 85 minutes per day after DS, whereas none of the controls experienced hypoglycemia.
Any patient reporting symptoms suggestive of episodic hypoglycemia should be provided
with a home glucose monitor and instructed in it use over a period of several days, to document
if hypoglycemia is actually occurring. This simple step often eliminates it as a diagnosis.
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4. Long term complications
4.1. Malnutrition
Various forms of nutritional deficiency can develop after bariatric surgery, and the operations
which produce the greatest weight loss tend to produce more nutritional problems. Modern
bariatric operations are much safer in this regard than the original Jejunoileal bypass opera‐
tions, but the risk remains. Deficiencies are least prominent after LAGB and SG, and greatest
after BPD and DS [33, 34]. Long term follow up with regular monitoring of weight and
nutritional status are designed to identify potential problems which can be addressed before
a serious clinical problem develops.
Laboratory assessment of nutritional status has become more standardized in recent years and
guidelines from numerous professional societies have been published. Most programs agree
on the need for annual monitoring of nutritional parameters, ideally through the operating
surgeon’s office or the patient’s primary care doctor. These annual visits include documenta‐
tion of the patient’s intake of food, vitamins and nutritional supplements, and measurement
of a range of laboratory values as indicated in the table. Those who are lost to follow-up or
whose psychosocial equilibrium is disrupted are at greater risk of nutritional deficiency. The
first step in caring for any patient who presents for follow up to a different physician, or after
a long interval of neglect, is to review the nature of the procedure, make a careful assessment
of the current eating practices, usually with the help of a dietitian, and obtain the above
laboratory values. Physicians should recognize that malnourished patients are often reluctant
to seek help because of fear of weight regain, and often only come to attention when some
other medical crisis occurs. It is therefore important to detect when a nutritional deficiency is
something that requires surgical revision of the procedure and when it is simply a matter of
education and compliance in taking additional supplements [35].
Protein Energy malnutrition is a consequence of either inadequate intake or inadequate absorp‐
tion. Poor intake is usually associated with restrictive operations which cause anorexia,
physical restriction of oral intake, or both. A history of extremely limited intake, frequent
dysphagia and regurgitation of food particles or saliva, is common. Patients will frequently
describe “bringing up foam” because the esophagus fills with saliva which then is displaced
proximally when food or liquid is ingested. Maladaptive eating patterns may involve so-called
“slider” foods such as ice cream and soups, often high in calories and fat but low in protein,
or may be described as bizarre or crazy, as in the obsession for crushed ice.
In contrast, patients with malabsorption may appear to eat well but will often report diarrhea
or steatorrhea. In both cases, there may be generalized weakness and fatiguability, and edema,
which in severe cases is not limited to the ankles and feet but may be obvious even in the back
and chest wall. Serum albumin is often very low, less than 3.0 g/l and in severest cases less
than 2.0 g/l. These extreme cases are more frequently observed after malabsorptive operations
but can occur after any bariatric operation.
Intensive dietary supervision and monitoring by the dietitian, and careful follow up to assess
the effect of these interventions are essential. If the underlying reason can be corrected,
Essentials and Controversies in Bariatric Surgery74
restoration is frequently achieved. Such factors as lack of awareness, divorce, unemployment,
financial crisis, psychiatric illness, or development of other addictions may all contribute. A
dietitian, psychologist, social worker, psychiatrist and counselor may all be necessary to help
get the patient back on track. Sometimes the nutritional problems persist despite removal of
any barriers to compliance. In this situation, consideration must be given to some kind of
revision or even reversal of the procedure.
4.2. Revision of bariatric procedures for malnutrition
In this section, we distinguish the need for revision to correct malnutrition from some other
clinical situations in which revision may be important. These other situations include failure
of weight loss, or late regain of weight after initial success. At other times intractable GI
dysfunction such as severe GERD or diarrhea may require surgical revision. Revisional surgery
specifically for malnutrition is relatively rare, especially for purely restrictive procedures. For
example, after LAGB, malnutrition is managed by deflation of the band, and after sleeve
gastrectomy nutrition may be improved by dilation of the gastric sleeve or temporary stent
insertion (Figure 8). One exception is the subset of patients who had some kind of banded
gastroplasty in the past, in which case the band can be removed and the pouch of stomach
used as the basis for a conventional gastric bypass. When malnutrition complicates banded
GBP, as is the form of operation recommended by Fobi et al, the band is simply removed. In
most cases this can be accomplished laparoscopically.
Figure 8. Correction of severe dysphagia after sleeve gastrectomy by insertion of a stent into the stomach. It is re‐
moved a few weeks later
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“slider” foods such as ice cream and soups, often high in calories and fat but low in protein,
or may be described as bizarre or crazy, as in the obsession for crushed ice.
In contrast, patients with malabsorption may appear to eat well but will often report diarrhea
or steatorrhea. In both cases, there may be generalized weakness and fatiguability, and edema,
which in severe cases is not limited to the ankles and feet but may be obvious even in the back
and chest wall. Serum albumin is often very low, less than 3.0 g/l and in severest cases less
than 2.0 g/l. These extreme cases are more frequently observed after malabsorptive operations
but can occur after any bariatric operation.
Intensive dietary supervision and monitoring by the dietitian, and careful follow up to assess
the effect of these interventions are essential. If the underlying reason can be corrected,
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restoration is frequently achieved. Such factors as lack of awareness, divorce, unemployment,
financial crisis, psychiatric illness, or development of other addictions may all contribute. A
dietitian, psychologist, social worker, psychiatrist and counselor may all be necessary to help
get the patient back on track. Sometimes the nutritional problems persist despite removal of
any barriers to compliance. In this situation, consideration must be given to some kind of
revision or even reversal of the procedure.
4.2. Revision of bariatric procedures for malnutrition
In this section, we distinguish the need for revision to correct malnutrition from some other
clinical situations in which revision may be important. These other situations include failure
of weight loss, or late regain of weight after initial success. At other times intractable GI
dysfunction such as severe GERD or diarrhea may require surgical revision. Revisional surgery
specifically for malnutrition is relatively rare, especially for purely restrictive procedures. For
example, after LAGB, malnutrition is managed by deflation of the band, and after sleeve
gastrectomy nutrition may be improved by dilation of the gastric sleeve or temporary stent
insertion (Figure 8). One exception is the subset of patients who had some kind of banded
gastroplasty in the past, in which case the band can be removed and the pouch of stomach
used as the basis for a conventional gastric bypass. When malnutrition complicates banded
GBP, as is the form of operation recommended by Fobi et al, the band is simply removed. In
most cases this can be accomplished laparoscopically.
Figure 8. Correction of severe dysphagia after sleeve gastrectomy by insertion of a stent into the stomach. It is re‐
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The malabsorptive component of bariatric procedures can be reversed surgically to some
extent, either by totally reversing the reconstruction or connecting the two intestinal limbs
more proximally. The situation after DS is managed optimally by identifying the J-J anasto‐
mosis, and tracing the biliopancreatic and roux limbs separately, and performing a side-to-
side anastomosis of the two limbs 100-200cm more proximally. This allows bile to enter the
Roux limb and food to enter the biliopancreatic limb, effectively lengthening the common
channel. (Figure 9) This operation, sometimes called the “Kissing X” anastomosis, effectively
corrects the problems with diarrhea and hypoalbuminemia and edema [36].
Figure 9. Correction of malabsorption by side-to-side anastomosis of the Roux limb to the Biliopancreatic limb after
duodenal switch (“kissing-X” anastomosis).
In the malnourished patient after Roux Y GBP, it is simplest to insert a laparoscopic gastro‐
stomy tube into the remnant stomach, so that all administered nutrients can be absorbed.
Thereafter, the patient will be in a safer state to undergo elective reversal. Bypass reversal is
accomplished by dividing the GJ anastomosis, isolating the gastric pouch, and then performing
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an anastomosis to the adjacent bypassed stomach, usually with a linear stapler. The Roux limb
can simply be excised, but in a malnourished patient it is preferable to divide the original J-J
anastomosis and reanastomose the limbs to restore as much intestinal absorptive area as
possible.
Sometimes these operations, despite the technical simplicity, result in serious complications
with catastrophic deterioration and rapid development of multi-system organ failure. The
cause of such deterioration has not been established but is presumed to be due to some critical
micronutrient deficiency. The most likely candidate appears to be thiamine deficiency, and
anecdotal evidence has confirmed that severe hypotension with lactic acidosis may be
improved by rapid administration of thiamine 100mg IV.
4.3. Specific nutritional deficiencies
4.3.1. Iron, vitamin B12 and folate
Iron deficiency is very common after any bypass operation because the maximal site of Iron
absorption, the duodenum and proximal jejunum, has been bypassed. It has also been observed
after sleeve gastrectomy or LAGB. Other factors contributing to Iron deficiency are the frequent
use of acid suppressants, the relatively small quantities of red meat consumed by bariatric
patients, and the unpleasant GI side effects associated with elemental iron ingestion. Iron
deficiency is naturally commoner in menstruating women. The symptoms of anemia are so
Routine annual measurements Purpose and clinical ituation
CBC Basic check for anemia
CMP Protein, liver and kidney function
Iron, TI BC, Ferritin Adequacy of Iron stores in anemia
B12 and Folate Work up of anemia
PTH and 25 (OH) vitamin D Adequacy of Calcium absorption
Lipid Panel Estimate of malabsorption
HbA1C Monitoring diabetic resolution
Measurement in symptomatic patients
Vitamin A May be low in malabsorptive procedures
Vitamin B1 (whole blood)
Elucidation of neurologic or cardiac symptoms, poor oral intake or
vomiting
Vitamin B6 High alcohol intake
Trace elements (Zn, Cu, Se ,Mn)
Obscure symptoms, refractory anemia especially in non-compliant
patients
Table 1. List of common nutritional factors measured during routine annual follow up in patients after bariatric
surgery
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non specific – weakness, tiredness, exertional dyspnea – that measurement of routine indices
is fundamental: consequently, anemia is easily and immediately recognized. Severe iron
deficiency may be associated with pica, a compulsion to eat things such as crushed ice or even
clay.
The treatment of iron deficiency requires replacement of iron and attention to reduce any
factors exacerbating it: women with heavy menstrual losses should be referred to a gynecol‐
ogist for management of menorrhagia, and acid suppression medication stopped if it is no
longer necessary. Oral iron supplements are generally prescribed and include ferrous sulfate,
ferrous gluconate, and ferrous fumarate. Ferrous glycine sulfate appears to have fewer side
effects and the best bioavailability. Typical doses are tailored to achieve 60-100mg/day of
elemental iron.
Intravenous iron supplementation may be necessary when oral iron is insufficient or cannot
be tolerated. It is often administered by a hematologist in an infusion center because of concerns
about allergic reactions. Intravenous iron must be complexed to other molecules to avoid iron
toxicity. Iron Dextran is commonly employed. The risk of anaphylactic and other reactions is
less than 1%, but recently Iron Sucrose has been used because the risk of allergic reactions is
much lower (0.1%) and more recently still, Iron Carboxymaltose has been used because larger
doses can be given in a short time (1000 mg over 15 minutes), making it much more convenient
to administer [37].
Regardless of how iron is given, correction of anemia is a gradual process and it takes 1-2
months to restore iron and hemoglobin levels.
4.3.2. Vitamin B12 and folate
Vitamin B12 deficiency is fairly common because oral ingestion of B12 is ineffective in patients
after gastric bypass, since the small gastric pouch produces so little intrinsic factor to complex
with the B12 molecule. It is less likely to happen after duodenal switch or sleeve gastrectomy
but it may still be present, and has been reported to be as high as 20% in some series. It typically
presents a year or more after surgery because the liver has substantial reserves of B12.
Vitamin B12 deficiency causes megaloblastic anemia, which is readily correctable by restora‐
tion of B12 stores. Deficiency also predisposes to neuropsychiatric issues, causing peripheral
neuropathy and symptoms of ataxia as a consequence of damage to the posterior columns of
the spinal cord. There may be ataxia or inability to drive a vehicle because of loss of proprio‐
ception in the feet. These neurological symptoms may be irreversible, especially if present for
longer than six months.
There is controversy about the cut-off point for the lower limit of normal for B12 levels. In USA
the lower limit of normal is about 200 pg/ml, but there is concern that this level is too low and
in Japan the lower limit of normal is now 550 pg/ml. In practice, it is easy to maintain healthy
levels of B12 in compliant patients. Sublingual tablets permit rapid absorption without the
need for intrinsic factor and are readily available over the counter in the USA. Monthly
injections are also easy to administer and patients can be taught to administer such injections
themselves.
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Folate participates in the same pathway as vitamin B12 and is associated with similar hema‐
tologic and neurologic manifestations. It is easy to absorb and since it is a major component
of multivitamin pills deficiency is rarely seen. In fact elevated levels of folate are frequently
observed and generally indicate small intestinal bacterial overgrowth (SIBO).
4.3.3. Calcium and vitamin D
Calcium is another critical divalent cation which is absorbed proximally in the jejunum and
may become deficient after bariatric surgery. Absorption of calcium requires vitamin D, a fat
soluble sterol with many different properties. Vitamin D is initially hydroxylated in the liver
to become 25 (OH) Vitamin D, and then converted to its active form, namely 1, 25 (OH)2 Vitamin
D in the kidney. Vitamin D is also produced by the action of UV light on the skin and in practice
this is the major source of vitamin D. Vitamin D deficiency is common in northern latitudes
where available sunlight exposure is limited, and also in certain ethnic subgroups where
exposure of the skin to sunlight is limited for cultural reasons. Deficiency of calcium can often
be detected clinically by a positive Chvostek sign, and biochemically is generally associated
with elevated Parathyroid Hormone (PTH) levels.
Prolonged vitamin D deficiency causes osteomalacia, visible radiologically as loss of bone
matrix, and clinically presenting with bone pain and predisposing to long bone or vertebral
fractures. It also causes a proximal myopathy, especially in the muscles of the hip girdle,
making it difficult to perform such simple activities as standing up from a sitting position.
Typically patients rising from a chair will use their hands and arms to assist the activity,
analogous to Gowers’ sign observed in children with muscular dystrophy. These musculos‐
keletal symptoms are often dismissed as arthritis or fibromyalgia and it is important to make
the diagnosis before the patient ends up being referred to a pain management clinic [38].
Vitamin D has many other advantageous qualities, including improved resistance to hospital
acquired infections. [39]
Patients should have annual measurement of [25] OH Vitamin D and PTH. Low Vitamin D
levels (< 30 ng/ml) require higher doses of Vitamin D than are typically present in multivitamin
tablets (400 IU). The patient should have 50, 000 IU weekly and the level rechecked after 3
months. Parenteral Vitamin D is rarely required. Bone density measurements are generally
within the purview of the primary care doctor, but the surgeon should regularly update and
even educate the primary doctor about the patients’ progress.
4.3.4. Vitamin A
Deficiency of Vitamin A is principally observed in malabsorptive operations such as DS or
BPD, or the Long Limb gastric bypass. The clinical problems are chiefly ocular, and both the
retina and the cornea are affected. The earliest manifestation may be night blindness, but
corneal irritation and the development of Bitot’s spots can also occur. There may be dry skin
and dry hair and pruritus. The ocular manifestations are generally reversible when adequate
supplementation is provided. The recommended dose is 10, 000 Units daily.
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non specific – weakness, tiredness, exertional dyspnea – that measurement of routine indices
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ogist for management of menorrhagia, and acid suppression medication stopped if it is no
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ferrous gluconate, and ferrous fumarate. Ferrous glycine sulfate appears to have fewer side
effects and the best bioavailability. Typical doses are tailored to achieve 60-100mg/day of
elemental iron.
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about allergic reactions. Intravenous iron must be complexed to other molecules to avoid iron
toxicity. Iron Dextran is commonly employed. The risk of anaphylactic and other reactions is
less than 1%, but recently Iron Sucrose has been used because the risk of allergic reactions is
much lower (0.1%) and more recently still, Iron Carboxymaltose has been used because larger
doses can be given in a short time (1000 mg over 15 minutes), making it much more convenient
to administer [37].
Regardless of how iron is given, correction of anemia is a gradual process and it takes 1-2
months to restore iron and hemoglobin levels.
4.3.2. Vitamin B12 and folate
Vitamin B12 deficiency is fairly common because oral ingestion of B12 is ineffective in patients
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with the B12 molecule. It is less likely to happen after duodenal switch or sleeve gastrectomy
but it may still be present, and has been reported to be as high as 20% in some series. It typically
presents a year or more after surgery because the liver has substantial reserves of B12.
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tion of B12 stores. Deficiency also predisposes to neuropsychiatric issues, causing peripheral
neuropathy and symptoms of ataxia as a consequence of damage to the posterior columns of
the spinal cord. There may be ataxia or inability to drive a vehicle because of loss of proprio‐
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need for intrinsic factor and are readily available over the counter in the USA. Monthly
injections are also easy to administer and patients can be taught to administer such injections
themselves.
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Folate participates in the same pathway as vitamin B12 and is associated with similar hema‐
tologic and neurologic manifestations. It is easy to absorb and since it is a major component
of multivitamin pills deficiency is rarely seen. In fact elevated levels of folate are frequently
observed and generally indicate small intestinal bacterial overgrowth (SIBO).
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soluble sterol with many different properties. Vitamin D is initially hydroxylated in the liver
to become 25 (OH) Vitamin D, and then converted to its active form, namely 1, 25 (OH)2 Vitamin
D in the kidney. Vitamin D is also produced by the action of UV light on the skin and in practice
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exposure of the skin to sunlight is limited for cultural reasons. Deficiency of calcium can often
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months. Parenteral Vitamin D is rarely required. Bone density measurements are generally
within the purview of the primary care doctor, but the surgeon should regularly update and
even educate the primary doctor about the patients’ progress.
4.3.4. Vitamin A
Deficiency of Vitamin A is principally observed in malabsorptive operations such as DS or
BPD, or the Long Limb gastric bypass. The clinical problems are chiefly ocular, and both the
retina and the cornea are affected. The earliest manifestation may be night blindness, but
corneal irritation and the development of Bitot’s spots can also occur. There may be dry skin
and dry hair and pruritus. The ocular manifestations are generally reversible when adequate
supplementation is provided. The recommended dose is 10, 000 Units daily.




Water soluble vitamins, with the exception of vitamin B12, are not appreciably stored in the
body and must be replenished regularly. Awareness amongst healthcare professionals and the
lay public tends to promote the consumption of vitamin supplements and vitamin-rich foods,
so that deficiency of water soluble vitamins is rarely a problem except in certain well defined
groups. These include patients after bariatric surgery, alcoholics, and patients with short-gut
syndromes. The importance of vitamin B12 and folate has been emphasized already. However,
deficiency of vitamin B1 (Thiamine) has recently received considerable attention because it
may present after periods of vomiting, such as can be frequent early after bariatric surgery of
any type. A patient returning to the hospital because of intractable vomiting in the early weeks
after bariatric surgery is at risk of developing thiamine deficiency. It can cause irreversible
neurologic changes, with confusion, ataxia and nystagmus (Wernicke’s encephalopathy) as
well as heart failure [40].
Thiamine is an essential cofactor in the metabolism of glucose, and in its absence pyruvate
cannot be processed in the citric acid cycle and is instead converted to lactate. The result is a
serious metabolic derangement with lactic acidosis and hypotension requiring high doses of
pressors. Such a patient is likely to be diagnosed with sepsis and given large volumes of fluid.
Administration of dextrose in the IV fluids makes the situation worse because the glucose load
cannot be metabolized. The patient should be given 200mg thiamine IV immediately and
repeated daily until the patient can take a diet reliably. The cardiac failure may be rapidly
improved by aggressive supplementation but the changes in Wernicke’s encephalopathy may
be permanent.
4.3.6. Rarer deficiencies: Vitamin B6, C, E, and trace elements
Other micronutrient deficiencies may involve other B vitamin deficiencies, but these are
generally overshadowed by the major factors discussed above. Vitamins C and E have been
found to be subnormal in some follow up studies after bariatric surgery. One recent report of
an isolated case of severe scurvy described a patient with large confluent ecchymoses who
developed multi-system organ failure, initially thought to be due to sepsis but which recovered
after aggressive vitamin C replacement. Finally, there are isolated reports of trace element
deficiencies, most notably Zinc, Copper and Selenium, which are important to consider in cases
where unusual features of illness do not fall into a well-known pattern. Zinc deficiency appears
to produce a scaly rash associated with edema. Copper deficiency produces refractory anemia
and neurologic symptoms. It should always be considered in cases of refractory anemia which
do not respond to iron and B12 and folate supplementation. Selenium has been implicated in
a case of refractory heart failure after BPD. These micronutrients are usually a manifestation
of lack of compliance since the necessary supplements are well absorbed and easy to obtain.
Taken together, these deficiencies have drawn attention to the profundity of the metabolic
alteration which bariatric surgery and its altered eating behavior induces. They also emphasize
the importance of facilitating long term follow up by knowledgeable providers. Prevention
and management of most of these deficiencies is fairly simple when the patient remains in
regular contact with the bariatric program. Regular follow up to inquire about eating habits
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and obtain regular laboratory monitoring of nutritional status will prevent most serious
problems. Ironically, patients who are doing poorly for whatever reason may be reluctant to
return to the surgeon’s office because of feelings of failure or shame and thus the patients most
in need of expert help are the hardest to reach. This tendency should reinforce in bariatric
programs the wisdom of offering ready access and a non-judgmental attitude.
4.4. Weight regain
Weight regain after initial weight loss can be thought of as the polar opposite of malnutrition.
This is the emerging as the greatest threat in the long term management of the bariatric patient.
There is no clear consensus on its incidence or severity, but it is estimated that upwards of 20%
of patients will regain a large proportion of the weight initially lost, and re-enter the category
of morbid obesity. Why some patients do this is not known, but the causes can be thought of
in two broad categories: (1) surgical factors and (2) lifestyle factors. The major surgical factors
are the size of the pouch and the size of the anastomosis. Where both are small, as they are
generally made these days, regain of weight is reduced. Large pouches and wider anastomoses
allow greater food intake with les satiety. Sometimes the pouch is larger than the surgeon
intended because a hiatal hernia was present but unrecognized.
It is widely believed, largely on anecdotal evidence that behavioral factors are the most
important factors in weight regain. Patients who do not use the “honeymoon” period (the first
6-12 months when weight loss is occurring rapidly) to bring about major changes in eating and
exercise patterns will gain weight in subsequent years when the restriction has worn off.
Sometimes the inability to eat leads to the development of other addictions such as alcohol.
Other stressful social factors, such as divorce or loss of employment, may push the patient in
the direction of her old habits.
The treatment of weight regain is very problematic from many points of view. There may
be  no  clear  anatomical  explanation.  Patients  frequently  request  reoperation  with  great
fervency, not realizing that the risk of serious complications may be up to ten times greater
than that of the initial surgery. If there is no identifiable mechanical reason for the weight
gain, reoperation may bring about some weight loss initially, but may only set the stage
for  weight  gain  once  more.  Further,  insurance  companies  frequently  deny  requests  for
authorization to perform revisional bariatric surgery for weight regain. Only if an identifi‐
able  complication such as  GERD is  found will  the  company generally  authorize  it.  The
options are either to make the pouch and anastomosis smaller,  or to convert  the opera‐
tion to a different type of procedure [41].
If  there  is  no  clear  abnormality  to  correct,  the  surgical  strategy  has  been  whimsically
summarized as “bypassing the band, and banding the bypass.” Patients with unsatisfacto‐
ry weight loss after LAGB may be converted to RNY GBP, but the risk of leakage is higher.
Failure of the RNYGBP has been reported to respond to placement of a laparoscopic band
round the gastric pouch to re-impose a sense of restriction. However both these strategies
are only reported in case series with limited follow up and so are only recommended on
an individualized basis [42, 43].
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than that of the initial surgery. If there is no identifiable mechanical reason for the weight
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If  there  is  no  clear  abnormality  to  correct,  the  surgical  strategy  has  been  whimsically
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In concert with weight regain is the recent recognition that Type 2 diabetes sometimes returns.
Even when it does, it is rarely as severe as it was preoperatively. The incidence is not known
but it may be as high as 30% of patients who were diabetic and who experience relief early
after surgery.
4.5. Psychiatric complications
Patients who are dependent on psychiatric medications may readily suffer exacerbation of
their psychiatric conditions if early swallowing and eating difficulty prevents them from
resuming their normal medications. Later in the evolution of the postoperative course, they
may require increasing doses (particularly antidepressants) because the reconstructed
intestine absorbs less, leading to lower blood levels of the medication. For this reason many
surgeons attempt to prevent such a crisis by inserting a gastrostomy tube into the remnant
stomach at the time of the original bariatric procedure and remove it only when the patient is
reliably consuming essential medications orally.
Some patients who have a so-called addictive personality become obese because food acts as
an addictive substance and after surgery such patients may develop so-called addiction
transfer, and become addicted to alcohol, drugs, or gambling.
Although most patients note enhancement of their psychosocial functioning after major weight
loss, it can result in serious interpersonal conflict within families and there is a substantial
incidence of breakup within marriages and domestic partnerships [44].
4.6. The disappointed patient
Some patients even without experiencing a complication may nevertheless be disappointed in
the outcome, either because their weight loss was less than expected, or weight was regained
a few years later, or because of the appearance of large floppy folds of skin on the abdomen,
under the arms, the medial thighs and buttocks. Although these can often be dealt with by
plastic surgery, such operations are themselves prone to complications of infection and seroma
formation. These problems emphasize the importance of preoperative counseling and creation
of realistic expectations, and the provision of postoperative counseling to assist patients in
maximizing the effect of such benefits as they have achieved.
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1. Introduction
Great societal changes have be found in the world with fast lifestyle, less activity or exercises
in recent 30 years. The epidemic of obesity continues to grow and affect almost every aspect
of the lives of patients and human life especially in children and adolencents. The growing
prevalence of diabetes and cardiovascular disease (CVD) parallels the increased revalence of
obesity.
The Center for Disease Control (CDC) in the United States defines overweight as a body mass
index(BMI, kg/m2) of 25.0 to 29.9 and obesity as a BMI greater than 30.0 kg/m2. It is different
from CDC in Asia or in China with the definition as overweight 24.0 to 27.9 and obesity as a
BMI greater than 28.0 kg/m2.
Obesity is strongly associated with severe medical problems including increased risk for
cardiovascular morbidity and mortality, hypertension, cholethiasis, nonalcoholic steatohepa‐
titis (NASH), sleep apnea, orthopedic dysfunction, depression, breast, colon and uterine
cancers. The disease profile changes in the adolencent population increasing of metabolic
syndrome or Type II diabetes and cancer. The great challenges associated with or directly
responsible for multiple medical problems or comorbidities to the traditional culture, educa‐
tion, medical system, multidisciplinary medical workers and healthy professionals.
It necessitates attention to care bariatric healthcare professionals. A multidisciplinary Ap‐
proach, to help healthcare professionals navigate the difficult road of treating adolescent
obesity.
© 2014 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
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2. The causes of obesity
The causes of obesity are multifactorial roles with genetics, environmental factors, food
consumption, and family interactions.
All obese children and adults develop from consistaining a positive-balance between energy
intake (high-calorie, nutrient-dense foods) and energy output (physical activity and exercise).
Parents have a major influence on their children regarding their intake and activity/inactivity.
Children from overweight/obese families have higher obesity rate with low cognitive stimu‐
lation and less physical activity than normal weight families
Exercise Prescription Guidelines for the obese Child and Adolecents
The emergence of Type 2 diabetes (T2D) in children and adolescents parallels the rising rates
of childhood obesity. As a condition of impaired insulin sensitivity and relative insulin
deficiency resulting in hyperglycemia, T2D has a complex underlying physiology that is
reflected by the multiple approaches used to optimize medical care and prevent the myriad
of diabetes-related complications [2].
Chinese famous philosopher Lao-Tzu said: The journey of a thousand miles begins with the
first step.
All the children and adolescents need eating disorder treatment [3]. They need an negative-
balance between energy intake (low-calorie, nutrient-dense foods) and energy output (phys‐
ical activity and exercise). Obese children or adolences have to work harder than normal
weight children or adolences to accomplish the same task and thus need adjusted workloads.
An exercise program and assessment for obese child and adolescents should be designed to
increase caloric expenditure rather than to improve cardiovascular fitness. However, medical
intervention is failure for long-term weight loss in most morbidly obese persons.
3. Effect of weight reduction or bariatric surgery in type 2 diabetes and
prediabetes
It has been demonstrated that weight reduction – even modest loss of 6 to 10 percent had a
remarkable effect on diabetes control in patients with type 2 diabetes and reduced the risk for
prediatetes patient developing to diabetes by a profound effect on preventing natural pro‐
gression of glucose intolerance from IGT to type 2 diatetes.
The weight reduction reduces the incidence of most obesity complications and improves
overall sense of wellbeing. Although lifestyle modification has been the traditional clinical
recommendation for overweightand obese prediabetic and diabetic patients, bariatric surgery
became another valid and effective option for long-term weight control among these high risk
patients because diabetes is a major comorbid condition.
The incidence of adolescent bariatric surgery is increasing with safely as evidenced by low
complication rates [5]. Extremely obese diabetic adolescents experience significant weight loss
Essentials and Controversies in Bariatric Surgery90
and remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass with Improvements
in insulin resistance, beta-cell function, and cardiovascular risk factors support Roux-en-Y
gastric bypass as an intervention that improves the health of these adolescents. It suggests that
Roux-en-Y gastric bypass is an effective option for the treatment of extremely obese adolescents
with type 2 diabetes mellitus [6].
4. Indications for bariatric surgery
The 1998 NHLBI obesity clinical guidelines for adults set the patient selection criterion for
obesity surgery as a BMI of 40 or more or a BMI between 35 and 40 accompanied by high-risk
obesity cormobidities such as type 2 diatetes, hypertension, sleep apnea, asthma, or osteoar‐
thritis of weight-bearing joints. Surgery is recommended only for patients who have an
acceptable risk for surgery, are well-informed, motivated, and able to participate in treatment
and long-term follow-up. Patients who choose surgery will require lifelong medical care and
should work with a multidisplinary team including medical, nutritional, and behavioral
specialists (NHLBI, 1998). While the NIH guidelines have remained unchanged since 1991.
Newer criteria for adults are being evaluated. The current BMI standard is changed by
evidence that bariatric surgery can reverse comorbidities such as type 2 diabetes even in
patients with a BMI of less than 30 (Pories, 2010) or 28 (Huang ZK,) that applying an adjusted
BMI which takes into account race, sex, age, fitness, or body fat composition, would be a more
realistic criterion.
5. Opinions of healthcare professionals in the world regarding bariatric
surgery
Opinions of healthcare professionals in the world regarding bariatric surgery in adolescents
are largely unknown. Although surgery may be a promising treatment for extreme obesity in
youth, the acceptability of bariatric surgical interventions for obese children and adolescents
remains a topic of controversy among patients, healthcare practitioners, researchers, policy‐
makers, and general public. An investigation study on the disagreement of bariatric surgery
for adolescent showed that almost half of the participating physicians would never refer an
obese adolencent for a bariatric operation, some physicians would referred with the minimum
age of 18 years (Woolford, 2010).
There is a study from the UK to explore the perspectives of medical professionals regarding
adolescent bariatric surgery [7]. Members of the British Obesity and Metabolic Surgery Society
and groups of primary care practitioners based in London were contacted by electronic mail
and invited to complete an anonymous online survey consisting of 21 questions. 66% of
professionals felt that adolescents with a body mass index (BMI) >40 or BMI >35 with significant
co-morbidities can be offered surgery. Amongst pre-requisites, parental psychological
counseling was chosen most frequently. 58% stated 12 months as an appropriate period for
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weight management programs, with 24% regarding 6 months as sufficient. Most participants
believed bariatric surgery should only be offered ≥16 years of age. However, 17% of bariatric
surgeons marked no minimum age limit. Over 80% of the healthcare professionals surveyed
consider bariatric surgery in adolescents to be acceptable practice. Most healthcare professio‐
nals surveyed feel that adolescent bariatric surgery is an acceptable therapeutic option for
adolescent obesity. These views can guide towards a consensus opinion and further develop‐
ment of selection criteria and care pathways.
6. Age limits
There are some specific limit for bariatric surgery although it may achieve a sustained weight
loss. For old adults age guidelines from the American Society for Metabolic & Bariatric Surgery
(ASMES) suggest that patients eligible for surgery should be 18 to 65 years old. Individuals
outside that age range who undergo surgery should have significant health conditions related
to obesity and the expectation of improved life expectancy or quality of life should outweigh
the risk of surgery (Mechanick, 2008). The NHLBI clinical guidelines summarized the available
data regarding any type of weight reduction after age 65 and recommended: A clinical decision
to forgo obesity treatment in an older adult should be guided by an evaluation of the potential
benefits of weight reduction for day-to –day functioning and reduction of the risk of future
cardiovascular events, as well as the patient’s motivation for weight reduction. (NHLBI, 1998).
The recommendations are supported by the Pediatric Surgical Association and the American
Society of Bariatric Surgery based on the opinions of “experts”. The adolescents should be
limited in age for girls (13 years) and boys (15 years).
6.1. Contraindication
The suggested contraindications would include an extremly high operative risk, such as severe
cardiovascular disease or severe respiratory problems. To help avoid adverse postoperative
outcomes, patients are also screened for sevsere depression, untreated mental illnesses, active
substance abuse, or binge eating disorders, severe cardiovascular disease or severe respiratory
problems. Patients who cannot comprehend the nature of the surgical intervention and the
lifelong measures required to maintain health, should not be offered this procedure (Mechan‐
ick, 2008).
7. Surgery for severe obesity
Although the increasing incidence of obesity is due to an imbalance of energy intake and energe
output, long-term weight loss is difficult to achive with diet, exercise, or pharmacotherapy.
Lack effective treatment for obesity is also a significant contributor to this serious public health
problem. To date, bariatric surgery has been shown to be the only intervention to induce
significant weight loss in patients with severe obesity and improve chronic health conditions,
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survival, and quality of life. Most bariatric surgery patients have already experienced numer‐
ous attempts to achieve a sustained weight loss by using nonsurgical treatment options.
Bariatric surgical procedures have increased exponentially for Severe Obesity in the world.
The three commonly performed procedures in obeses aldults are laparoscopic Roux-en-Y
gastric bypass (LRYGB), laparoscopic adjustable gastric banding (LAGB), and the novel
laparoscopic sleeve gastrectomy (LSG) have acceptable efficacy and safety for resolution of
obesity-related comorbidities [8] The best option from the different developing surgery
procedures with evaluated results are the new clinical problems.
A systematic literature review (2004 from Royal Australasian College of Surgeons) compare
the safety and efficacy of laparoscopic adjustable gastric banding with vertical-banded
gastroplasty and gastric bypass [9]. The results showed that LAGB was associated with a mean
short-term mortality rate of approximately 0.05% and an overall median morbidity rate of
approximately 11.3%, compared with 0.50% and 23.6% for RYGB, and 0.31% and 25.7% for
VBG. Overall, all 3 procedures produced considerable weight loss in patients up to 4 years in
the case of LAGB (the maximum follow-up available at the time of the review), and more than
10 years in the case of the comparator procedures. The Australian Safety and Efficacy Register
of New Interventional Procedures-Surgical Review Group concluded that the evidence base
was of average quality up to 4 years for LAGB. Laparoscopic gastric banding is safer than VBG
and RYGB, in terms of short-term mortality rates. LAGB is effective, at least up to 4 years, as
are the comparator procedures. Up to 2 years, LAGB results in less weight loss than RYGB;
from 2 to 4 years there is no significant difference between LAGB and RYGB, but the quality
of data is only moderate. Although Laparoscopic adjustable gastric banding is now promoted
as a safer, potentially reversible and effective alternative to Roux-en-Y gastric bypass.
A systematic review [10] comparing the two most popular bariatric procedures-Gastric
banding or bypass? The conclusion strongly favored Roux-en-Y gastric bypass over laparo‐
scopic adjustable gastric banding for weight loss outcomes. Patients treated with laparoscopic
adjustable gastric banding had lower short-term morbidity than those treated with Roux-en-
Y gastric bypass, but reoperation rates were higher among patients who received laparoscopic
adjustable gastric banding. Gastric bypass should remain the primary bariatric procedure used
to treat obesity in the United States. Lee WJ [11] conducted a randomized trial of moderately
obese Chinese patients (BMI < 35) with troublesome, difficult diabetes. Patients were followed
for 1 year. Nearly all patients (93%) in the gastric bypass group had a remission of diabetes,
compared with less than half of patients (47%) with sleeve gastrectomy. Weight loss was also
more pronounced after gastric bypass. A meta-analysis of international bariatric surgery
studies from 2003 to 2012 provides reassurance that the surgery is effective for candidates of
procedures with 3 main types of bariatric surgery [12]. Gastric bypass resulted in more effective
weight loss, but was associated with more complications. Adjustable gastric banding was
linked with lower mortality and complication rates; however, it had a higher reoperation rate
and was associated with less substantial weight loss than gastric bypass. Sleeve gastrectomy,
which is becoming more popular, resulted in weight loss comparable to that obtained with
gastric bypass and greater than that with adjustable.
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outside that age range who undergo surgery should have significant health conditions related
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problem. To date, bariatric surgery has been shown to be the only intervention to induce
significant weight loss in patients with severe obesity and improve chronic health conditions,
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survival, and quality of life. Most bariatric surgery patients have already experienced numer‐
ous attempts to achieve a sustained weight loss by using nonsurgical treatment options.
Bariatric surgical procedures have increased exponentially for Severe Obesity in the world.
The three commonly performed procedures in obeses aldults are laparoscopic Roux-en-Y
gastric bypass (LRYGB), laparoscopic adjustable gastric banding (LAGB), and the novel
laparoscopic sleeve gastrectomy (LSG) have acceptable efficacy and safety for resolution of
obesity-related comorbidities [8] The best option from the different developing surgery
procedures with evaluated results are the new clinical problems.
A systematic literature review (2004 from Royal Australasian College of Surgeons) compare
the safety and efficacy of laparoscopic adjustable gastric banding with vertical-banded
gastroplasty and gastric bypass [9]. The results showed that LAGB was associated with a mean
short-term mortality rate of approximately 0.05% and an overall median morbidity rate of
approximately 11.3%, compared with 0.50% and 23.6% for RYGB, and 0.31% and 25.7% for
VBG. Overall, all 3 procedures produced considerable weight loss in patients up to 4 years in
the case of LAGB (the maximum follow-up available at the time of the review), and more than
10 years in the case of the comparator procedures. The Australian Safety and Efficacy Register
of New Interventional Procedures-Surgical Review Group concluded that the evidence base
was of average quality up to 4 years for LAGB. Laparoscopic gastric banding is safer than VBG
and RYGB, in terms of short-term mortality rates. LAGB is effective, at least up to 4 years, as
are the comparator procedures. Up to 2 years, LAGB results in less weight loss than RYGB;
from 2 to 4 years there is no significant difference between LAGB and RYGB, but the quality
of data is only moderate. Although Laparoscopic adjustable gastric banding is now promoted
as a safer, potentially reversible and effective alternative to Roux-en-Y gastric bypass.
A systematic review [10] comparing the two most popular bariatric procedures-Gastric
banding or bypass? The conclusion strongly favored Roux-en-Y gastric bypass over laparo‐
scopic adjustable gastric banding for weight loss outcomes. Patients treated with laparoscopic
adjustable gastric banding had lower short-term morbidity than those treated with Roux-en-
Y gastric bypass, but reoperation rates were higher among patients who received laparoscopic
adjustable gastric banding. Gastric bypass should remain the primary bariatric procedure used
to treat obesity in the United States. Lee WJ [11] conducted a randomized trial of moderately
obese Chinese patients (BMI < 35) with troublesome, difficult diabetes. Patients were followed
for 1 year. Nearly all patients (93%) in the gastric bypass group had a remission of diabetes,
compared with less than half of patients (47%) with sleeve gastrectomy. Weight loss was also
more pronounced after gastric bypass. A meta-analysis of international bariatric surgery
studies from 2003 to 2012 provides reassurance that the surgery is effective for candidates of
procedures with 3 main types of bariatric surgery [12]. Gastric bypass resulted in more effective
weight loss, but was associated with more complications. Adjustable gastric banding was
linked with lower mortality and complication rates; however, it had a higher reoperation rate
and was associated with less substantial weight loss than gastric bypass. Sleeve gastrectomy,
which is becoming more popular, resulted in weight loss comparable to that obtained with
gastric bypass and greater than that with adjustable.
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A first report [13] from the American College of Surgeons Bariatric Surgery Center Network
showed showed that laparoscopic sleeve gastrectomy has morbidity and effectiveness
positioned between the band and the bypass. for data up to 1 year.
A retrospective short-and mid-term follow-up of a single institution of the American College
of Surgeons Bariatric Surgery Centers of Excellence reviewed the experience and the proce‐
dure-related morbidity among all 3 procedures between the years 2005 and 2011 to identified
and compared complications, mortality, readmissions, and reoperations in patients who
underwent LRYGB, LAGB, and LSG. A total of 2,199 bariatric procedures were performed
during this period of time. Of those procedures, 1,327 were LRYGB, 619 were LSG, and 253
were LAGB. Perioperative mortality was not applicable for all 3 procedures. The leak rate was
0.5% for LRYGB and 0.3% for LSG, and was not applicable for LAGB. The average number of
readmissions postoperatively was less than 2 times for all 3 procedures: LRYGB 1.96 times,
LSG 1.49 times, and LAGB 1.54 times. The percentages of procedures requiring reoperations
due to complications or failures were 14.6% in the LAGB group, 6.6% in the LRYGB group,
and 1.8% in the LSG group. The conclusion showed that LSG appears to have the lowest
procedure-related morbidity when compared with LRYGB and LAGB in short-and mid-term
follow-up [14].
8. Bariatric surgery in adolescents
Medical therapy to lose weight including exercise, diet, psychological behavior modification,
and pharmacotherapy. Published long-term in obese and morbidly obese patients are non-
existent. It is estimated that failure of medical therapy to reduce significant weight for a
sustained a mount of time is close to 100 percent in the morbidly obese person.
Surgery as an alternative procedure to treat morbidly obese patients was first performed in
the mil-1960s with the negative results due to high incidence of complications, temporary
weight loss, and significant metabolic complications. In the last decade, the laparoscopic
minimally invasive procedures performed to treat morbid obesity have been established as
preferred weight loss method for safe and effectiveness with 20 years follow-up with less
comorbidities.
An increasing number of young people with a BMI of greater than 40 and severe comorbidities,
such as type 2 diatetes, and sleep apnea, are undergonging bariatric surgery. Supporting
research shows bariatric surgery in adolescents is associated with weight loss, reducing the
risks associated with metabolic disorders, and improved self-image and socialization (Lawson,
2006; Xanthakos, 2008). Long-term data including information on malabsorption of critical
nutrients and effects on maturation is needed by long-term follow-up MDT clinical study.
Experts advise that bariatric surgical therapy should be reserved for full-grow adolescents
with treatment by experienced multidisciplinary teams who can provide comprehensive
medical and psychological care (Livingston, 2010b). Bariatric procedures are generally
contraindicated for preadolescent age groups, as long-term health effects, durability of the
weight loss, and life expectancy for teens who undergo operations remain largely unknown.
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The lack of data regarding bariatric surgery in adolescents has created a significant controversy
regarding the benefits and indications.
Bariatric surgery should be offered to adolescents using a set of more conservative criteria.
These could include failure of medical therapy for at least 3-6 months.
Bariatric surgery is an increasingly utilized option for the treatment of morbid obesity among
adolescents [15]. The procedures can be performed safely as evidenced by low complication
rates. There is plenty of evidence that three procedures have been performed with LAGB,
Sleeve gastrectomy and gastric bypass by the different weight loss results. The follow-up
studies in 2003 showed the majority of adolescent patients with good results by losing over 50
percent of excess body weight (EBW) after LAP-BAND at 2 to 3 years and lose more weight
(60-80% of EBW) after gastric bypass at 1 to 2 years.
There are very few complications with band slippage in 5 percent, port leak in 5 percent, and
erosion of the band in 2 percent. Intolerance to food, nausea, and vomiting, bowel obstruction,
and vitamin deficiencies or regaining problems during long-term follow-up which increased
the re-operating procedures. The complications were more frequent in the gastric bypass
procedure that including pulmonary embolism, strictures, anastomotic leaks and bleeding,
and bowel obstructions. There are more data indicating that LAGB procedure may not be as
effective in “superobese” patients (BMI > 50) because of insufficient weight loss. However, this
concept is currently chanllenged by different mechanism studies in different bariatric proce‐
dures. In fact, many patients and also surgeons are preferred one procedure.
There is increasing consensus that bariatric surgery is superior to medical intervention for
long-term weight loss in morbidly obese persons. Most postoperative patients are able to lose
a significant amount of weight, profit from reduced or resolved comorbidities with an
improved quality of life (QOL). Despite these benefits from bariatric surgery, 5-30% patients
either lose little weight or unable to maintain their weight lose or regaining weight over the
long term. Aside from medical or surgical complications, postoperative weight loss success
deponds upon the patient’s abilities and willingness with family to follow the prescribed
nutritional and lifestyle guidelines by Multidisciplinary team (MDT). Whereas the surgery
provides the tool for weight loss the patient must provide the motivation and ability to obtain
the long-term success. New researches, mechanisms new operating options and evaluation or
effects of obesity on the causes, continues to evolve.
9. Multidisciplinary care for obese patients
Obesity is strongly associated with severe medical problems. Before bariatric surgery, we need
to set up the multidisciplinary team in hospital.
Multidisciplinary care for obese patient is an integrated, collaborative approach to treatment
planning and ongoing patient care and management. To understand the roles and the
management of MDT is important to realize the safe and effeciency for bariatric surgery
purpose.
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To understand the benefits of the MDT approach on obese patient outcomes, we need to know
the problems of obese patients. Morbidly obese patients may have significant sympotoms of
depression, evidence of eating disorders, negative body image, low QOL, and other coexisting
mental disorders. Bariatric surgery candidates have a varity of psychiatric and behavioral
problems such as anxiety depression, eating disorders, and history of sexual abuse. Psycho‐
pathology and various psychological difficulties exist prior to the bariatric surgery can direct
adverse effects on the postoperative outcome.
Physical system exam, preoperative weight loss, psychological and preoperative tests or
assessment may prove identified and valuble factors predicting postoperative success.
An MDT comprises all relevant medical and allied HCPs from different disciplines who are
required to effectively plan personalised treatment and care for obese patients [17]. This
involves: 1. To comprehensive review of clinical and diagnostic findings; 2. To consideration
of all treatment options relevant to the case; 3. To educate the patient with the parents and
families; 4. To development of an individual treatment plan for each patient. To follow-up and
resolve the problems and complications such as regaining or nutrition deficiency.
The carrer of treatment for obese and morbidly obese individuals must be a multidisciplinary
approach.
Members of an bariatric surgery with MDT include core members and supported members.
Core members including general surgical surgeons or GI surgeons, endocrinologists, dieti‐
tians, radiaologists, cardiovascular specialists, respiratory and anesthesia specialists, psychol‐
ogists and behavioral specialists. Supported members include nurses, data managers,
researchers, healthcare practionares, social workers.
10. Before surgery — Psychological test and education assessment
From a psychological perspective, bariatric surgery is unique because it is a behavioral surgery
in which the “outcomes are independent of the technical performance of the operation.”
Surgery outcome, especially long-term maintaince of weight loss, relies almost completely on
patient ability and / or willingness to make significant changes in eating and exercise habits
and often in the emotional relationship with food. Bariatric surgery provides anatomical tools
that make it easier to restrict food consumption and nutrient absorption, allowing patients to
correct imbalances in caloric intake and metabolic demand. In addition to the numerous
behavioral demands following surgery, there are significant risks for serious postoperative
complications, even death.
For these reasons, patient education and knowledge play critical roles in bariatric surgery,
influencing nearly every part of the surgery process and outcome, including patients’ abilities
to give informed consent, develop realistic expectations, prepare psychologically, and succeed
in making the behavioral changes that lead to sustained weight loss. Unfortuneately, there is
often a gap in patient’s knowledge and misconceptions about surgery that interfere with the
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goals. The knowledge of patient with their parents and family would impact on bariatric
surgery outcome.
In order to improve the patient education process in bariatric surgery, it is necessary to identify
areas of knowledge that tend to be ploblematic. It also suggested that patient knowledge needs
to be assessed after educational interventions to insure that information has been assimilated.
As healthcare professionals we need continue to educate and update ourselves with the
growing and difficulty road of surgical Intervention or treating obesity, weight management,
and multidisciplinary approaches surrounding this obese patients with their parents and
family.
11. Conclusions and recommendations
Obesity is a major worldwide problem in public health, reaching epidemic proportions in
many countries, especially in urbanized regions. Bariatric procedures have been shown to be
more effective in the management of morbid obesity, compared to medical treatments in terms
of weight loss and its sustainability
Management of Pediatric and Adolescent Type 2 Diabetes is a special long-term healthcare
and research work. All of the bariatric surgery adolescent patients should be managed in a
comprehensive multidisciplinary program and operaed on in hospitals and centers with
extensive experience performing bariatric surgery [16-17]. The decision and the type of surgery
should be individualized for each patients and experience of the individual surgeon.
The LAGB insertion should be the first  choice for  adolescent  patients  to bring behavior
changes with less obstacles to the growth after bariatric surgery. However, in recent years
surgeons  are  likely  to  perform LAP-sleeve  gastrectomy with  the  better  results  and less
complications  especially  for  “superobese”  patients  or  LAGB  failed  patients.  All  the
adolescent patients and their parents should be informed in detail on the advantages and
disadvantages  of  each  available  procedure,  possibly  in  several  interviews  and  always
accompanied by a specialized interdisciplinary team. The long-term follow-up evaluation.
Studies should to be continued.
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1. Introduction
Laparoscopic Sleeve Gastrectomy (LSG) is an increasingly popular procedure for weight loss.
Compared to other bariatric procedures, sleeve gastrectomy remains a relatively young stand-
alone weight loss operation. However, despite being relatively new it has gained grounds not
only in the west where bariatric surgery has been around for long but also in Asia where it is
increasingly becoming the procedure of choice for weight loss [1, 2]. Its attractiveness is
attributed not only to its significant weight loss outcome, but also the technical austerity of the
operation as well as the significant improvement or remission of medical co morbidities.
1.1. History
Sleeve gastrectomy may be seen as an extension of the Magenstrasse and Mill procedure.
The first open sleeve gastrectomy was performed in March 1998 by Doug Hess [3]. A year
later, the first laparoscopic duodenal switch with a sleeve gastrectomy was reported on a
porcine model [4]. LSG was first performed in 2000, by Gagner et al as part of a duode‐
nal switch procedure and he subsequently also reported sleeve gastrectomy after BPD/DS
as  a  salvage  procedure  for  poor  weight  loss  [5,  6].  Regan  et  al.  then  reported  sleeve
gastrectomy as a first step for sufficient weight loss prior to performing a more definite
procedure  such as  Roux-en-Y bypass  or  duodenal  switch  in  high-risk  obese  patients  to
decrease mortality and morbidity [7].
1.2. Indications
The NIH Consensus conference [8] in 1991 stipulated that patients with BMI equal to or
exceeding 40kg/m2 or patients with high risk co-morbid conditions and BMI exceeding or
equal to 35 kg/m2 were candidates for bariatric surgery. For Asian patients, the BMI cut-
off  is  2.5kg/m2  lower  [9].  More  recently,  the  International  Sleeve  Gastrectomy  Expert
© 2014 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
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Consensus  Statement  stipulated that  laparoscopic  sleeve  gastrectomy (LSG)  was  a  valid
stand-alone procedure for patients with metabolic syndrome as well as patients with a BMI
of 30 – 35 kg/m2 in presence of associated comorbidities [10]. Obese patients with Child’s
A or B liver cirrhosis, inflammatory bowel disease or potential transplant recipients were
also potential candidates for LSG [10]. LSG was also deemed suitable for morbidly obese
patients in their adolescence as well as elderly morbidly obese patients. Medical tourism is
on the rise and people traveling from far-fetched regions with minimal support may seek
bariatric surgery and once stationed back in their remote locations may not have access to
care needed for maintenance. A very low of long term complications is seen as an advantage
to recommend this procedure.
1.3. Contraindications
LSG has been reported to increase the incidence of gastroesophageal reflux disease (GERD)
[11]. A history of GERD is a relative contraindication for undergoing laparoscopic sleeve
gastrectomy as their symptoms might worsen after surgery and these patients may be better
served with other procedures e.g. gastric bypass [12].
Caution should be exercised in patients with concurrent Barrett’s Esophagus. Performing a
sleeve gastrectomy will decrease the amount of gastric tissue available for creation of a gastric
tube after esophagectomy if there is malignant progression of the Barrett’s Esophagus. LSG is
preferred and favored over Roux-en-Y bypass in patients / regions at high risk of developing
gastric cancer as performing the latter procedure will make endoscopic surveillance of the
remnant stomach for cancer almost impossible.
2. The procedure
2.1. Preoperative considerations
The preoperative management does not differ from other bariatric procedures. Patients with
a history of smoking should be encouraged to stop smoking. Dietary counseling should be
mandatory and should address preoperative weight loss, immediate and long term diet
recommendations after sleeve gastrectomy. Initiation of a low calorie diet prior to surgery
should be considered as this helps shrink the large fatty liver and thus optimizes intra-
abdominal operating space. Investigations to evaluate peri-operative risk, exclude other causes
of obesity and those on long term follow up nutritional monitoring are a norm. A visit to a
physiotherapist, psychologist, pulmonologist, anesthetist and other physicians should be
considered on need basis. The role of a multidisciplinary team to manage these patients cannot
be further emphasized [13].
2.2. Technique
a. Positioning
It should be ensured that the operating table has the capacity to support the weight of the
patient. The patient may be positioned supine or in French position with legs apart (Figure
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1). The feet are secured to the foot board so that reverse trendeleburg position is possible. The
arms should be well padded to prevent neurological injury should the arms be stretched out
and secured to an arm board. Once the patient is strapped down, the table should be tilted to
extremes to ensure that the patient is well secured and would not slip off the table (Figure 2).
Figure 1. French position
Figure 2. Patient secured on operating table
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b. Decompression of the stomach
This can be achieved by insertion of orogastric tube, a hollow calibration tube by gastroscopy.
We insert our disposable 38F calibration tube after positioning the patient and prior to draping.
In doing so, we are able to empty the gastric contents prior to surgery and during surgery, to
maneuver the calibration tube to size the sleeve. The insertion of a calibration tube is not
without problems. If one faces resistance during insertion of it is better to use a gastroscope or
colonoscope as calibration tube. There are reports of esophageal perforation resulting from
improper handling of calibration tubes [14].
c. Port placement
5 ports are typically inserted for LSG in our patients. A 10-12 optical trocar is inserted 20 cm
below the left costal margin along the midclavicular line to gain access to the abdominal cavity.
Other techniques like the use of Veress needle and open Hassan technique may be used. A
5mm epigastric port is inserted for introduction of a liver retractor. For patients where the
distance between the xyphoid and umbilicus is up to 35cm we insert an infra-umbilical 15mm
port as the working port for the surgeon. If the distance is more or the patient has central
obesity this port is changed to a 10-12mm port that is placed approximately 20cm from xyphoid
to the left of the mid line. Two 5mm ports are inserted in the left and right hypochondria regions
of the patient for assistant and surgeon (Figure 3).
Figure 3. Port placement
d. Measurement of the Antral pouch:
Once pneumoperitoneum is established, a diagnostic laparoscopy is performed and hepatic
steatosis assessed. The greater gastrocolic omentum is divided 5 cm from the pylorus with the
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aid of an energy device (Figure 4). There is consensus among bariatric surgeons that the antral
pouch should be measured 2-6cm from the pylorus along greater curve [10] as risk benefit ratio
is best within these limits. However, some surgeons also believe that cutting too close to
pylorus increases risk of leak and most would prefer to stay 4-6cm away. Michalsky D et al
compared patients who underwent radical resection of antrum (resection 2.5cm from pylorus)
versus those with preserved antrum (resection 6cm from pylorus), they found no difference
in % excess weight loss, complications, gastric emptying and food retention between both
groups [15].
Figure 4. Measuring antral pouch
e. Devascularization:
In the lateral technique, the devascularization process is continued up the greater curve of the
stomach to the short gastric vessels with the help of the assistant who maintains traction and
exposure during this process (Figure 5a&b). Eventually, one reaches the left crus which is an
important landmark of dissection (Figure 6). The left crus muscle is then routinely dissected
and hiatus explored by some for a hernia, while others may differ. We selectively explore the
hiatus of the symptomatic and endoscopically proven hiatus hernia as all our patients are
evaluated for symptoms of reflux by questionnaire pre-operative and also have a gastroscopy
performed. In patients with hiatus hernia, the hernia should be reduced and the defect
repaired.
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Figure 5. a) Gaining entry into lesser sac, (b) Division of gastro colic ligament
Figure 6. Exposure of left crus of diaphragm
In the medial approach, once the lesser sac is entered the process of stapling starts and
devascularization is done only upon completion of sleeve. Dapri et al randomized 20 patients
to each arm and looked at the technical outcomes of both medial and lateral approaches; they
reported no difference in operative time, preoperative bleeding and hospital stay [16]
f. Gastric tube calibration
The 38 Fr Bougie inserted preoperatively is then advanced into the stomach along the lesser
curve. This serves as the border of transection with the linear staple with the remnant lesser
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curve forming the neo gastric pouch. One of the controversies lies in the optimal size of bougie
to be used to size the sleeve. Baltazar uses a 32-French bougie with transection starting at 2-3
cm from the pylorus [17] as opposed to Gagner using a bougie of 60-French bougie and starting
the transection at 10 cm away from the pylorus [6]. The bougie size does not affect mean excess
weight loss in the short-term but weight loss is significantly different in calibrated sleeves
compared to non calibrated sleeve [18]. The meta-analysis of Parikh et al did not show
significant difference in %EWL outcomes between bougie <40 Fr and bougie ≥40 Fr up to 36
months (mean: 70.1% EWL; P=0.273) [19]. All panelists in the Expert consensus statement
agreed that it was important to use a bougie to size the sleeve and the optimal size of the bougie
should be between 32 to 36F [10]. The use of a bougie < 32F may increase postoperative
strictures while using bougie of > 36F may bring about limited weight loss effects due to
possible dilatation of the sleeve. The size to tube finally achieved will also depend on other
factors like over sewing the staple line and whether ones’ stapling is snug or lax in relation to
the bougie.
g. Creating the gastric tube:
Linear transection of the stomach can be performed using 3.5mm, 3.8 mm or 4.1 mm staples
height depending on the thickness of the stomach wall. Any serosal tears during stapling
or excessive unexpected bleeding should be carefully evaluated as it  may be signaling a
poorly stapled area.  As the incisura is a common area of narrowing and in indicted for
being the cause of the high pressure system resulting in apical leaks in many patients, every
effort should be made to stay away and prevent narrowing during stapling. We mark our
stapling trajectory with a  marker  before  commencing stapling as  over  enthusiasm often
leads to disasters (Figure 7)
The use of staple-line reinforcement either through suturing or buttressing with biological or
synthetic material is a hotly debated topic. Perioperative and postoperative bleeding is a
concern for the staple line in sleeve gastrectomy and has been quoted to be between 0 to 14%
[20]. Methods to contravene this include the over sewing the staple line with non-absorbable
suture material, use of fibrin glue as well as the use of buttressing material along the suture
line. Several authors have advocated the use of buttress material to reduce staple line bleeding
and leak rates [21], while other reinforcement techniques do not reliably reduce staple line
leaks in sleeve gastrectomy [22, 23]. D’Ugo et al. found that in 1162 undergoing LSG, the overall
leak rate was 2.8%; Leak rate was lower in patients who had their staple line reinforced with
bovine pericardium strips (0.3%) compared to those with synthetic polyester (7.8%) or no
reinforcement (4.8%). Postoperative bleeding in patients who had staple line reinforcement
was lower (3% vs. 13.7%) [24]
In summary it is suffice to state that current evidence supports the use of buttress material to
decrease staple line bleeding [19]. However, buttress material may potentially lower leak rates
as it increases burst pressure but the evidence is of poor scientific strength to make a recom‐
mendation for their routine use to prevent leaks [23].
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The specimen is then delivered via the umbilical port (Figure 8). The staple line is then checked
for any leaks; we do not routinely oversew the staple line. The 15mm port site is then closed
with absorbable suture and the overlying skin stitched with a monofilament absorbable suture
after local anesthesia is administered.
Figure 8. Resected stomach
Figure 7. Marking prior to stapling
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3. Learning curve
Laparoscopic sleeve gastrectomy looks easy to perform, but yet is a technically demanding
procedure; it has to learned through proctorship and mentorship. LSG can be safely and
efficiently performed in a newly established bariatric center following a mentorship program.
Proficiency seems to require 68 cases. The operative time and hospital stay may significantly
decrease with experience early in the learning curve, as opposed to mortality and morbidity
rates, conversion rate, and %EWL which will likely remain unchanged [25].
3.1. Post-operative care
For our team, a standardized post operative pathway not only ensures quality care for patients
but also help juniors on call staff managing patients strategize management and know who to
call when the need arises. We stratify patients based on their ASA grade and the anesthesia
team will dictate their admission to intensive care, high dependency or general ward post-
operatively. We have standard pain control protocol to prevent narcotic overdose and yet
provide effective pain relief.
Clear fluids and ambulation are started on the day of surgery. Patients are reviewed by the
dietician and post-operative diet reinforced prior to being discharged home. A phone consult
is done 24-48hrs after discharge to reinforce hydration and to ensure patients are recovering
well. The clinician nurse, surgical team and dietician review patients 1-2 weeks postoperatively
as they slowly progress from clear feeds to soft diet within 4-6 weeks. We believe that the main
pillars leading to the success of the sleeve is long term nutritional care. Nutrition relies on a
professional medical team providing constant, ongoing patient support throughout all the
bariatric process stages working side by side. Patients are regularly reviewed by the dieticians
to re-enforce diet recommendations. Long-term, they are prescribed vitamin supplements as
advocated by the American Society of Bariatric and Metabolic Surgery guidelines for post
bariatric surgery patients [26]. Patients are educated on the need for regular follow up, alike
other batriatric procedures. Keren D et al reported improved weight loss and better comor‐
bidity outcomes for those with regular follow up. A total 119 patients were followed up for 30
months with the mean percentage of excess BMI loss being 82.08 ± 9.83 kg for the follow up
group and 74.88 ± 8.75 kg for those without follow up [27].
3.2. Complications and management
Chang SH et al reported that the mortality rate for all bariatric procedures within 30 days was
0.08% (95% CI, 0.01%-0.24%); the mortality rate after 30 days was 0.31% (95% CI, 0.01%-0.75%)
[28]. Mortality after LSG is exceedingly rare, the 30 days mortality being 0.11% and 1 year
mortality of 0.21% [29]. The 30 day morbidity of sleeve gastrectomy is 5.61% which is higher
in comparison to the laparoscopic adjustable gastric band of 1.44% but similar to that of the
gastric bypass of 5.91% [29].
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While the general complications of bariatric procedures remain unchanged among procedures,
we will discuss important complications specific to sleeve gastrectomy. Staple line leakage,
strictures, and gastrointestinal reflux are the most common complications after LSG.
3.2.1. Leak
Staple line leaks can be divided into acute (< 7 days), early (1-6 weeks), late (after 6 weeks) and
chronic (after 12 weeks) [10]. The risk of a leak after LSG was quoted to be 2.4% with 89% of
these leaks occurring in the proximal third of the stomach near the angle of His [30]. The
pathophysiology of post sleeve is multifactorial and include
a. Tissue Ischemia from
i. Excessive devascularisation resulting in ischemia of tissue near angle of His
ii. Removal of fat pad at angle of His
b. Faulty stapling technique
i. Use of improper staple height leading to poor B formation of staples
ii. Stapling across esophageal fibers at gastroesophageal junction muscle fibers
c. Functional or anatomical obstruction of gastric tube further increasing intra-gastric
pressure of an already elevated pressure system. The sleeve is considered a high pressure
tube because there are anatomical sphincters at both ends i.e. the lower esophageal
sphincter and the pylorus. This can be contributed by
i. Creation of a gastric tube that is not cylindrical shape as shown in the last three
drawing of figure 9 results in a high pressure being built at the proximal most corner
of the staple line based on Laplace Law and thus higher chances of leak at the proximal
1/3rd of the tubular stomach
Figure 9. Possible shapes of sleeve created by improper stapling
ii. A staple line that is spiral shaped can result in functional obstruction of the sleeve
and a high pressure system develops
iii. Stapling too close to the incisura results in anatomical narrowing, a preventable cause
of leak
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iv. Post sleeve gastrectomy the tubular sleeve can acquire various shapes-"S" or "L" shape
that can potential result in a high pressure system.
A detailed discussion of leak management is beyond the scope of this chapter. The diagnosis
of a leak can be made clinically where patients have fever, tachycardia and abdominal pain.
The diagnosis can be confirmed with a computerized tomography scan of the abdomen and
pelvis or a oral contrast study like gastrograffin meal (Figure 10) The management of the
patients with suspected leaks depends first, on whether these patients are haemodynamically
stable. In patients who are well with small contained leaks, non-operative management with
percutaneous radiological drainage, endoscopic stenting and supportive therapy with
antibiotics and total parenteral nutrition has been demonstrated to be effective [31]. In patients
who are septic and suspected to have contained or uncontained leaks, immediate operation
for washout and drainage of the contaminated field is indicated. These patients will need
nutritional support via total parenteral nutrition (TPN), or enteral nutrition via a feeding
jejunostomy inserted at time of emergency surgery (preferred option) or naso-jejunal feeding
tube. The following interventions (Figure 11) have been described as options in management
of simple sleeve leak but they have to be individualized to circumstances and resources at
individual centers. For more complex leaks with pleural, bronchial and pulmonary fistulae,
detailed discussion with the thoracic surgeon is needed prior to intervention.
Figure 10. CT scan showing collection and leak of contrast from a proximal sleeve leak
1. Simple suture repair
2. Suture repair with omental patch+/-pyloroplasty
3. El Hassan et al. described a novel method of cannulating a leak site via endoscopy and
laparoscopy with a T tube in patients presenting with early leaks, therefore convert‐
ing the leak site into a controlled fistula together with wide drainage of the abdomi‐
nal cavity [32].
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iv. Post sleeve gastrectomy the tubular sleeve can acquire various shapes-"S" or "L" shape
that can potential result in a high pressure system.
A detailed discussion of leak management is beyond the scope of this chapter. The diagnosis
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stable. In patients who are well with small contained leaks, non-operative management with
percutaneous radiological drainage, endoscopic stenting and supportive therapy with
antibiotics and total parenteral nutrition has been demonstrated to be effective [31]. In patients
who are septic and suspected to have contained or uncontained leaks, immediate operation
for washout and drainage of the contaminated field is indicated. These patients will need
nutritional support via total parenteral nutrition (TPN), or enteral nutrition via a feeding
jejunostomy inserted at time of emergency surgery (preferred option) or naso-jejunal feeding
tube. The following interventions (Figure 11) have been described as options in management
of simple sleeve leak but they have to be individualized to circumstances and resources at
individual centers. For more complex leaks with pleural, bronchial and pulmonary fistulae,
detailed discussion with the thoracic surgeon is needed prior to intervention.
Figure 10. CT scan showing collection and leak of contrast from a proximal sleeve leak
1. Simple suture repair
2. Suture repair with omental patch+/-pyloroplasty
3. El Hassan et al. described a novel method of cannulating a leak site via endoscopy and
laparoscopy with a T tube in patients presenting with early leaks, therefore convert‐
ing the leak site into a controlled fistula together with wide drainage of the abdomi‐
nal cavity [32].
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4. Loop drainage: using a free loop of jejunum anastomosed to the leak site
5. Transection of gastroesophageal junction and proximal esophago-jejunostomy leaving
gastric tube in place
6. Total gastrectomy with esophago-jejunostomy
7. However currently the most favored approach for acute leak is stenting. Baltazar first
reported the use of coated self-expanding stents (CSES) in patients with gastric leaks post
sleeve gastrectomy; successful resolution of the leak was reported in 4 out of the 5 patients
who underwent CSES. None out of 5 patients required a re-operation and all patients
recovered within 6 to 8 weeks. In our opinion early stenting help because stenting
a. Obliterates the defect thus preventing on going leak and thus helps control sepsis
b. Neutralises pressure in the stomach as it traverses gastroesophageal junction to across
pylorus
c. It corrects any abnormal axis along the sleeved tube especially acute bends at incisura
d. Promotes healing by allowing tissue apposition and omental adherence
e. Reduces the risk of gastro-atmospheric fistula formation
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8. For chronic leak with small cavities, endoscopic septoplasty of the bridging stomach wall
can be considered
9. Use of tissue glue for closure of chronic fistula
10. Use of endoscopic vacuum therapy (Endosponge) is now a novel approach to upper
gastrointestinal tracts and well as the over the scope clips [33].
3.2.2. Strictures / Gastric volvulus
The formation of strictures and gastric pouch stenosis is an uncommon but important com‐
plication of LSG. The mean stricture rate in a meta-analysis of 4888 patients who have
undergone LSG was 0.5% [30]. Regurgitation is the most common presenting complaint for
patients with significant stenosis with the most common site of stenosis at the angular incisura.
A smaller bougie size used to size the sleeve is associated with a greater risk for developing
of strictures post operatively. In patients whom strictures are suspected, assessment can be via
contrast swallow studies or endoscopy. The latter also allows for dilatation to be performed
in the same setting. After gastroscopy in patients with short segment stenosis dilatation with
or with out stenting is an option, should they respond to this treatment repeat dilatation is
advisable. In cases of failed dilatation therapy or long segment stenosis, revisional surgery in
the form of conversion to other procedures like gastric bypass or stricturoplasty may be
considered. Eubanks reported that in patients who underwent stenting for strictures, 84%
achieved immediate symptomatic control and subsequent resolution of the stricture. 16% (1
out of 6 patients) had unsuccessful stent treatment [34, 35]. Burgos also reported success in the
use of endoscopic balloon dilatation (preferably a Rigilflex balloon) and endoscopic bougie
dilatation in the treatment of stricture post sleeve gastrectomy [34]. In patients with excessive
length of stricture where endoscopic dilatation was not possible, Dapri reported that laparo‐
scopic seromyotomy enabled patients to tolerate regular diet with improvement in mean
dysphagia score. The aim of the procedure was to achieve a myotomy 1 cm beyond the stenosis
proximally and distally [36]. Conversion to a roux-en-Y bypass is the last resort for patients
with strictures post sleeve gastrectomy. Other options include stricturoplasty, gastro-gastro‐
stomy and gastrectomy [37].
Gastric volvulus post sleeve gastrectomy is a rare complication. After sleeve gastrectomy the
stomach has no fixation along its greater curve, this together with the increased laxity of tissue
after weight loss increases the risk of a gastric volvulus. Classically patients present with the
Borchardt clinical triad of epigastric pain, retching and inability to pass a nasogastric tube.
Laparoscopic fixation of the gastric tube as one would do for congenital malrotation of the
stomach will fix the problem.
3.2.3. Gastroesophageal reflux disease (GERD)
In patients with symptoms of pre-existing reflux prior to surgery, Roux-en-Y bypass should
be the treatment of choice instead of sleeve gastrectomy. A recent review of the Bariatric
Outcomes Longitudinal Database with 4832 patients concluded that LSG did not reliably
relieve or improve GERD symptoms and that preoperative GERD was associated with worse
A New Emerging procedure — Sleeve Gastrectomy
http://dx.doi.org/10.5772/58844
113
4. Loop drainage: using a free loop of jejunum anastomosed to the leak site
5. Transection of gastroesophageal junction and proximal esophago-jejunostomy leaving
gastric tube in place
6. Total gastrectomy with esophago-jejunostomy
7. However currently the most favored approach for acute leak is stenting. Baltazar first
reported the use of coated self-expanding stents (CSES) in patients with gastric leaks post
sleeve gastrectomy; successful resolution of the leak was reported in 4 out of the 5 patients
who underwent CSES. None out of 5 patients required a re-operation and all patients
recovered within 6 to 8 weeks. In our opinion early stenting help because stenting
a. Obliterates the defect thus preventing on going leak and thus helps control sepsis
b. Neutralises pressure in the stomach as it traverses gastroesophageal junction to across
pylorus
c. It corrects any abnormal axis along the sleeved tube especially acute bends at incisura
d. Promotes healing by allowing tissue apposition and omental adherence
e. Reduces the risk of gastro-atmospheric fistula formation




Figure 11. Approaches to sleeve leak 
1. Simple suture repair 
2. Suture repair with omental patch +/- pyloroplasty 
3. El Hassan et al. described a novel method of cannulating a leak site via endoscopy and laparoscopy 
with a T tube in patients presenting with early leaks, therefore converting the leak site into a controlled 
fistula together with wide drainage of the abdominal cavity [32]. 
4. Loop drainage: using a free loop of jejunum anastomosed to the leak site 
5. Transection of gastroesophageal junction and proximal esophago-jejunostomy leaving gastric tube in 
place 
6. Total gastrectomy with esophago-jejunostomy 
7. However c rrently the most favored pproach for acute leak is stenting. Baltazar first reported the use 
of coated self-expanding stents (CSES) in patients with gastric leaks post sleeve gastrectomy; successful 
resolution of the leak was reported in 4 out of the 5 patients who underwent CSES. None out of 5 
patients required a re-operation and all patients recovered within 6 to 8 weeks. In our opinion early 
stenting help because stenting 
a. Obliterates the defect thus preventing on going leak and thus helps control sepsis 
b. Neutralises pressure in the stomach as it traverses gastroesophageal junction to across pylorus 
c. It corrects any abnormal axis along the sleeved tube especially acute bends at incisura 
d. Promotes healing by allowing tissue apposition and omental adherence 
e. Reduces the risk of gastro-atmospheric fistula formation 
f. Prevents on going air leak into abdominal cavity in patients who need BIPAP support. 
8. For chronic leak with small cavities, endoscopic septoplasty of the bridging stomach wall can be 
considered 
9. Use of tissue glue for closure of chronic fistula 
10. Use of endoscopic vacuum therapy (Endosponge) is now a novel approach to upper gastrointestinal 
tracts and well as the over the scope clips [33]. 
Conservative 
Suture repair 
± Omental patch or 
pyloroplasty  
T –Tube  Loop Drainage  
EJ 
Anastomosis   
Leak exclusion Total gastrectomy Stenting 
Figure 11. Approaches to sleev  leak
Essentials and Controversies in Bariatric Surgery112
8. For chronic leak with small cavities, endoscopic septoplasty of the bridging stomach wall
can be considered
9. Use of tissue glue for closure of chronic fistula
10. Use of endoscopic vacuum therapy (Endosponge) is now a novel approach to upper
gastrointestinal tracts and well as the over the scope clips [33].
3.2.2. Strictures / Gastric volvulus
The formation of strictures and gastric pouch stenosis is an uncommon but important com‐
plication of LSG. The mean stricture rate in a meta-analysis of 4888 patients who have
undergone LSG was 0.5% [30]. Regurgitation is the most common presenting complaint for
patients with significant stenosis with the most common site of stenosis at the angular incisura.
A smaller bougie size used to size the sleeve is associated with a greater risk for developing
of strictures post operatively. In patients whom strictures are suspected, assessment can be via
contrast swallow studies or endoscopy. The latter also allows for dilatation to be performed
in the same setting. After gastroscopy in patients with short segment stenosis dilatation with
or with out stenting is an option, should they respond to this treatment repeat dilatation is
advisable. In cases of failed dilatation therapy or long segment stenosis, revisional surgery in
the form of conversion to other procedures like gastric bypass or stricturoplasty may be
considered. Eubanks reported that in patients who underwent stenting for strictures, 84%
achieved immediate symptomatic control and subsequent resolution of the stricture. 16% (1
out of 6 patients) had unsuccessful stent treatment [34, 35]. Burgos also reported success in the
use of endoscopic balloon dilatation (preferably a Rigilflex balloon) and endoscopic bougie
dilatation in the treatment of stricture post sleeve gastrectomy [34]. In patients with excessive
length of stricture where endoscopic dilatation was not possible, Dapri reported that laparo‐
scopic seromyotomy enabled patients to tolerate regular diet with improvement in mean
dysphagia score. The aim of the procedure was to achieve a myotomy 1 cm beyond the stenosis
proximally and distally [36]. Conversion to a roux-en-Y bypass is the last resort for patients
with strictures post sleeve gastrectomy. Other options include stricturoplasty, gastro-gastro‐
stomy and gastrectomy [37].
Gastric volvulus post sleeve gastrectomy is a rare complication. After sleeve gastrectomy the
stomach has no fixation along its greater curve, this together with the increased laxity of tissue
after weight loss increases the risk of a gastric volvulus. Classically patients present with the
Borchardt clinical triad of epigastric pain, retching and inability to pass a nasogastric tube.
Laparoscopic fixation of the gastric tube as one would do for congenital malrotation of the
stomach will fix the problem.
3.2.3. Gastroesophageal reflux disease (GERD)
In patients with symptoms of pre-existing reflux prior to surgery, Roux-en-Y bypass should
be the treatment of choice instead of sleeve gastrectomy. A recent review of the Bariatric
Outcomes Longitudinal Database with 4832 patients concluded that LSG did not reliably
relieve or improve GERD symptoms and that preoperative GERD was associated with worse
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outcomes and decreased weight loss with LSG and thus may be a relative contraindication [12].
Institutional practices may vary; some like ours do routine preoperative gastroscopy to
establish any reflux esophagitis and exclude the presence of hiatus hernia and if a hiatal hernia
is found we would in asymptomatic patients suture repair the hiatal hernia, the surgeon should
actively look out for a hiatal hernia intraoperatively and repair the hernia if it is identified. [10]
Soricelli et al compared their obese patients with GERD undergoing sleeve with or without
hiatal hernia repair and reported 80.4% versus 57.9% remission of GERD and persistent GERD
in 7.5% versus 42.2% respectively [38].
The notion that sleeve gastrectomy is a refluxogenic operation remains controversial, as Chiu
S et al reviewed 15 published reports of which 4 found sleeve to increase reflux and 7 showed
reduction in prevalence of GERD [39]. The anatomic and physiological factors influencing
GERD after sleeve gastrectomy are listed as such
a. Worsen GERD
Decrease in gastric emptying
Lower LES pressure
Blunting angle of HIS
Decrease in gastric compliance and volume
Increase gastric pressure
Dilated proximal sleeve (technical) and fundus regeneration,






removal of fundus (Source of relaxation waves to LES)
Reduced wall tension (Laplace's Law)
In patients who develop reflux symptoms after sleeve gastrectomy, the first line treatment
should be with proton pump inhibitors [10]. Early reports have shown that in patients with
GERD but refuse gastric bypass, laparoscopic Nissen fundoplication with gastric plication may
be an acceptable weight loss option but long-term weight loss data is still required [40].
3.2.4. Nutritional complications
As LSG is a relatively young operation, there is a lack of reliable data arising from long-term
follow up of patients who have undergone the procedure. Being a restrictive procedure, it is
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postulated that no long-term nutritional deficiencies should result from laparoscopic sleeve
gastrectomy unless there is inadequate intake of nutrients. If a large sleeve has been resected,
Vitamin B12 and resultant megaloblastic anaemia may result due to the lack of Intrinsic factor
produced by the remnant stomach. In a cross sectional study reported during a mean follow
up period of 4 years post gastric bypass or LSG, patients were identified with several micro‐
nutrient deficiencies, including vitamin D, folate, and vitamin B12. LSG had a more favorable
effect on the metabolism of vitamin B12 compared with gastric bypass [41]. Thus, postoperative
prophylactic iron and B12 supplementation, in addition to general multivitamin and mineral
supplementation, is recommended based on the comparable deficiency risk.
4. Outcomes
4.1. Weight loss
A meta-analysis in 2012 comprising of 12,129 patients showed that mean percentage of excess
weight loss (EWL) at 12 months follow up was 59.0% [42], and this further increased to 64.5%
and 66.0% at 24 and 36 months follow up respectively [42]. At 48 months follow up, %EWL
declined to 60.9% but this decline was not statistically significant. The same paper also
elucidated that patients who underwent Laparoscopic Roux-en-Y bypass had significantly
higher %EWL at 12 months follow up but this difference was negligible at 24 months. In a
recent review of European data, mean excess weight loss was 68.4%, and 67.4% after 1 and 2
years respectively. Excess weight loss peaked at 70.5% at the 4-year mark before decreasing to
58.3% at the 5-year mark. The authors concluded that the long-term results regarding weight
loss were satisfactory [43]. Among super obese patients, the reported mean EWL is be 52%,
43%, 46% at 72, 84 and 96 months follow up respectively [44].
Durability of LSG has been debated and available data does suggest that it is durable. A review
of 492 patients with follow-up of at least 5 years after laparoscopic sleeve gastrectomy (373 at
5 years, 72 at 6 years, 13 at 7 years, and 34 at 8 or more years) was performed by Daimantis T
at al [45]. Mean preoperative body mass index in all 16 studies was 49.2 kg/m2. The mean
percentage excess weight loss (%EWL) was 62.3%, 53.8%, 43%, and 54.8% at 5, 6, 7, and 8 or
more years after LSG, respectively [45]. The overall mean %EWL (defined as the average
%EWL at 5 or more years after LSG) was 59.3% (12 studies, n=377 patients). The overall attrition
rate was 31.2% (13 studies). They concluded that the existing data supports the role of LSG in
the treatment of morbid obesity. It seems to maintain its well-documented weight loss outcome
at 5 or more years postoperatively, with the overall mean %EWL at 5 or more years after LSG
still remaining in excess of 50%.
4.2. Eating behavior
Several studies had elicited a change of eating behavior following bariatric surgery. Schweiger
et al [46] studied the effect of different bariatric operations on food tolerance and quality of
eating. On a score of 1 to 27 with 27 points standing for excellent quality of eating, there was
no significant difference between patients who underwent RYGB, LAGB, SG and BPD at 3-6
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outcomes and decreased weight loss with LSG and thus may be a relative contraindication [12].
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months follow-up. At 6-12 months and long-term follow-up, patients who underwent sleeve
gastrectomy achieved a score of 22.27+/-4.66 and 20.25+/-4.9 respectively. Adjusting for other
variables, the total score in the 3 follow up periods was 20.1 for RGYB, 14.3 for LAGB, 19.7 for
SG and 21.6 for BPD/DS patients. Food tolerance at 2-4 years post surgery was also shown to
be best after LSG, followed closely by RYGBP [47].
4.3. Quality of life
In a study of 78 consecutive patients who underwent LSG subjected to the Medical outcomes
Study Short Form Questionnaire (SF-36) coupled with the Impact of Weight on Quality of Life-
Lite Questionnaire pre-operatively and 12 months post-operatively, scores show a significant
overall improvement of the scores 12 months post operatively [48]. Subset analysis showed
that lesser patients reported improvement in self-esteem if they suffered complications as a
result of the surgery or had negative or moderate loss of weight compared to those who had
excellent or satisfactory loss of weight [48]. Studies have also shown that the perceived quality
of life after LSG is better compared to LAGB [47, 49]. However, LSG is the only truly irreversible
procedure.
5. Sleeve as a metabolic procedure
a. Proposed mechanisms of T2 DM remission
Multiple studies have recently demonstrated that patients with raised BMI and diabetes
experience remission of T2DM after laparoscopic sleeve gastrectomy. In a meta-analysis of 27
studies including 673 patients by Gill et al [50], it was shown that DM resolved in 66.2% of
patients and improved in another 26.9% with a mean decrease of 1.7 in HbA1c after sleeve
gastrectomy at mean follow up of 13 months. Perathoner et al reported a resolution rate of 85%
and 50% for Type 2 diabetes mellitus and dyslipidemia respectively in his patients [51]. LSG
has been shown to be superior to intensive medical therapy in the resolution of comorbidities
and improved quality of life [52].
The mechanism behind T2DM remission following LSG has not been clearly defined. It has
been postulated that decreasing oral intake and decreasing insulin resistance instead of
increase in insulin secretion is the reason behind T2DM remission. It has been found that in
patients who underwent sleeve gastrectomy, their postprandial levels of glucagon like peptide
(GLP-1) and total peptide YY (PYY) levels increased significantly at 6 weeks post operation
and remained elevated for at least 1 year [53]. By reducing the volume of the stomach, chyme
could theoretically be exposed to the L cells earlier in the small bowel earlier, resulting in earlier
production of hind gut hormones. Melissas J et al in their gastric emptying study demonstrated
faster gastric emptying after sleeve gastrectomy [54]. It has also been postulated that there is
restoration of the first phase of insulin secretion after sleeve gastrectomy. N Basso et al reported
his "Gastric hypothesis" that a loss in HCL in the stomach stimulated release of GRP which in
turn stimulates the release of GLP-1 [55]. GLP-1 initiates what is known as the incretin effect,
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which increases insulin secretion while inhibiting glucagon release, thereby leading to better
glucose hemostasis.
Ghrelin, an appetite stimulant, produces the orexigenic (appetite stimulating) effects via
stimulation of neuropeptide Y from the hypothalamus. Ghrelin is mainly produced by the
oxyntic cells of the stomach, and has been implicated in obesity and metabolic syndrome. Diet
induced weight loss raises circulating ghrelin levels. In sleeve gastrectomy patients, ghrelin
levels was markedly reduced and remained low for several months after the operation. The
reduction in serum ghrelin levels persisted at five year follow-up post sleeve gastrectomy [56].
Ghrelin not only increases one’ appetite but also has counter insulin effects which causes
increased insulin resistance. A decrease in ghrelin levels hence, would partly explain improved
glucose hemostasis in post SG patients [57]. Most authors would agree that the effect of T2 DM
resolution is not due to solely one hormone, but the added effects of appetite suppression and
regulation of foregut (e.g. ghrelin) and hindgut (e.g. GLP-1) hormones resulting in improved
glucose control overall. PYY a hormone co-secreted with GLP 1 from the distal intestine after
meals. It increases insulin sensitivity and also inhibits the hypothalamic production of
neuropeptide Y. PYY levels are increased after either sleeve gastrectomy or gastric bypass [58].
b. Metabolic outcomes
Increasingly, more trials have demonstrated the effectiveness of SG for excess weight loss.
Himpens et al reported the percentage excess weight loss (EWL) after sleeve gastrectomy as
77.5% and 57.3% at 3 and 6 years respectively [59].
Direct comparison of medical versus bariatric surgical management of obesity and diabetes
was performed in the STAMPEDE prospective randomized controlled trial at the Cleveland
Clinic [60]. Gastric bypass (Roux-en-Y) or sleeve gastrectomy provided a mean percentage
reduction in weight from baseline of 24.5±9.1% and 21.1±8.9% respectively, versus 4.2±8.3% in
the intensive medical group. Regarding diabetes, the success rate for reduction in HbA1c to
6.0% at 36 months was met by 5% of the patients in the medical-therapy group, as compared
with 38% of those in the gastric-bypass group (P<0.001) and 24% of those in the sleeve-
gastrectomy group (P=0.01) respectively). As a result, lesser medications for diabetes, hyper‐
tension and hyperlipidaemia were needed with composite improvement in all parameters of
metabolic syndrome. Long-term follow up of sleeve gastrectomy patients at 6-8 years showed
a 77% improvement or remission of diabetes [44].
Apart from T2 DM remission, LSG patients also have improved overall cardiovascular risk
profiles with improved in dyslipidemia as well as improved blood pressure control.
A systematic analysis of 33 studies comprising 3997 patients demonstrated reduction in
hypertension in 75% of cases, with resolution in 58%, at an average follow up of 16.9±9.8
months [61]. Cardiac remodeling following sleeve gastrectomy has been shown on echocar‐
diography. Reduced left ventricular mass, septum and posterior wall thickness, was demon‐
strated in the study by Cavarretta et al, resulting in improvement in cardiac function [62]. Lipid
profile improvement, specifically HDL and triglyceride levels, total cholesterol/HDL and
A New Emerging procedure — Sleeve Gastrectomy
http://dx.doi.org/10.5772/58844
117
months follow-up. At 6-12 months and long-term follow-up, patients who underwent sleeve
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excellent or satisfactory loss of weight [48]. Studies have also shown that the perceived quality
of life after LSG is better compared to LAGB [47, 49]. However, LSG is the only truly irreversible
procedure.
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and improved quality of life [52].
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increase in insulin secretion is the reason behind T2DM remission. It has been found that in
patients who underwent sleeve gastrectomy, their postprandial levels of glucagon like peptide
(GLP-1) and total peptide YY (PYY) levels increased significantly at 6 weeks post operation
and remained elevated for at least 1 year [53]. By reducing the volume of the stomach, chyme
could theoretically be exposed to the L cells earlier in the small bowel earlier, resulting in earlier
production of hind gut hormones. Melissas J et al in their gastric emptying study demonstrated
faster gastric emptying after sleeve gastrectomy [54]. It has also been postulated that there is
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Ghrelin not only increases one’ appetite but also has counter insulin effects which causes
increased insulin resistance. A decrease in ghrelin levels hence, would partly explain improved
glucose hemostasis in post SG patients [57]. Most authors would agree that the effect of T2 DM
resolution is not due to solely one hormone, but the added effects of appetite suppression and
regulation of foregut (e.g. ghrelin) and hindgut (e.g. GLP-1) hormones resulting in improved
glucose control overall. PYY a hormone co-secreted with GLP 1 from the distal intestine after
meals. It increases insulin sensitivity and also inhibits the hypothalamic production of
neuropeptide Y. PYY levels are increased after either sleeve gastrectomy or gastric bypass [58].
b. Metabolic outcomes
Increasingly, more trials have demonstrated the effectiveness of SG for excess weight loss.
Himpens et al reported the percentage excess weight loss (EWL) after sleeve gastrectomy as
77.5% and 57.3% at 3 and 6 years respectively [59].
Direct comparison of medical versus bariatric surgical management of obesity and diabetes
was performed in the STAMPEDE prospective randomized controlled trial at the Cleveland
Clinic [60]. Gastric bypass (Roux-en-Y) or sleeve gastrectomy provided a mean percentage
reduction in weight from baseline of 24.5±9.1% and 21.1±8.9% respectively, versus 4.2±8.3% in
the intensive medical group. Regarding diabetes, the success rate for reduction in HbA1c to
6.0% at 36 months was met by 5% of the patients in the medical-therapy group, as compared
with 38% of those in the gastric-bypass group (P<0.001) and 24% of those in the sleeve-
gastrectomy group (P=0.01) respectively). As a result, lesser medications for diabetes, hyper‐
tension and hyperlipidaemia were needed with composite improvement in all parameters of
metabolic syndrome. Long-term follow up of sleeve gastrectomy patients at 6-8 years showed
a 77% improvement or remission of diabetes [44].
Apart from T2 DM remission, LSG patients also have improved overall cardiovascular risk
profiles with improved in dyslipidemia as well as improved blood pressure control.
A systematic analysis of 33 studies comprising 3997 patients demonstrated reduction in
hypertension in 75% of cases, with resolution in 58%, at an average follow up of 16.9±9.8
months [61]. Cardiac remodeling following sleeve gastrectomy has been shown on echocar‐
diography. Reduced left ventricular mass, septum and posterior wall thickness, was demon‐
strated in the study by Cavarretta et al, resulting in improvement in cardiac function [62]. Lipid
profile improvement, specifically HDL and triglyceride levels, total cholesterol/HDL and
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triglyceride/HDL ratios at one year follow-up have been reported without lowering of total
cholesterol and LDL levels after sleeve gastrectomy [63].
The Asian population in general is known to develop metabolic syndrome at lower BMIs in
comparison to their Caucasian counterparts and hence, studies have reported outcomes from
Asia in this cohort. In Asian populations with T2DM and non-morbid obesity (BMI 25-35kg/
m2), sleeve gastrectomy has demonstrated up to 50% resolution in diabetes at 1 year [64]. The
principal mechanism is thought to be related to calorie restriction and weight loss, and C-
peptide levels returning to >3ng/ml appears to be the most reliable marker of resolution.
5.1. Sleeve gastrectomy as a revisional procedure
Revising a restrictive procedure to yet another revisional procedure and even more to the same
procedure does not sound promising to many. However for patients where technical failure
has led to failure to lose weight or weight regain, re-sleeve is an option. Rebibo L et all reported
15 patients undergoing repeat sleeve and compared to 30 matched primary sleeve patients.
The weight loss for the re-sleeve group was 66% versus 77% for the primary sleeve group at
12 months, which was deemed similar [65]. Cheung et al reviewed the literature on procedures
after failed sleeve and concluded that re-sleeve was associated with good weight loss and its
technically less challenging nature may make its clinical use more acceptable [66].
Also, sleeve for failed gastric band and vertical banded gastroplasty is a good and effective
revisional procedure with 60% EWL at 26 months follow up [67]. Where sleeve took off as a
first stage procedure of duodenal switch, it is also finding its way as a first stage procedure for
conversion of failed gastric bypass to duodenal switch and has been shown to be safe and
effective, leaving patients in better condition to have a duodenal switch [68].
5.2. Sleeve gastrectomy in combination with other bariatric procedures
Gastric bypass has a long history and long-term results support its efficacy in treating obese
patients with metabolic disorders. It is an established fact that there are mechanisms beyond
weight loss that are responsible for the excellent metabolic outcomes of gastric bypass and that
these are related to bypassing the foregut. In order to maximize the scope of sleeve gastrectomy
as a metabolic procedure, innovative procedures possessing benefits of both sleeve gastrecto‐
my and gastric bypass are being employed. The sleeve duodeno-jejunal bypass surgery (LSG/
DJB), single-anastomosis duodeno-jejunal bypass with sleeve gastrectomy (SADJB-SG), sleeve
gastrectomy with loop bipartition, and loop duodeno-jejunal bypass with sleeve gastrectomy,
are all largely based on manipulation of foregut. The short-term outcomes have been promis‐
ing . However, they are still considered experimental as both intermediate and long term data
are awaited. Loop duodenal bypass in combination with sleeve gastrectomy for type II diabetes
in individuals with BMI 21-38kg/m2, has shown promising early results, with 91% of achieving
HbA1c of 7.0g/dl at 6 months from surgery [69].
Laparoscopic Roux-En-Y gastric bypass prohibits visualization of the excluded stomach. For
populations with a high risk of gastric cancer, including Japan, the ability to perform endo‐
scopic visualization after bariatric surgery is paramount. In obese individuals with risk factors
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such as Helicobacter pylori infection, atrophic gastric mucosa including intestinal metaplasia,
or a family history of gastric cancer, Kasama et al. published a series of laparoscopic sleeve
gastrectomy with duodeno-jejunal bypass [70]. The procedure was found to be feasible, and
safe, with similar EWL to Roux-En-Y gastric bypass. Additional EWL compared to sleeve
gastrectomy was attributed to the added malabsorptive effects of the duodenojejunal bypass.
Sleeve with ileal interposition is an example of sleeve with hindgut manipulation. Patients
undergoing this procedure have demonstrated restoration of insulin sensitivity, with in‐
creased insulin output, and doubling of β-cell glucose sensitivity [71]. The mechanism is
postulated to be intestinal over-stimulation, with increased GLP-1 and incretin secretion.
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1. Introduction
The acceptance of bariatric surgery among morbidly obese patients is highly credited to the
introduction of laparoscopy. It has been proven beyond doubt that in morbid obesity, bariatric
surgery remains the mainstay management. [1] Although Roux-en-Y gastric bypass has
enjoyed the status of being gold standard bariatric surgery for long, it not only involves
creation of a severely restrictive gastric pouch, but also excludes a portion of the small bowel.
This puts patients at a high risk of developing nutritional deficiencies and some metabolic
complications. [2, 3].
Laparoscopic adjustable gastric banding (LAGB) became popular because of its safety profile
but its use has decreased over the last decade due to its unfavourable long term outcomes.[4].
Last decade has seen rise in popularity of laparoscopic sleeve gastrectomy (LSG) and has
shown promise in medium term results.[5] However, this procedure has the longest staple line
among all bariatric procedures which gives rise to the concerns of staple line leak, bleeding
and stricture. Furthermore, post-operative decrease in lower esophageal sphincter pressure
has been observed.[6] Talebpour and Amoli introduced plication of greater curvature as an
alternative to cutting it and recently published their 12 year results with good outcome. [7]
However, the possibility of postoperative weight regain owing to plicated gastric tube dilation
remains debatable.
In 2009 we introduced a new bariatric procedure to overcome the concerns raised by LSG,
LAGB  and  plication  and  named  it  as  laparoscopic  adjustable  gastric  banded  plication
(LAGBP).[8] It involves dual restriction by combining plication with banding. No cutting
of stomach is involved. Plication results in initial rapid weight loss and adjustable band
ensures long term maintenance of weight loss. Our case-matched comparative study with
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LSG, LAGBP showed similar results at 2 years in terms weight loss, comorbidity resolu‐
tion and complications. [9]
2. Case selection
Indications: As for other bariatric procedures, BMI ≧ 40 or BMI ≧35 with co-morbidity is an
indication for surgery.[10] This BMI limit may be reduced by 3 for Asian population as per
Asia Pacific surgical criteria; BMI ≧ 37 or BMI ≧32 with co-morbidity. [11]
Thorough pre-operative evaluation should be done as for any other bariatric procedure as per
protocols of the institution.
Super-obesity (BMI >50 kg/m2) patients may be better served with a mal-absorptive or
combined (LRYGB) procedures.
Large hiatus hernia or severe gastro-esophageal reflux is a relative contra-indication.
Patients who cannot follow-up in the clinic for weight loss monitoring and band adjustments
must not be offered this procedure.
Patients allergic to silicon must not be offered LAGBP.
3. Surgical technique
All patients should receive prophylaxis against deep vein thrombosis and antibiotics as per
the policy of the hospital before starting the procedure.
A bariatric operating table providing at least 45° of reverse Trendelenburg position is pref‐
erable.
Room Setup: Patient lies supine on the table with arms extended. Patient must be fastened to
the table to prevent slippage during change of posture. Adequate padding must be ensured.
Surgeon stands on the right side, camera-man and first assistant on the left side of the patient.
Room set-up is depicted in Figure 1.
Port placement: Four or five ports are used (Figure 2). Pneumo-peritoneum is created using
Veress needle. Surgeon’s left hand port in right upper quadrant (5mm) and right hand at supra-
umbilicus (15mm). 5mm assistant port is in left upper quadrant.
Liver retraction: The left lobe of liver could be retracted by Nathanson liver retractor or
elevated using T-shaped liver suspension technique.[12] A silicon or rubber drain attached to
2-0 polypropylene suture on long straight needle is used. Two such suspensions usually
suffice. The needle is then passed into the inferior surface of the left lobe of the liver so as to
exit at the superior surface. The needle is exteriorized by piercing the anterior abdominal wall.
The thread is clamped close to the abdominal wall after lifting the left lobe of liver
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Figure 1. Operation Theater Setup
Figure 2. Trocar Placement
Mobilisation of greater curvature: The junction of right and left gastro-epiploic vessels is seen
and greater omentum is divided close to the stomach above this point till left crus of diaphragm
is clearly seen. Below this point the omentum is divided distal to right gastro-epiploic vessels
thereby maintaining venous drainage of the stomach. This helps in decreasing oedema of the
stomach wall. Dissection is carried out distally till 3 cm from the pylorus.
Gastric plication formula: Stomach is measured transversely at the level of 6 cm below gastro-
esophageal junction (x cm) and plication formula is applied to determine the amount of
plication (y=(x+1) / 2). Stomach is marked from lesser curvature side y cm away. (Figure 3)
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Figure 3. Plication Formula
Plication: It is started from the fundus and progresses towards the pylorus stopping 3 cm from
it. The greater curvature is inverted using non-absorbable sutures (2–0 Ethibond Excel Ethicon,
St. Stevens-Woluwe, Belgium) at every 2 cm and is then reinforced with a continuous sero-
muscular suture (polypropylene 2-0). Second continuous layer is important in preventing the
herniation of inverted stomach out of the first layer.
Adjustable band: Band is then inserted using pars flaccida technique with minimal dissection
and is locked in proper position. The band is checked for proper functioning after its placement.
Band need not be fixed to the stomach (Figure 4). The reservoir port is placed over rectus sheath
near the umbilicus.
Figure 4. Completed LAGBP
Wound closure: The ports are removed, fascial defects closed and skin is closed with sub-
cuticular sutures.
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4. Post-operative course
Patients were given oral sips of water 4–6 hours after the surgery. Proton pump inhibitors
(PPIs), anti-emetics and dexamethasone are given for 1–2 days.
Patients are discharged if there is no vomiting and they are able to drink enough liquids. Oral
PPIs are given for 1 month following surgery.
Liquid diet is prescribed for first week followed by pureed diet for the second week.
This is followed by semi-solid diet for another 2 weeks after which solid food is introduced in
a stepwise fashion.
Patient is seen in clinic one week following surgery and thereafter at 1, 3, 6, 9, 12 months.
Following which every 6 monthly follow-up is done.
Adjustment of the gastric band is started after 3 months from the surgery if patient complains
of less satiety, increased food intake volume or there is inadequate weight loss.
Full evaluation of patient including upper GI endoscopy is performed after 1 year for surveil‐
lance and yearly thereafter.
5. Complications
Nausea/vomiting: This can be usually managed with anti-emetics, prokinetics, antacids and
adequate hydration.
Acute gastric obstruction: A very tight plication can result in acute gastric obstruction and will
require emergent release of plication sutures. This condition settles promptly after the reversal
of plication.
Herniation of plicated stomach: May be asymptomatic or may cause acute gastric obstruction
presenting with pain, vomiting etc. It may further complicate to ischemia and perforation.
Maintaining no more than 2 cm distance between first layer of sutures and a continuous second
layer is important to prevent this complication. If symptomatic, surgical correction is necessary
by de-plication or re-plication depending upon the condition of the patient.
Perforation peritonitis: This is a rare but serious complication of LAGBP. A high degree of
clinical suspicion is important. Pain, tachycardia and high leukocyte count should raise alarm.
Computed tomography of abdomen or contrast study may be performed but in the end, clinical
judgement must prevail. Laparoscopic exploration should be performed, band removed and
plication must be released. Perforation can usually be repaired primarily. However, wedge
resection or sleeve gastrectomy may be required for ischemic part.
Band infection: As with LAGB, band may get infected and usually needs removal.
Band adjustment schedule: First adjustment is not done before 3 months from surgery so as to
let the oedema subside. Later, patient is followed at intervals as mentioned before and band
is adjusted according to weight loss and feeling of satiety.
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Proper case selection is important. Patients must understand the need for follow-up and band
adjustment.
By preserving the right gastroepiploic vessels, the oedema of stomach can be decreased thereby
decreasing the post-operative vomiting. And adopting the gastric plication formula could
facilitate and standardize the surgery to prevent the complications from over-plication.
Advantages of LAGBP: It avoids cutting of stomach thereby decreasing chances of leak,
haemorrhage and stricture. The placement of adjustable band over plication helps in prevent‐
ing dilatation of stomach over long time. Plication decreases number of band adjustments
required for adequate weight loss and hence decreases complications of banding. Stomach
wall near cardia is not cut as in LSG and hence may decrease gastro-esophageal reflux. No part
of stomach is removed and hence vitamin / mineral deficiencies may be less as compared to
LSG.
Proper follow-up is of paramount importance for adequate weight loss.
7. Conclusion
Laparoscopic adjustable gastric banded placation (LAGBP) owns dual effect of plication and
band adjustment without side effects of gastrointestinal anastomosis and mal-absorption,
proved to be a safe and effective bariatric surgery.
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1. Introduction
Metabolic surgery is now a well-established concept which originated from diabetic remission
of bariatric surgery. Roux-en-Y gastric bypass (RYGB), biliopancreatic diversion with duode‐
nal switch (BPD-DS), mini-gastric bypass (MGB) and even the new entrant, sleeve gastrectomy
(SG), have been shown to achieve good results in diabetic control and glycaemia result of type
II Diabetes Mellitus. [1, 2, 3, 4] But all these procedures come with their own set of limitations
and long-term complications. Marginal ulcer, intractable dumping syndrome, internal
herniation, bile reflux, malnutrition are to name a few and some patients require reoperation
in the future because of these complications.
Laparoscopic RYGB (LRYGB) has been taken as the gold standard procedure now in the world
in treating morbid obese patients with type II Diabetes Mellitus. LRYGB can be accomplished
using either an antecolic or retrocolic approach which creates 3 or 2 potential mesenteric defects
respectively. Otherwise, internal hernia has been the most common causes of small bowel
obstruction following LRYGB, with an incidence ranging from 1% to 9%. [5, 6, 7] It has become
ever more frequent following laparoscopic RYGB than it was during open surgery era. [8]
Marginal ulceration has been also reported in 1%–16% of patients. [9] Stricture of the gastro‐
jejunal anastomosis happens in 2.9% to 23.0% of patients. [10, 11] Gastrogastric fistula has been
reported in 1.5% and 6.0% of cases. [12]
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Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and eproduction in any medium, provided the original work is properly cited.
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Another rare but potentially devastating complication of RYGB involves the inadvertent
anastomosis of the proximal biliopancreatic limb of the jejunum to the gastric pouch in
conjunction with a misplaced jejunojejunostomy. [13]
Compared with gastric bypass, duodenal switch could not get rid of all these complications
mentioned above and even is associated with a greater risk of vitamin deficiencies. [14] Kevin
et al reported that 18% of patients were hypoalbuminemic, 32% anemic, 25% hypocalcemic,
and almost half had low vitamin A, D, and K levels, despite more than 80% taking vitamin
supplementation. [15]
Though LSG is a simpler procedure and owns satisfactory weight loss, a recent meta-analysis
and some randomized controlled trials have demonstrated inferiority of LSG over LRYGB in
the treatment of diabetes and control of metabolic syndrome. [16, 17, 18, 19] Evidence suggests
that MGB has real risk of bile reflux due to the loop configuration that may have long-term
damaging effects to the gastric pouch and possibly cancer of the distalesophagus. [20, 21, 22]
McCarthy et al performed endoscopy in 28 patients who had undergone loop gastroenteros‐
tomy, loop gastroenterostomy plus diverting enteroenterostomy between the afferent and
efferent loops or Roux-en-Y anastomosis. [23] Total bile acid levels in the gastric pouch were
2080. 1 μg/mL in patients who had undergone loop gastroenterostomy alone compared with
165.0 μg/mL in patients who had undergone Roux-en-Y anastomosis. Gastritis by endoscopy
was only 13% in Roux-en-Y group compared to 71% in loop gastroenterostomy group. In 2007
Johnson WH et al concluded that MGB does require revision in some patients (because of leak,
bile reflux, intractable marginal ulcer, mal-absorption/malnutrition, weight gain etc.) and that
conversion to RYGB is a common form of revision. [24]
The never-ending search of a more physiological and less complex surgery has led surgeons
to develop novel procedures. “Laparoscopic Loop Duodenojejunal Bypass with Sleeve
Gastrectomy (LDJB-SG)” [25] was first invented and described by Chih-Kun Huang since
October 2011, which was reported in 2013. The pyloric preserving mechanism could decrease
the incidence of dumping syndrome. Also, the mixture of alkaline bile and pancreatic enzyme
with gastric acid around anastomosis also decrease the incidence of marginal ulcer. The acid
and intrinsic factor secretion would be maintained. Thus, iron, vitamin and protein deficiency
should be less because some part of antrumis preserved. Moreover, one anastomosis and only
Petersen’s defect may help in decreasing the chances of anastomotic leakage and internal
hernia as compared to RYGB and BPD-DS. It also eliminates the chances of gastro-gastric fistula
with sometimes complicates LRYGB. And less bypassed bowel (200-300 cm) would improve
the malnutrition part as compared to BPD-DS.
2. Mechanism of action
LDJB-SG works by combining restriction of food (Sleeve Gastrectomy) with bypassing
duodenum and proximal jejunum. This procedure predominantly owned the part of duode‐
nojejunal bypass for glycemic control based on the foregut hypothesis. And sleeve gastrectomy
is incorporated into this to eliminate the ghrelin effect to make sufficient weight loss and
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reversal of insulin resistance. The rapid gastric emptying ensures swifter nutrient delivery to
the hindgut with secretion of incretins like GLP-1 which are responsible for augmenting satiety
and improving pancreatic function.
Restriction: It is achieved by performing sleeve gastrectomy along a 38 Fr orogastric tube.
Bypass: 200-300 cm of duodenum and proximal jejunum is bypassed.
Special features:
• Single loop duodenojejunal anastomosis other than Roux-en-Y anastomosis could prevent
more possibility of anastomotic stricture or leakage.
• Only Peterson defect to decrease the chances of internal hernia.
• Pyloric preservation to avoid dumping syndrome.
• Mixture of alkaline bile and pancreatic enzyme with gastric acid around anastomosis to
decrease the incidence of marginal ulcer.
• Less chances of hypo-proteinemia, vitamins deficiency and diarrhoea as compared to BPD-
DS which has only 75-100 cm of common limb.
• Easy post-operative endoscopic surveillance of remnant stomach.
2.1. Indications of the procedure
• Body mass index (BMI) ≧ 35 with co-morbidities or BMI ≧ 40
• BMI ≧ 27. 5with poorly controlled Type 2 Diabetes Mellitus (HbA1c >7)




• Severe gastro-esophageal reflux disease
• Chronic duodenal ulcer
2.3. The procedure
a. Preoperative Considerations
The preoperative examination does not differ from other bariatric procedures. The patients
are admitted one day before surgery to maintain stable glucose level less than 200mg/dL by
insulin infusion if necessary, and keep patients on clear liquid diet one day before surgery.
One dose antibiotics (cephalosporin) and 40 mg pantoprazole is given half an hour before
surgery. Antithrombotic devise and low molecular weight heparin are prescribed to avoid
deep vein thrombosis and thrombo-embolic events.
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• Positioning: Patient is laid supine on the table (Figure 1). Surgeon stands on the right side of
the patient. Cameraman and first assistant stand on the left of the patient.
Figure 1. OT Setup
• Port-positions: 5 ports technique to access the abdominal cavity as shown in figure 2.
Figure 2. Port Placement
• Liver retraction: The liver could be retracted by Nathanson liver retractor or T-shape liver
suspension tapes in order to achieve good exposure of both stomach and duodenal area.
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• Sleeve Gastrectomy: The first step involves devascularisation of greater curvature of stomach,
4 cm from the pylorus till the left crus of diaphragm, using an energy source like LigaSure
vessel sealing (Covidien, USA), sealing the gastric branches of gastroepiploic vessels and
short gastric vessels. Sleeve gastrectomyis then performed using 38 Fr orogastric tube as a
stent with sequential firing of Endo GIATM 60 mm articulating medium/thick Reload with
Tri-StapleTM (Covidien, USA) (Figure 3). Black reloads are used for the first two firings while
purple reloads are used for the subsequent firings toward the gastric fundus.
Figure 3. Loop Duodenojejunal Bypass with sleeve gastrectomy
• Duodenal transaction: After ensuring haemostasis, a stay suture is placed at the distal end of
stomach tube for counter-traction and better visualization of the first part of the duodenum.
A tunnel is created posterior to the first part of duodenum 2 cm distal to pylorus using
Goldfinger (Ethicon Endo Surgery USA). A tape is passed and lifted cranially and laterally
for traction so as to aid in insertion of the stapler. The first part of the duodenumis trans‐
ected2cm distal to the pylorus with Endo GIATM 45 mm Curved Tip Articulating Vascular/
Medium Reload with Tri-StapleTM (Covidien, USA) and take care not to injure common bile
duct, pancreas and major vessels in the area. Routine over-sewing of the distal duodenal
stump is not necessary.
• Duodeno-jejunostomy: Jejunum is measured for 200-300 cm from the ligament of Treitz. A 1.
5 cm enterotomy is created in jejunum and the first part of duodenum. Iso-peristaltic totally
hand-sewn side to side anastomosis is then performed using 3/0 absorbable suture. The air
leak test is performed to check the anastomosis. After the anastomosis, we place an antitor‐
sion suture between the antrum and upper jejunum, 4 cm proximal to the duodenojejunos‐
tomy.




• Positioning: Patient is laid supine on the table (Figure 1). Surgeon stands on the right side of
the patient. Cameraman and first assistant stand on the left of the patient.
Figure 1. OT Setup
• Port-positions: 5 ports technique to access the abdominal cavity as shown in figure 2.
Figure 2. Port Placement
• Liver retraction: The liver could be retracted by Nathanson liver retractor or T-shape liver
suspension tapes in order to achieve good exposure of both stomach and duodenal area.
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• Sleeve Gastrectomy: The first step involves devascularisation of greater curvature of stomach,
4 cm from the pylorus till the left crus of diaphragm, using an energy source like LigaSure
vessel sealing (Covidien, USA), sealing the gastric branches of gastroepiploic vessels and
short gastric vessels. Sleeve gastrectomyis then performed using 38 Fr orogastric tube as a
stent with sequential firing of Endo GIATM 60 mm articulating medium/thick Reload with
Tri-StapleTM (Covidien, USA) (Figure 3). Black reloads are used for the first two firings while
purple reloads are used for the subsequent firings toward the gastric fundus.
Figure 3. Loop Duodenojejunal Bypass with sleeve gastrectomy
• Duodenal transaction: After ensuring haemostasis, a stay suture is placed at the distal end of
stomach tube for counter-traction and better visualization of the first part of the duodenum.
A tunnel is created posterior to the first part of duodenum 2 cm distal to pylorus using
Goldfinger (Ethicon Endo Surgery USA). A tape is passed and lifted cranially and laterally
for traction so as to aid in insertion of the stapler. The first part of the duodenumis trans‐
ected2cm distal to the pylorus with Endo GIATM 45 mm Curved Tip Articulating Vascular/
Medium Reload with Tri-StapleTM (Covidien, USA) and take care not to injure common bile
duct, pancreas and major vessels in the area. Routine over-sewing of the distal duodenal
stump is not necessary.
• Duodeno-jejunostomy: Jejunum is measured for 200-300 cm from the ligament of Treitz. A 1.
5 cm enterotomy is created in jejunum and the first part of duodenum. Iso-peristaltic totally
hand-sewn side to side anastomosis is then performed using 3/0 absorbable suture. The air
leak test is performed to check the anastomosis. After the anastomosis, we place an antitor‐
sion suture between the antrum and upper jejunum, 4 cm proximal to the duodenojejunos‐
tomy.
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• Mesenteric defect closure and drainage: Peterson’s defect is repaired with a continuous non-
absorbable suture. Jackson-Pratt drain is placed behind the duodeno-jejunal anastomosis
reaching up to the sleeve to complete the procedure.
2.4. Post-operative care
A postoperative antibiotic (Cephalosporin) is given for one day. Deep-breathing exercises,
early mobilization and adequate pain control administration are given in order to avoid
postoperative pulmonary complications. A clear-liquid diet is started once the patient is fully
conscious. The patients are discharged once they can tolerate oral fluid well, which is usually
by postoperative day 2-3. Pantoprazole 40 mg is given for 30 days daily after discharge. Patients
are scheduled for follow-up in the outpatient clinic 1 week after the discharge. They are
advanced to take soft diet by the third week and solid diet intake after 1 month. Subsequent
routine follow-ups are done at 1, 3, 6, 9 and 12 months after surgery. Thereafter, patients are
advised to visit hospital every 6 months.
3. Complications
Bleeding: This usually happens from the long staple line of sleeve gastrectomy or divided
mesentery, but mostly could be managed conservatively. Re-laparoscopy is indicated if the
patient presents as persistent drop in hematocrit despite blood transfusion or shock.
Leak: Leakage of sleeve gastrectomy mostly occurs near the upper end of staple line which
could be treated initially by stent placement endoscopically and drainage of abscess. And if
leakage occurs in anastomosis of duodeno-jejunosotomy, conversion to Roux-en-Y gastric
bypass with removal of distal stomach and first part of duodenum would be a rescue proce‐
dure.
Stricture: Stricture of sleeve gastrectomy could be managed by endoscopic stent or balloon
dilatation, laparoscopic stricturoplasty or conversion to Roux-en-Y gastric bypass.
Internal Hernia: Even we routinely repair Peterson defect during the procedure, but internal
hernia is still a possibility to happen. Suspicion should be made when patient presented as
intermittent cramping upper abdominal pain or acute/chronic intestinal obstruction. Abdomi‐
nal CT Scan is mandatory in diagnosis and laparoscopic exploration would be necessary when
definite diagnosis is obscure.
4. Micronutrient supplementation after this procedure
We recommended taking two multivitamin tablets each containing B1, B12, folate, iron and
vitamin D in a dose of 1.1 mg, 2.4 microgram, 400 microgram, 10-15 mg and 10 microgram
respectively and 2000 mg of calcium citrate in two divided doses.
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4.1. Surgical results
To compare the safety and diabetic remission and metabolic results after LDJB-SG and RYGB
in patients with BMI < 35 kg/m2, we did a prospective non-randomized study starting from
July 2006 to March 2012 in Bariatric & Metabolic International Surgery Centre, E-Da Hospital,
Taiwan (Table 1). A total of 109 patients were involved with a follow-up period of at least one
year. 89 patients underwent Laparoscopic RYGB and 20 underwent Laparoscopic LDJB-SG.
Mean age (50.0 ± 8.6 years in LDJB-SG group vs. 50.0 ± 10.6 in RYGB group), BMI (27.9 ± 3.0
vs. 28.9 ± 3.8 kg/m2), FPG (126.0 ± 37.8 vs. 168.0 ± 68.9 mg/dl), HbA1c (7.5 ± 1.8 vs. 9.0 ± 1.9), c-
peptide (2.1 ± 1.0 vs. 2.2 ± 1.6ng/ml), and duration of diabetes (78.0 ± 65.5 vs. 84.0 ± 70.1 months)
were similar in two groups. Fasting plasma glucose (FPG=126.0 ± 37.8 vs 168.0 ± 68.9 mg/dl)
and HbA1c (7.5 ± 1.8 vs. 9.0 ± 1.9 %) were significantly higher in LRYGB group though.
Operative time (119.0 ± 46.9 vs. 73.0 ± 51.3 minutes) and length of stay in the hospital (3.0 ± 1.3
vs. 2.0 ± 2.4 days) were significantly higher in LDJB-SG group.
Parameters LDJB-SG group LRYGB group P value
Gender (M/F) 13/7 54/35 0.719
Age (y) 50.0 ± 8.6 50.0 ± 10.6 0.745
BMI (kg/m2) 27.9 ± 3.0 28.9 ± 3.8 0.121
FPG (mg/dl) 126.0 ± 37.8 168.0 ± 68.9 0.002
HbA1c (%) 7.5 ± 1.8 9.0 ± 1.9 0.004
C-peptide (ng/ml) 2.1 ± 1.0 2.2 ± 1.6 0.270
TG (mg/dl) 158.0 ± 182.1 166.0 ± 115.6 0.585
CHO (mg/dl) 182.5 ± 35.6 202.0 ± 193.0 0.039
HDL (mg/dl) 46.0 ± 12.8 45.0 ± 9.8 0.993
LDL (mg/dl) 106.5 ± 245.2 110.0 ± 35.7 0.267
AST (U/L) 35.0 ± 15.5 30.0 ± 38.5 0.666
ALT (U/L) 33.0 ± 29.5 34.0 ± 64.8 0.663
Family history DM (N;%) 12;60% 65;73% 0.247
Duration of DM (month) 78.0 ± 65.5 84.0 ± 70.1 0.064
Operation time (min) 119.0 ± 46.9 73.0 ± 51.3 0.000
LOS (day) 3.0 ± 1.3 2.0 ± 2.4 0.000
BMI: Body Mass Index; FPG: Fasting Plasma Glucose; CHO: Cholesterol; TG: Triglyceride; LOS: Length of Stay
Table 1. Comparison of clinical and biochemical characteristics at baseline between the patients underwent LDJB-SG
and RYGB
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• Mesenteric defect closure and drainage: Peterson’s defect is repaired with a continuous non-
absorbable suture. Jackson-Pratt drain is placed behind the duodeno-jejunal anastomosis
reaching up to the sleeve to complete the procedure.
2.4. Post-operative care
A postoperative antibiotic (Cephalosporin) is given for one day. Deep-breathing exercises,
early mobilization and adequate pain control administration are given in order to avoid
postoperative pulmonary complications. A clear-liquid diet is started once the patient is fully
conscious. The patients are discharged once they can tolerate oral fluid well, which is usually
by postoperative day 2-3. Pantoprazole 40 mg is given for 30 days daily after discharge. Patients
are scheduled for follow-up in the outpatient clinic 1 week after the discharge. They are
advanced to take soft diet by the third week and solid diet intake after 1 month. Subsequent
routine follow-ups are done at 1, 3, 6, 9 and 12 months after surgery. Thereafter, patients are
advised to visit hospital every 6 months.
3. Complications
Bleeding: This usually happens from the long staple line of sleeve gastrectomy or divided
mesentery, but mostly could be managed conservatively. Re-laparoscopy is indicated if the
patient presents as persistent drop in hematocrit despite blood transfusion or shock.
Leak: Leakage of sleeve gastrectomy mostly occurs near the upper end of staple line which
could be treated initially by stent placement endoscopically and drainage of abscess. And if
leakage occurs in anastomosis of duodeno-jejunosotomy, conversion to Roux-en-Y gastric
bypass with removal of distal stomach and first part of duodenum would be a rescue proce‐
dure.
Stricture: Stricture of sleeve gastrectomy could be managed by endoscopic stent or balloon
dilatation, laparoscopic stricturoplasty or conversion to Roux-en-Y gastric bypass.
Internal Hernia: Even we routinely repair Peterson defect during the procedure, but internal
hernia is still a possibility to happen. Suspicion should be made when patient presented as
intermittent cramping upper abdominal pain or acute/chronic intestinal obstruction. Abdomi‐
nal CT Scan is mandatory in diagnosis and laparoscopic exploration would be necessary when
definite diagnosis is obscure.
4. Micronutrient supplementation after this procedure
We recommended taking two multivitamin tablets each containing B1, B12, folate, iron and
vitamin D in a dose of 1.1 mg, 2.4 microgram, 400 microgram, 10-15 mg and 10 microgram
respectively and 2000 mg of calcium citrate in two divided doses.
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4.1. Surgical results
To compare the safety and diabetic remission and metabolic results after LDJB-SG and RYGB
in patients with BMI < 35 kg/m2, we did a prospective non-randomized study starting from
July 2006 to March 2012 in Bariatric & Metabolic International Surgery Centre, E-Da Hospital,
Taiwan (Table 1). A total of 109 patients were involved with a follow-up period of at least one
year. 89 patients underwent Laparoscopic RYGB and 20 underwent Laparoscopic LDJB-SG.
Mean age (50.0 ± 8.6 years in LDJB-SG group vs. 50.0 ± 10.6 in RYGB group), BMI (27.9 ± 3.0
vs. 28.9 ± 3.8 kg/m2), FPG (126.0 ± 37.8 vs. 168.0 ± 68.9 mg/dl), HbA1c (7.5 ± 1.8 vs. 9.0 ± 1.9), c-
peptide (2.1 ± 1.0 vs. 2.2 ± 1.6ng/ml), and duration of diabetes (78.0 ± 65.5 vs. 84.0 ± 70.1 months)
were similar in two groups. Fasting plasma glucose (FPG=126.0 ± 37.8 vs 168.0 ± 68.9 mg/dl)
and HbA1c (7.5 ± 1.8 vs. 9.0 ± 1.9 %) were significantly higher in LRYGB group though.
Operative time (119.0 ± 46.9 vs. 73.0 ± 51.3 minutes) and length of stay in the hospital (3.0 ± 1.3
vs. 2.0 ± 2.4 days) were significantly higher in LDJB-SG group.
Parameters LDJB-SG group LRYGB group P value
Gender (M/F) 13/7 54/35 0.719
Age (y) 50.0 ± 8.6 50.0 ± 10.6 0.745
BMI (kg/m2) 27.9 ± 3.0 28.9 ± 3.8 0.121
FPG (mg/dl) 126.0 ± 37.8 168.0 ± 68.9 0.002
HbA1c (%) 7.5 ± 1.8 9.0 ± 1.9 0.004
C-peptide (ng/ml) 2.1 ± 1.0 2.2 ± 1.6 0.270
TG (mg/dl) 158.0 ± 182.1 166.0 ± 115.6 0.585
CHO (mg/dl) 182.5 ± 35.6 202.0 ± 193.0 0.039
HDL (mg/dl) 46.0 ± 12.8 45.0 ± 9.8 0.993
LDL (mg/dl) 106.5 ± 245.2 110.0 ± 35.7 0.267
AST (U/L) 35.0 ± 15.5 30.0 ± 38.5 0.666
ALT (U/L) 33.0 ± 29.5 34.0 ± 64.8 0.663
Family history DM (N;%) 12;60% 65;73% 0.247
Duration of DM (month) 78.0 ± 65.5 84.0 ± 70.1 0.064
Operation time (min) 119.0 ± 46.9 73.0 ± 51.3 0.000
LOS (day) 3.0 ± 1.3 2.0 ± 2.4 0.000
BMI: Body Mass Index; FPG: Fasting Plasma Glucose; CHO: Cholesterol; TG: Triglyceride; LOS: Length of Stay
Table 1. Comparison of clinical and biochemical characteristics at baseline between the patients underwent LDJB-SG
and RYGB
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At one year after surgery, there was no significant difference in BMI (22.5 ± 2.4 in LDJB-SG vs.
21.0 ± 2.7 LRYGB group), HbA1c (6.0 ± 0.9 vs. 6.3 ± 1.2) or c-peptide (1.4 ± 0.5 vs. 1.3 ± 1.5
ng/ml) but FPG was significantly lower (98.0 ± 18.0 vs. 106.0 ± 31.7 mg/dl) in LDJB-SG group
(Table 2). There were 17 late complications seen in LRYGB group vs nil in LDJB-SG group
during first one year after surgery (Table 3). LDJB-SG had higher remission rate (60% vs. 40%)
of diabetes and also better glycemic control (90% vs. 71%) as compared to RYGB (Figure 4).
Parameters LDJB-SG group RYGB group P value
BMI (kg/m2) 22.5 ± 2.4 21.0 ± 2.7 0.234
FPG (mg/dl) 98.0 ± 18.0 106.0 ± 31.7 0.048
HbA1c (%) 6.0 ± 0.9 6.3 ± 1.2 0.442
C-peptide (ng/ml) 1.4 ± 0.5 1.3 ± 1.5 0.881
TG (mg/dl) 119.0 ± 81.4 84.0 ± 46.3 0.257
CHO (mg/dl) 180.5 ± 33.7 173.0 ± 39.4 0.339
HDL (mg/dl) 49.5 ± 12.2 52.0 ± 13.7 0.540
LDL (mg/dl) 99.0 ± 20.3 85.0 ± 27.8 0.503
AST (U/L) 24.0 ± 12.1 30.0 ± 38.5 0.157
ALT (U/L) 26.5 ± 21.6 34.0 ± 64.8 0.062
BMI: Body Mass Index; FPG: Fasting Plasma Glucose; CHO: Cholesterol; TG:Triglyceride
Table 2. Comparison of clinical and biochemical characteristics at 1 year between the patients underwent LDJB-SG and
RYGB.
LDJB-SG group (20) RYGB group (89)








T2DM: Type II Diabetes Mellitus
Table 3. Operative outcomes of LDJB-SG and RYGB.
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Figure 4. Effect of LRYGB on T2DM
This study concluded that LDJB-SG has higher remission rate and better glycemic control as
compared to RYGB in patient with BMI < 35kg/m2.
5. Conclusion
LDJB-SG is a novel metabolic surgery, with single anastomosis and mesenteric defect aimed
at achieving less mal-absorption, decreased gastrointestinal complications, adequate weight
loss and good remission of T2DM. From the preliminary results of weight loss and glycemic
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Figure 4. Effect of LRYGB on T2DM
This study concluded that LDJB-SG has higher remission rate and better glycemic control as
compared to RYGB in patient with BMI < 35kg/m2.
5. Conclusion
LDJB-SG is a novel metabolic surgery, with single anastomosis and mesenteric defect aimed
at achieving less mal-absorption, decreased gastrointestinal complications, adequate weight
loss and good remission of T2DM. From the preliminary results of weight loss and glycemic
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controls, this novel procedure will not only become an important surgical procedure of treating
type II D.M in the near future, but also in treating morbid obesity.
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